
<html lang="en"     class="pb-page"  data-request-id="1deedb2b-0b0c-4d2a-8d70-644d869d9d36"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm3005866"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer" /></meta><meta name="dc.Creator" content="Richard T.  Lewis" /></meta><meta name="dc.Creator" content="Christiane M.  Bode" /></meta><meta name="dc.Creator" content="Deborah M.  Choquette" /></meta><meta name="dc.Creator" content="Michele  Potashman" /></meta><meta name="dc.Creator" content="Karina  Romero" /></meta><meta name="dc.Creator" content="John C.  Stellwagen" /></meta><meta name="dc.Creator" content="Yohannes  Teffera" /></meta><meta name="dc.Creator" content="Earl  Moore" /></meta><meta name="dc.Creator" content="Douglas A.  Whittington" /></meta><meta name="dc.Creator" content="Hao  Chen" /></meta><meta name="dc.Creator" content="Linda F.  Epstein" /></meta><meta name="dc.Creator" content="Renee  Emkey" /></meta><meta name="dc.Creator" content="Paul S.  Andrews" /></meta><meta name="dc.Creator" content="Violeta L.  Yu" /></meta><meta name="dc.Creator" content="Douglas C.  Saffran" /></meta><meta name="dc.Creator" content="Man  Xu" /></meta><meta name="dc.Creator" content="Allison  Drew" /></meta><meta name="dc.Creator" content="Patricia  Merkel" /></meta><meta name="dc.Creator" content="Steven  Szilvassy" /></meta><meta name="dc.Creator" content="Rachael L.  Brake" /></meta><meta name="dc.Description" content="A class of 2-acyliminobenzimidazoles has been developed as potent and selective inhibitors of anaplastic lymphoma kinase (ALK). Structure based design facilitated the rapid development of structure..." /></meta><meta name="Description" content="A class of 2-acyliminobenzimidazoles has been developed as potent and selective inhibitors of anaplastic lymphoma kinase (ALK). Structure based design facilitated the rapid development of structure..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 10, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3005866" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3005866" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3005866" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3005866" /></link>
        
    
    

<title>The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3005866" /></meta><meta property="og:title" content="The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0013.jpeg" /></meta><meta property="og:description" content="A class of 2-acyliminobenzimidazoles has been developed as potent and selective inhibitors of anaplastic lymphoma kinase (ALK). Structure based design facilitated the rapid development of structure–activity relationships (SAR) and the optimization of kinase selectivity. Introduction of an optimally placed polar substituent was key to solving issues of metabolic stability and led to the development of potent, selective, orally bioavailable ALK inhibitors. Compound 49 achieved substantial tumor regression in an NPM-ALK driven murine tumor xenograft model when dosed qd. Compounds 36 and 49 show favorable potency and PK characteristics in preclinical species indicative of suitability for further development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3005866"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3005866">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3005866&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3005866&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3005866&amp;href=/doi/10.1021/jm3005866" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6523-6540</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300575y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300599x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+T.++Lewis">Richard T. Lewis</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christiane+M.++Bode">Christiane M. Bode</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah+M.++Choquette">Deborah M. Choquette</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michele++Potashman">Michele Potashman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karina++Romero">Karina Romero</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+C.++Stellwagen">John C. Stellwagen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yohannes++Teffera">Yohannes Teffera</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Earl++Moore">Earl Moore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+A.++Whittington">Douglas A. Whittington</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hao++Chen">Hao Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Linda+F.++Epstein">Linda F. Epstein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Renee++Emkey">Renee Emkey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+S.++Andrews">Paul S. Andrews</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Violeta+L.++Yu">Violeta L. Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+C.++Saffran">Douglas C. Saffran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Man++Xu">Man Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allison++Drew">Allison Drew</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patricia++Merkel">Patricia Merkel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Szilvassy">Steven Szilvassy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rachael+L.++Brake">Rachael L. Brake</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-444-5232. Fax: 617-577-9511. E-mail: <a href="/cdn-cgi/l/email-protection#20524943484152440e4c4557495360414d47454e0e434f4d"><span class="__cf_email__" data-cfemail="a6d4cfc5cec7d4c288cac3d1cfd5e6c7cbc1c3c888c5c9cb">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3005866&amp;href=/doi/10.1021%2Fjm3005866" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6523–6540</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 26, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 April 2012</li><li><span class="item_label"><b>Published</b> online</span>10 July 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 July 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3005866" title="DOI URL">https://doi.org/10.1021/jm3005866</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6523%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRichard%2BT.%2BLewis%252C%2BChristiane%2BM.%2BBode%252C%2BDeborah%2BM.%2BChoquette%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D14%26contentID%3Djm3005866%26title%3DThe%2BDiscovery%2Band%2BOptimization%2Bof%2Ba%2BNovel%2BClass%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BAnaplastic%2BLymphoma%2BKinase%2B%2528ALK%2529%2BInhibitors%2Bwith%2BPotential%2BUtility%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6540%26publicationDate%3DJuly%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3005866"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3674</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3005866" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;T. Lewis&quot;},{&quot;first_name&quot;:&quot;Christiane&quot;,&quot;last_name&quot;:&quot;M. Bode&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;M. Choquette&quot;},{&quot;first_name&quot;:&quot;Michele&quot;,&quot;last_name&quot;:&quot;Potashman&quot;},{&quot;first_name&quot;:&quot;Karina&quot;,&quot;last_name&quot;:&quot;Romero&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;C. Stellwagen&quot;},{&quot;first_name&quot;:&quot;Yohannes&quot;,&quot;last_name&quot;:&quot;Teffera&quot;},{&quot;first_name&quot;:&quot;Earl&quot;,&quot;last_name&quot;:&quot;Moore&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;A. Whittington&quot;},{&quot;first_name&quot;:&quot;Hao&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Linda&quot;,&quot;last_name&quot;:&quot;F. Epstein&quot;},{&quot;first_name&quot;:&quot;Renee&quot;,&quot;last_name&quot;:&quot;Emkey&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;S. Andrews&quot;},{&quot;first_name&quot;:&quot;Violeta&quot;,&quot;last_name&quot;:&quot;L. Yu&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;C. Saffran&quot;},{&quot;first_name&quot;:&quot;Man&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Allison&quot;,&quot;last_name&quot;:&quot;Drew&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;Merkel&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Szilvassy&quot;},{&quot;first_name&quot;:&quot;Rachael&quot;,&quot;last_name&quot;:&quot;L. Brake&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;6523-6540&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3005866&quot;},&quot;abstract&quot;:&quot;A class of 2-acyliminobenzimidazoles has been developed as potent and selective inhibitors of anaplastic lymphoma kinase (ALK). Structure based design facilitated the rapid development of structure–activity relationships (SAR) and the optimization of kinase selectivity. Introduction of an optimally placed polar substituent was key to solving issues of metabolic stability and led to the development of potent, selective, orally bioavailable ALK inhibitors. Compound 49 achieved substantial tumor regression in an NPM-ALK driven murine tumor xenograft model when dosed qd. Compounds 36 and 49 show favorable potency and PK characteristics in preclinical species indicative of suitability for further development.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3005866&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3005866" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3005866&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3005866" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3005866&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3005866" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3005866&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3005866&amp;href=/doi/10.1021/jm3005866" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3005866" /></input><a href="/doi/pdf/10.1021/jm3005866" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3005866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3005866%26sid%3Dliteratum%253Aachs%26pmid%3D22734674%26genre%3Darticle%26aulast%3DLewis%26date%3D2012%26atitle%3DThe%2BDiscovery%2Band%2BOptimization%2Bof%2Ba%2BNovel%2BClass%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BAnaplastic%2BLymphoma%2BKinase%2B%2528ALK%2529%2BInhibitors%2Bwith%2BPotential%2BUtility%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D14%26spage%3D6523%26epage%3D6540%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jmcmar.2012.55.issue-14/production/jmcmar.2012.55.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A class of 2-acyliminobenzimidazoles has been developed as potent and selective inhibitors of anaplastic lymphoma kinase (ALK). Structure based design facilitated the rapid development of structure–activity relationships (SAR) and the optimization of kinase selectivity. Introduction of an optimally placed polar substituent was key to solving issues of metabolic stability and led to the development of potent, selective, orally bioavailable ALK inhibitors. Compound <b>49</b> achieved substantial tumor regression in an NPM-ALK driven murine tumor xenograft model when dosed qd. Compounds <b>36</b> and <b>49</b> show favorable potency and PK characteristics in preclinical species indicative of suitability for further development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase classified as belonging to the insulin receptor superfamily. Expressed at high levels prenatally, it is thought to play an important role in the development of the central nervous system. However, its expression is dramatically decreased in healthy adult tissues. Aberrant expression of full-length ALK occurs in neuroblastoma and is associated with increased gene copy number or activating point mutations.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Furthermore, chromosomal translocation or inversion of the ALK gene can lead to the generation of novel fusion-ALK proteins that possess constitutive kinase activity and contribute to oncogenic processes. The best validated of these include an ALK fusion protein with nucleophosmin (NPM-ALK), which has been characterized in a subset of anaplastic large-cell lymphomas<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and an alternate gene splicing event pairing the ALK kinase domain with echinoderm microtubule-associated protein-like 4 (EML4-ALK), which provides the driving oncogene in a subset of nonsmall cell lung carcinomas (NSCLC).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> A potent and selective inhibitor of the ALK kinase domain would have potential therapeutic utility in a range of cancers. Compound <b>3</b>, PF-02341066, now known as Crizotinib, afforded the first clinical validation of EML4-ALK as an oncology target and is now FDA approved as a first-line treatment for this patient population.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Reports of developing resistance to crizotinib have provided added impetus to seek significantly more potent molecules with potential to treat refractory patients.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Identification of an ALK inhibitor with significant selectivity over the majority of the known kinome would be very desirable in order to capitalize on a key characteristic of ALK, namely a therapeutic target functionally expressed in a subset of cancers, which is seldom expressed in healthy adult tissue. In pursuit of this goal, enzymatic activity was routinely monitored against related tyrosine kinase family members SRC kinase, insulin-like growth factor receptor 1 (IGF1R), and the janus kinase (JAK) family<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> during the triage of hits from high-throughput screening (HTS) to identify selective leads and also in the subsequent lead optimization phase described herein. Selectivity ratios with respect to ALK enzyme potency are used in this account of the work; the IC<sub>50</sub> values against these off-target enzymes are reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information (Table S3)">Supporting Information (Table S3)</a>. IGF1R was used as a convenient enzymatic surrogate for the insulin receptor (INSR), against which a 100-fold selectivity margin was sought. Inhibition of ALK phosphorylation, measured by monitoring inhibition of ALK phosphorylation at Tyr1604 in a whole cell context (pALK cell), was used to assess cellular potency and was the principal driver of SAR. A functional cellular assay assessing the ability of compound to inhibit the in vitro proliferation of an NPM-ALK-driven cell line (Karpas-299) was also utilized.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Excellent correlation between compound potency as measured in the pALK cellular biochemical assay and the in vitro functional proliferation assay was observed. Consequently, the pALK cellular biochemical readout proved a reliable means to select at an early point in the screening cascade those compounds possessing good cellular penetration and hence of identifying compounds with a greater probability of achieving superior in vivo potency.</div><div class="NLM_p">X-ray quality crystals of the ALK kinase domain were obtained at an early stage of this program; the detailed structural information from ligand–protein cocrystal structures proved to be invaluable for structure based design, particularly in addressing kinase selectivity issues (vide infra).</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0014.gif" alt="" id="fx1" /></img><div class="NLM_p">Two representative members <b>1</b> and <b>2</b> of a structural class of hits that emerged from an HTS screen of the Amgen compound library were intriguing. The 2-acyliminobenzimidazole kinase hinge-binding motif is not widely represented in the kinase literature.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Selected data for compounds <b>1</b> and <b>2</b> is presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. These leads possessed significant selectivity with respect to c-Met in comparison with <b>3</b>, which is reported to have 2 nM affinity for c-Met enzyme and to have an ALK cellular potency of 20 nM.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Understanding the reason for the difference in JAK kinase selectivity between <b>1</b> and <b>2</b> was of significant interest; X-ray crystal structures of both compounds bound in the ALK kinase domain were obtained (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> These compounds interact with the hinge region of ALK by making hydrogen bonds to Met1199 of the linker using the benzoyl carbonyl oxygen atom and a benzimidazole ring NH resulting from adoption of the exocyclic acyliminium tautomer.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The benzoyl ring sits adjacent to gatekeeper residue Leu1196. An overlay of their structures is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. It appears that by very different means each molecule contrives to place a predominantly lipophilic moiety in a pocket in the enzyme defined by Leu1256, Gly1269 (the X-DFG residue at the start of the activation loop), and the backbone atoms of Arg1253/Asn1254. The sulfonamide moiety of <b>1</b> sits just below catalytic Lys1150 (but does not hydrogen bond to it). The sulfonamide NH forms a hydrogen bond with the backbone carbonyl of Gly1269, with the allyl appendage occupying the remainder of the lipophilic pocket; a water mediated H-bond network between the cyclohexylmethanol substituent (accommodated in the ribose binding pocket) and sulfonyl carbonyl appears to stabilize the ligand in its preferred binding conformation. Compound <b>2</b> does not engage with Gly1269, but the <i>cis</i>-1,4-disposition of the cyclohexyl carboxylate substitution pattern allows the methyl ester moiety to project into this region of the protein (which is also occupied by the fluoro-substituent of <b>3</b><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a>). The crystallographic data clearly indicated that a larger substituent would more effectively engage with this pocket.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Different orientations of the “water solubilizing” piperidine side chains are adopted by <b>1</b> and <b>2</b>. The piperidine moiety in <b>2</b> allowed it to reach up and apparently engage in van der Waals interactions with two backbone carbonyls on the N-terminal lobe (Gly1121, Leu1122) in a shallow pocket on the surface of the protein at the entrance to the ATP binding pocket. For compound <b>1</b>, the pendant piperidine ring points out toward residues in the C-terminal lobe (Gly1201, Glu1202, Pro 1260); its electron density was poorly defined in the crystallographic data set, indicating disorder and a lack of a distinctly preferred binding mode for this moiety.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Selected Data<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> for Screening Hit Compounds <b>1</b> and <b>2</b> in Amgen In-House Assays</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">ALK enz IC<sub>50</sub> μM <br /></br>(±SD)</th><th class="colsep0 rowsep0" align="center">c-Met enz IC<sub>50</sub> μM</th><th class="colsep0 rowsep0" align="center">JAK2 enz selectivity <br /></br>(fold)</th><th class="colsep0 rowsep0" align="center">SRC enz selectivity <br /></br>(fold)</th><th class="colsep0 rowsep0" align="center">IGF1R enz selectivity <br /></br>(fold)</th><th class="colsep0 rowsep0" align="center">pALK cell IC<sub>50</sub> μM <br /></br>(±SD)</th><th class="colsep0 rowsep0" align="center">liver microsomes Cl<sub>int</sub>μL/min/mg<br /></br>rat/human</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.005 (±0.002)</td><td class="colsep0 rowsep0" align="left">5.92</td><td class="colsep0 rowsep0" align="center">0.4</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="center">60</td><td class="colsep0 rowsep0" align="left">0.048 (±0.020)</td><td class="colsep0 rowsep0" align="left">314/100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0.003 (±0.001)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">64</td><td class="colsep0 rowsep0" align="center">103</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="left">0.054 (±0.017)</td><td class="colsep0 rowsep0" align="left">459/85</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Not determined for compound <b>2</b>; for ethyl ester analogue <b>14</b> c-Met IC<sub>50</sub> 5.12 μM.</p></div></div></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overlay of cocrystal structures of <b>1</b> (purple) and <b>2</b> (green) in the ATP binding pocket of the ALK kinase domain. Dashed lines indicate hydrogen bonds and the red sphere denotes an ordered water molecule associated with <b>1</b>. PDB codes: <b>1</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOB">4FOB</a>; <b>2</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOC">4FOC</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While we did not obtain crystal structures of <b>1</b> and <b>2</b> bound to JAK2, existing JAK2 cocrystal structures permitted modeling of compounds <b>1</b> and <b>2</b> in the active site and hence development of a hypothesis for the difference in selectivity between these two potent ALK inhibitors with regard to JAK2.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, it is notable that the ATP binding pocket of JAK2 appears to be somewhat shorter in length and narrower in width by comparison with that of ALK. Compound <b>2</b> appears unable to adopt a conformation of the cyclohexyl linkage capable of projecting the ester side chain into the corresponding affinity pocket of JAK2 due to a steric clash of the cyclohexyl linkage with residues Leu855 and Gly856 of the narrower ATP binding cavity of JAK2 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, right panel). This may explain a significant loss in binding affinity against JAK2 vs ALK<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> for compound <b>2</b>. The flexible sulfonamide side chain of <b>1</b> appears able to negotiate the confines of the JAK2 protein and may reside in a very similar binding mode to that which it adopts in ALK, consistent with the similar affinity for both proteins. Presumably the loss of the water bridged-hydrogen bond between the alcohol and sulfonamide functionalities is compensated by other means, allowing the cyclohexane moiety to rotate to alleviate the steric clash without incurring a major impact on the JAK2 binding energy. By virtue of the shorter cavity in JAK2 vs ALK, the surface interaction between the protein and the piperidine side chain of <b>2</b> is also potentially disrupted; it is unclear whether this contributes to the 2 orders of magnitude selectivity observed. With significant enzymatic potency, adequate cellular potency (10× enzyme-cell shift) and a working hypothesis for the understanding of the selectivity determinants based on crystallographic data, <b>2</b> represented an attractive starting point for lead optimization despite compromised in vitro microsomal stability (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. A comparison of the binding modes of compounds <b>1</b> and <b>2</b>, cocrystallized with ALK (left panel) and superimposed onto a JAK2 crystal structure (right panel). A comparison of the binding modes of compound <b>1</b> (purple) and <b>2</b> (green), cocrystallized with ALK (left panel; PBB = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOB">4FOB</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOC">4FOC</a>) and superimposed onto a JAK2 crystal structure (right panel; PDB = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LPB">3LPB</a>). The surfaces of residues Leu855 and Gly856 in JAK2 are colored yellow. Both proteins are shown at the same scale and relative orientation to illustrate differences in the dimensions of their ATP binding pockets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds of this class were readily synthetically accessible.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The initial route adopted (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) permitted independent variation of the three main structural appendages for early SAR exploration purposes.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,6-lutidine, TIPSOTf, DCM, 99%; (b) DIPEA, CH<sub>3</sub>CN, 50 °C, 60%; (c) NH<sub>4</sub>HCO<sub>2</sub>, 10% Pd/C, EtOH, 100%; (d) CNBr, EtOH, 25 °C, 92%; (e) (i) PhCOCl, Et<sub>3</sub>N, DCM, 0 °C, (ii) TBAF, THF, 0–25 °C, 63%; (f) (i) SOCl<sub>2</sub>, 0 °C, (ii) piperidine, DMSO, 25°, 75%; (g) NaOH, MeOH, 95%; (h) (i) SOCl<sub>2</sub>, neat, 0 °C, (ii) EtNH<sub>2</sub>, THF 0–25 °C, 90%.</p></p></figure><div class="NLM_p">Commercially available benzyl alcohol <b>4</b> was protected as its TIPS ether, <b>5</b>, which was then subjected to S<sub>N</sub>Ar reaction with ester <b>6</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> to afford adduct <b>7</b>. Transfer hydrogenation gave aniline <b>8</b>, which was then reacted with cyanogen bromide to give 2-aminobenzimidazole <b>9</b>. Acylation of <b>9</b> with benzoyl chloride, followed by fluoride mediated deprotection of the silyl ether, afforded benzyl alcohol <b>10</b>, which was converted into benzyl chloride <b>11</b> using thionyl chloride and then displaced with piperidine to give <b>2</b>. Saponification of the methyl ester, conversion of the resulting acid <b>12</b> to acid chloride <b>13</b>, and subsequent treatment with ethylamine gave compound <b>15</b>. The substitution of ethylamine with other nucleophiles gave access to the compounds shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Cyclohexylcarboxyl SAR<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Affords a Means of Achieving Selectivity over JAK2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0010.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">For optimization of the piperidine moiety, the order of steps in the synthetic route was modified to allow more efficient access to SAR in this region of the molecule: the invariant isopropyl carboxamide would be installed early in the sequence (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Thus isopropyl amide <b>19</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> underwent S<sub>N</sub>Ar reaction with 3-fluoro-4-nitrobenzyl alcohol <b>4</b> to give adduct <b>20</b>, which was reduced to the diamine and then reacted with 4-fluorobenzoyl isothiocyanate <b>21</b>. Benzimidazole ring closure was effected in situ by treatment with EDCI to afford <b>22</b>. Finally, the benzyl alcohol of <b>22</b> was converted to the corresponding benzyl chloride on exposure to thionyl chloride and then reacted with with <b>23</b> to produce <b>36</b>. Substitution of piperidine <b>23</b> with the nucleophile of choice gave the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup>i</sup>Pr<sub>2</sub>EtN, CH<sub>3</sub>CN, 50 °C, 71%; (b) (i) H<sub>2</sub>/10% Pd/C, EtOH, (ii) <b>21</b>, THF, (iii) EDCI, <sup>i</sup>Pr<sub>2</sub>EtN, 80% overall; (c) (i) SOCl<sub>2</sub>, 0 °C, (ii) <b>23</b>, DCM, 25 °C; 56% overall.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Selected Piperidine Replacement SAR<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Addressing Metabolic Stability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0011.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">A further modification to the route was made to explore a diversity of benzoyl substituents (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Reductive amination of benzaldehyde <b>41</b> with amine <b>23</b> gave adduct <b>42</b>, which underwent S<sub>N</sub>Ar with amine <b>19</b> and was then reduced to diamine <b>44</b>. For exploration of benzamide SAR, <b>44</b> was reacted with acetyl isothiocyanate, ring closure was effected with EDCI, and the acetyl protecting group cleaved by acidic hydrolysis to afford aminobenzimidazole <b>46</b> as a key precursor for subsequent benzoylation. EDCI/HOBt coupling conditions were not particularly efficient on this substrate (yields of 15–24% were typical), however, the procedure was widely applicable. Ultimately, this route was adapted for an efficient larger scale synthesis of compounds advancing to animal studies. The diamine <b>44</b> reacted smoothly with benzoyl isothiocyanates such as <b>45</b> (conveniently generated by the action of potassium isothiocyanate on the corresponding benzoyl chloride), followed by EDCI mediated ring closure to give good yields (72% for <b>49</b>) of final product (46% overall from benzaldehyde <b>41</b>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Na(AcO)<sub>3</sub>BH, DCM, 88%; (b) <sup>i</sup>Pr<sub>2</sub>EtN, CH<sub>3</sub>CN, 50 °C, 73%; (c) NH<sub>4</sub>HCO<sub>2</sub>, Pd/C, EtOH, 100%; (d) <sup>i</sup>Pr<sub>2</sub>EtN/EDCI, 72%; (e) (i) MeCONCS, dioxan, 100 °C, (ii) EDCI, <sup>i</sup>Pr<sub>2</sub>EtN, 60 °C, HCl aq (2N), 50 °C, 82% overall; (f) ArCO<sub>2</sub>H, EDCI, HOBt, <sup>i</sup>Pr<sub>2</sub>EtN, DMF, 50 °C, 15–24%</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34864" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34864" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ester <b>2</b> afforded a good starting point in terms of potent enzymatic inhibition of ALK. However, significant improvements to cellular potency, off-target kinase selectivity profile, and a dramatic improvement in metabolic stability were required. A brief examination of SAR of the methyl ester moiety of <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) indicated that replacement of the ester moiety of <b>14</b> with an ethyl amide <b>15</b> afforded an improvement in cellular potency, together with significant enhancement of selectivity against JAK2. A modest impact on SRC selectivity was noted, without significant change in selectivity against IGF1R.</div><div class="NLM_p">An unsubstituted primary amide <b>17</b>, or bis-substitution of the amide nitrogen <b>16</b>, resulted in a significant loss in both cellular and enzymatic potency and consequent erosion in selectivity against SRC. From a wide range of ester and amide isosteres and alternative alkyl substituents explored (data not shown), the isopropyl amide <b>18</b> emerged as offering the most atom efficient combination of cellular potency and selectivity. It was also noted that the primary amide <b>17</b> displayed significantly improved microsomal stability<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> in comparison with the more elaborate derivatives. Oxidative N-dealkylation of the amide was observed to be a significant metabolic pathway in liver microsomal incubations. A second site of extensive metabolism was, as expected, the piperidine moiety. A wide variety of changes to this part of the molecule were explored, and a selection of the more informative is included in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. A variety of standard techniques to modify the basicity of the nitrogen (e.g., <b>26</b>) retained the cell potency but also retained the poor microsomal stability of lead <b>25</b>. Attempts to block metabolism by the introduction of steric crowding in the vicinity of the amine nitrogen led to a loss of potency. Complete excision of the side chain (<b>24</b>) resulted in a 35-fold loss in cellular potency without impacting microsomal stability. A range of aromatic heterocyclic replacements for the piperidine were explored, again without utility. Typically these compounds either retained cellular potency but had marginal impact on microsomal stability as with triazole (<b>27</b>) or suffered from a significant loss in cellular potency as with pyridine <b>28</b>. Interestingly, piperazine <b>29</b> retained cellular potency and displayed a marked improvement in microsomal stability but had clearance greater than liver blood flow on IV dosing in rat. Piperidinone analogue <b>30</b> behaved likewise, however, 4-aminomethylpiperidine <b>31</b> displayed astonishing microsomal stability, which translated into improved rat IV clearance amounting to 30% of liver blood flow. As a result of this unexpected finding, a wide range of polar substituents were explored in a variety of configurations. Carboxylic acids such as <b>32</b> and <b>33</b> furnished zwitterions which were stable toward microsomal transformation, however, cellular potency was significantly impacted. The primary amides of these acids were investigated and found to retain cellular potency, however, they varied significantly in their microsomal stability depending on the location of the amide moiety; compare, for example, <b>34</b> and <b>35</b>. The most promising, <b>34</b>, was found to have high clearance on IV dosing in rat. A tertiary alcohol at the 4-position of the piperidine ring <b>36</b> recapitulated the remarkable metabolic stability of amine <b>31</b> and displayed good PK properties in rat (vide infra). The disposition of the alcohol substituent relative to the amine was important for controlling the in vitro metabolic stability of this class of molecule. Analogues <b>36</b> and <b>40</b> shared the improved PK characteristics of <b>31</b>, whereas analogues <b>37, 38</b> and <b>39</b> were less optimal. Tertiary alcohol <b>36</b> appeared to be optimal. These observations lead us to speculate that a correctly placed polar moiety influences microsomal stability by perturbing CYP molecular recognition; docking of the molecule in the active site of the metabolizing CYP<sub>450</sub> in an orientation that presents the metabolic soft spots to the catalytic heme is disfavored.</div><div class="NLM_p">X-ray crystallography (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) shows that the benzamide motif of <b>36</b> sits deep in the ATP binding site of the kinase, in relatively close proximity to gatekeeper residue, Leu 1196, in a pocket also defined by Val1180 and Leu1256. It was therefore anticipated that the substitution pattern of the aryl ring may permit fine-tuning of the kinase selectivity profile.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In exploration of the SAR of the iminobenzamide moiety, it was necessary to retain the bias toward the exocyclic acylimine tautomer in order to maintain key H-bond donor–acceptor interactions with the hinge region of the kinase. This tautomer is favored by extended π-delocalization into the pendant aryl ring, achieved by retaining a coplanar arrangement between benzamide and benzimidazole moieties.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The SAR was necessarily constrained to aryl or heteroaryl substituents lacking ortho-substitution to avoid steric or lone-pair–lone-pair peri-interactions, disrupting the optimal coplanar disposition of these moieties. In the crystal structure of <b>36</b>, there is also evidence of a favorable interaction between the ortho-CH and backbone carbonyl of Glu1197 (3.2 Å), which was desirable to preserve. Initial SAR studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) concentrated on the evaluation and optimization of selectivity over the related SRC and IGF1R kinases, with an expectation that the cyclohexylbenzamide motif would provide the necessary selectivity over the JAK family kinases as discussed above. Overall, this proved to be correct, however, it was notable that meta- or para- cyano substituents (<b>55</b>, <b>51</b>) resulted in a measurable erosion of selectivity against JAK 2. Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> illustrates a selection of substitution patterns that retained high enzymatic potency on ALK. <i>meta</i>-Chloro or -cyano substituents (<b>54</b>, <b>55</b>, <b>57</b>, <b>58</b>) conferred improved IGF1R selectivity as did <i>meta</i>-pyridyl <b>52</b>, however, these changes resulted in compromised cellular activity against ALK. The cellular context was used to drive SAR development, as this strategy provided a means of identifying those compounds most likely to have superior potency in vivo. Fluoro substituents were well tolerated at the meta- and para- positions (<b>36</b>, <b>48</b>, <b>49</b>, <b>53</b>) and retained the low ALK enzyme cell shift of the parent benzamide.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Co-crystal structure of ALK with compound <b>36</b>. The solubilizing group is observed to adopt two possible orientations (A or B). Dashed lines indicate hydrogen bonds. PDB code is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOD">4FOD</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Optimization of the Acylbenzamide Moiety to Enhance Kinase Selectivity<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0012.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">Analogues with acceptable selectivity profiles (>50-fold) and liver microsomal stability indicative of modest clearance were progressed to rat PK, where <i>p</i>-fluoro analogue <b>36</b> and 3,5-difluoro analogue <b>49</b> had acceptable PK distribution and clearance parameters and were therefore progressed to beagle dog PK, where results were superior to the rat (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Plasma protein binding in dog was comparable with that measured in human plasma. The bioavailability obtained with an unoptimized formulation was considered acceptable at this stage and prompted further profiling of these two molecules. Routes of metabolism studies for both <b>36</b> and <b>49</b> in isolated liver microsomes indicated that the principal oxidative transformations were oxidative hydrolysis of the piperidine ring, leading to a primary benzylamine as an observable metabolite as well as oxidative dealkylation of the isopropyl amide moiety to afford a primary cyclohexylcarboxamide. These metabolites were observed in the microsomal incubations of all four species studied (mouse, rat, dog, human). Oxidations on the core molecular scaffold were not observed.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters and Plasma Protein Binding Measured for Compounds <b>36</b> and <b>49</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">rat</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">dog</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">plasma protein binding %</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center" char=".">Vss L/kg</th><th class="colsep0 rowsep0" align="center" char=".">Clp L/kg/h</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (IV) h</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> %</th><th class="colsep0 rowsep0" align="center" char=".">Vss L/kg</th><th class="colsep0 rowsep0" align="center" char=".">Clp L/kg/h</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (IV) h</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> %</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">dog</th><th class="colsep0 rowsep0" align="center" char=".">human</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">0.813</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">1.58</td><td class="colsep0 rowsep0" align="char" char=".">0.201</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">92.5</td><td class="colsep0 rowsep0" align="char" char=".">94.8</td><td class="colsep0 rowsep0" align="char" char=".">94.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="char" char=".">5.42</td><td class="colsep0 rowsep0" align="char" char=".">0.717</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">1.82</td><td class="colsep0 rowsep0" align="char" char=".">0.167</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">71</td><td class="colsep0 rowsep0" align="char" char=".">95.1</td><td class="colsep0 rowsep0" align="char" char=".">97.8</td><td class="colsep0 rowsep0" align="char" char=".">96.3</td></tr></tbody></table></div></div><div class="NLM_p">Both compounds were profiled against an Ambit panel of 442 kinases, which indicated that the difluoroaryl ring of <b>49</b> conferred an overall superior selectivity profile in comparison with <b>36</b> as indicated by the kinome tree plots of Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. The S(10) selectivity score was 0.07 for <b>36</b> and 0.036 for <b>49</b>. Selected kinases identified from the most active hits in the Ambit kinome panel were followed up with titrated <i>K</i><sub>d</sub> determinations, shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. AMBIT kinome screening at 1 μM, annotated on (<i>n</i> = 442) enzymes in the human <b>36</b> and <b>49</b> with hits showing % control at 1 μM (i.e., 0%, largest spot is most active) overlaid on the kinome phylogenetic tree.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Selected Ambit Kinome Panel Data (442 Kinases from the Human Kinome with POC Data Generated at 1.0 μM Compound Concentration) with Titrated <i>K</i><sub>d</sub> Follow Up</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><b>36</b></th><th class="rowsep1 colsep0" colspan="3" align="center"><b>49</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">POC at1 μM</th><th class="colsep0 rowsep0" align="center">Ambit titrated <i>K</i><sub>d</sub> (nM)</th><th class="colsep0 rowsep0" align="center">selectivity vs ALK</th><th class="colsep0 rowsep0" align="center">POC at1 μM</th><th class="colsep0 rowsep0" align="center">Ambit titrated <i>K</i><sub>d</sub> (nM)</th><th class="colsep0 rowsep0" align="center">selectivity vs ALK</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALK</td><td class="colsep0 rowsep0" align="center">0.55</td><td class="colsep0 rowsep0" align="center">0.36</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">2.7</td><td class="colsep0 rowsep0" align="center">0.24</td><td class="colsep0 rowsep0" align="center">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AXL</td><td class="colsep0 rowsep0" align="center">0.75</td><td class="colsep0 rowsep0" align="center">29</td><td class="colsep0 rowsep0" align="center">80</td><td class="colsep0 rowsep0" align="center">82</td><td class="colsep0 rowsep0" align="center">1600</td><td class="colsep0 rowsep0" align="center">6656</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLT3</td><td class="colsep0 rowsep0" align="center">7.9</td><td class="colsep0 rowsep0" align="center">42</td><td class="colsep0 rowsep0" align="center">116</td><td class="colsep0 rowsep0" align="center">42</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">INSR</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">38</td><td class="colsep0 rowsep0" align="center">72</td><td class="colsep0 rowsep0" align="center">300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IRAK1</td><td class="colsep0 rowsep0" align="center">0.2</td><td class="colsep0 rowsep0" align="center">5.7</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">0.15</td><td class="colsep0 rowsep0" align="center">5.6</td><td class="colsep0 rowsep0" align="center">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LCK</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">28</td><td class="colsep0 rowsep0" align="center">77</td><td class="colsep0 rowsep0" align="center">6.4</td><td class="colsep0 rowsep0" align="center">110</td><td class="colsep0 rowsep0" align="center">458</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LTK</td><td class="colsep0 rowsep0" align="center">0.1</td><td class="colsep0 rowsep0" align="center">2.5</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">0.35</td><td class="colsep0 rowsep0" align="center">8.2</td><td class="colsep0 rowsep0" align="center">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAP4K2</td><td class="colsep0 rowsep0" align="center">0.05</td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center">31</td><td class="colsep0 rowsep0" align="center">0.35</td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">104</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MER</td><td class="colsep0 rowsep0" align="center">1.3</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">50</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">72</td><td class="colsep0 rowsep0" align="center">300</td></tr></tbody></table></div></div><div class="NLM_p">Insulin receptor (INSR) activity was followed up separately in a functional cellular context;<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> pINSR activity was measured for both compounds: <b>49</b> pINSR IC<sub>50</sub> 536 nM (pALK IC<sub>50</sub> 5.5 nM; 97-fold selective) and <b>36</b> pINSR IC<sub>50</sub> 231 nM (pALK IC<sub>50</sub> 6.0 nM; 38-fold selective).</div><div class="NLM_p">Compounds <b>36</b> and <b>49</b> were also profiled against ALK enzymes bearing point mutations R1275Q or L1196M and were found to fully retain their potency against these mutants.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The L1196 M “gatekeeper mutation” has been observed clinically in patients with developed resistance to crizotinib.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Upon examination of compound <b>36</b> in a murine PD model,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> very rapid clearance of the compound from plasma was observed; the clearance mechanism was traced to a murine-specific amidase, resulting in cleavage of the benzamide moiety. The compound was not subject to this route of metabolism in rat, dog, or human whole blood, but it did limit the value of performing further experiments in mice with <b>36</b>. A detailed study of the mechanism, kinetics, and SAR of this mode of metabolism will be reported elsewhere.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In contrast, close analogue <b>49</b> had significantly better mouse PK (<i>T</i><sub>1/2</sub> (IV) 1.05 h), which permitted evaluation in a range of pharmacodynamic (PD) and tumor xenograft models of ALK driven disease.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In particular, compound <b>49</b> exhibited dose-dependent inhibition in an NPM-ALK driven tumor xenograft model utilizing the Karpas-299 cell line, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. Approximately 10–12 days after Karpas-299 cell implantation, SCID-beige mice with well-formed tumors of similar size were placed into groups (<i>n</i> = 10/group) so that the average tumor size was similar in each group (ranging from approximately 150–250 mm<sup>3</sup>) at initiation of dosing. Compound was dosed orally (po) at 10, 30, or 60 mg/kilogram (mpk), once daily (qd); tumor volume was assessed for each animal periodically over the 15 day treatment period and compared with tumors growing in a vehicle control group; *<i>p</i> values were calculated using RMANOVA with Dunnett’s comparison. A 10 mpk qd dose of <b>49</b> resulted in observed tumor growth inhibition (TGI) of 41% (*<i>p</i> = 0.019) after 15 days of dosing. At 30 mpk qd 89% (*<i>p</i> < 0.0001) TGI was observed at day 15. Furthermore, a 60 mpk qd dose of <b>49</b> over the same period led to 96% (*<i>p</i> < 0.0001) tumor regression, with no visible tumor remaining in 6 of 10 animals at study termination. The compound was very well tolerated by the animals at all tested doses, as assessed by minimal change in body weight observed over the course of the study.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>49</b> dosed (10, 30, 60 mpk, po, qd) in SCID-beige mice bearing Karpas-299 xenografts. **After 15 days of treatment with <b>49</b> at the 60 mpk dose, the tumors in 6 of the 10 animals had completely regressed. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure S1">Supporting Information Figure S1</a> for body weight data from this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Terminal PK measurement following the final dose indicated that the 60 mpk dose maintained a plasma free fraction level of drug above the cellular IC<sub>50</sub> for 17 h post dose, with target IC<sub>50</sub> coverage exceeding 13 h at the 30 mpk dose. The data provides an indication of the benefits of extended duration of target coverage over the cellular IC<sub>50</sub>, resulting in substantial tumor regression in this model.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A class of 2-acyliminobenzimidazoles was identified as potent and selective inhibitors of anaplastic lymphoma kinase. Structure based design was instrumental in developing an understanding of SAR and facilitated the optimization of kinase selectivity. Introduction of an optimally placed polar substituent was key to solving issues of metabolic stability and led to the development of potent orally bioavailable ALK inhibitors with substantial in vivo potency in an ALK-driven xenograft model of cancer. These compounds appear to be able to better retain their potency against point mutations in the enzyme which are thought to confer resistance to crizotinib. Compounds from this class have significant promise for development as useful therapeutics for the treatment of ALK driven cancers.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Additional in vivo characterization of these molecules will be the subject of subsequent publications.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Details</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General</h3><div class="NLM_p last">All reagents and solvents were obtained from commercial suppliers and used without further purification. Silica gel chromatography was performed using prepacked silica gel cartridges (ISCO). <sup>1</sup>H NMR spectra were obtained on either a Bruker Avance 1 400 MHz spectrometer or a Bruker Avance 2 600 MHz spectrometer with a 5 mm TXI cryoprobe using the residual solvent peak as the reference. All tested compounds were purified to >95% purity at 215 and 254 nm as determined by HPLC. HPLC analysis was obtained on an Agilent 1100 system, using an Agilent Zorbax SB-C8 column (150 mm × 4.6 mm, 5 μ) at 40 °C with a 1.5 mL/min flow rate using a gradient of 5–100% [0.1% TFA in acetonitrile] in [0.1% TFA in water] over 15 min. Electrospray mass (ESI) measurements were obtained on an Agilent 1100 series LC/MSD system, using one of the following two separation methods: [A] Agilent Zorbax SB-C18 column (50 mm × 3.0 mm, 3.5 μ) at 40 °C and a gradient of 5–95% [0.1% TFA in acetonitrile] in [0.1% TFA in water] over 3.5 min; [B] Phenomenex Gemini C18 column (50 mm × 3.0 mm, 3 μ) at 40 °C with a 1.5 mL/min flow rate using a gradient of 5–95% [0.1% formic acid in acetonitrile] in [0.1% formic acid in water] over 3.5 min. Preparative HPLC was performed on one of two systems: (A) Gilson preparative HPLC system using a Phenomenex Gemini-NX C18 110A column (100 mm × 21 mm, 5 μ); (B) Agilent mass-directed preparative HPLC system using an xBridge C18 column (100 mm × 19 mm, 10 μ). Exact mass (HRMS) measurements were performed on an Agilent 1100 HPLC by flow injection analysis, eluting with [1:1 water/acetonitrile with 0.1% formic acid] at 2 mL/min, with MS detection by an Agilent G1969A time-of-flight (TOF) mass spectrometer</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> ((3-Fluoro-4-nitrobenzyl)oxy)triisopropylsilane (<b>5</b>)</h3><div class="NLM_p last">To a solution of <b>4</b> (Bionet, 4.7 g, 27.5 mmol) in DCM (47 mL) was added triisopropylsilyl trifluoromethanesulfonate (9.26 g, 30.2 mmol) and 2,6-dimethylpyridine (3.53 g, 33.0 mmol). The resulting mixture was stirred for 3 h at ambient temperature and then washed with saturated aqueous ammonium chloride and water. The organic layer was collected, dried over sodium sulfate, filtered, and concentrated to produce <b>5</b> (8.9 g, 99% yield) as a light-yellow oil.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (1<i>s</i>,4<i>s</i>)-Methyl 4-Aminocyclohexanecarboxylate (<b>6</b>)</h3><div class="NLM_p last">To a solution of (1<i>s</i>,4<i>s</i>)-4-aminocyclohexanecarboxylic acid (15 g, 105 mmol) in methanol (150 mL) was added sulfuric acid (10.27 g, 105 mmol), and the reaction was stirred at 80 °C for 18 h. The reaction mixture was then cooled to 0 °C, neutralized with aqueous ammonium hydroxide, and extracted with DCM. The organic layer was dried over sodium sulfate, filtered, and concentrated to afford <b>6</b> (16.00 g, 97% yield) as a light-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.68 (s, 3 H), 2.86–2.92 (m, 1 H), 2.34–2.58 (m, 1 H), 2.14 (br s, 2 H), 2.00–2.06 (m, 2 H), 1.66–1.78 (m, 2 H), 1.54–1.66 (m, 2 H), 1.32–1.50 (m, 2 H).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (1<i>s</i>,4<i>s</i>)-Methyl 4-((2-Nitro-5-(((triisopropylsilyl)oxy)methyl)phenyl)amino)cyclohexanecarboxylate (<b>7</b>)</h3><div class="NLM_p last">To a solution of <b>5</b> (6.3 g, 19.2) and <b>6</b> (3.63 g, 23.1 mmol) in acetonitrile (32 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (10.0 mL, 57.7 mmol), and the reaction mixture was stirred at 50 °C for 20 h. After the reaction was complete, the reaction mixture was allowed to cool to ambient temperature and diluted with water (20 mL) and DCM (50 mL). The organic layer was collected, dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product was purified by column chromatography, eluting with 10–30% ethyl acetate in hexanes, to produce <b>7</b> (5.35 g, 60% yield) as an orange solid.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (1<i>s</i>,4<i>s</i>)-Methyl 4-(2-Amino-5-((triisopropylsilyloxy)methyl)phenylamino)cyclohexanecarboxylate (<b>8</b>)</h3><div class="NLM_p last">To a solution of <b>7</b> (2.80 g, 6.0 mmol) in ethanol (48.5 mL), under a nitrogen atmosphere, was added 10% palladium on carbon (0.65 g, 0.6 mmol) and ammonium formate (3.79 g, 60.0 mmol). The reaction was stirred at ambient temperature for 2 h and then filtered through a Celite pad. The filter cake was rinsed with ethanol and DCM, and the combined filtrates were concentrated and partitioned between DCM and water. The organic portion was dried over anhydrous sodium sulfate, filtered, and concentrated to afford <b>8</b> (2.61 g, 100% yield) as a purple oil. LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 435.2 (M + H).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (1<i>s</i>,4<i>s</i>)-Methyl 4-(2-Amino-6-((triisopropylsilyloxy)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)cyclohexanecarboxylate (<b>9</b>)</h3><div class="NLM_p last">To a solution of <b>8</b> (2.50 g, 5.8 mmol) in ethanol was added cyanogen bromide (0.91 g, 8.6 mmol), and the reaction was stirred at ambient temperature for 16 h. The reaction mixture was concentrated in vacuo, diluted with DCM, and washed with aqueous sodium hydroxide. The organic portion was dried over anhydrous sodium sulfate, filtered, and concentrated to afford <b>9</b> (2.4 g, 92% yield) as a brown solid. LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 460.2 (M + H).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (1<i>s</i>,4<i>s</i>)-Methyl 4-((<i>E</i>)-2-(Benzoylimino)-6-(hydroxymethyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)cyclohexanecarboxylate (<b>10</b>)</h3><div class="NLM_p">Step 1: To a solution of benzoyl chloride (0.33 g, 2.3 mmol) in dichloromethane (7.3 mL), cooled to 0 °C, was added <b>9</b> (1.00 g, 2.2 mmol) portionwise, followed by triethylamine (1.21 mL, 8.7 mmol). The reaction was stirred at 0 °C for 30 min. The ice bath was then removed, and the reaction was stirred at ambient temperature for 1 h. The reaction mixture was partitioned between aqueous ammonium chloride and DCM. The organic portion was dried over sodium sulfate, filtered, and concentrated to afford (1<i>s</i>,4<i>s</i>)-methyl 4-((<i>E</i>)-2-(benzoylimino)-6-(((triisopropylsilyl)oxy)methyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)cyclohexanecarboxylate as a brown oil.</div><div class="NLM_p last">Step 2: To a solution of (1<i>s</i>,4<i>s</i>)-methyl 4-((<i>E</i>)-2-(benzoylimino)-6-(((triisopropylsilyl)oxy)methyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)cyclohexanecarboxylate (1.22 g, 2.2 mmol) in THF (4.33 mL), cooled to 0 °C, was added a 1 M solution of tetrabutylammonium fluoride in THF (3.30 mL, 3.3 mmol) dropwise. The reaction was stirred at 0 °C for 15 min and then stirred at ambient temperature for 2 h. The reaction mixture was quenched with water and diluted with DCM. The organic portion was dried over sodium sulfate, filtered, and concentrated. The crude product was purified by column chromatography, eluting with 30–50% ethyl acetate in hexanes, to afford <b>10</b> (0.56 g, 63% yield). LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 408.2 (M + H).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (1<i>s</i>,4<i>s</i>)-Methyl 4-((<i>E</i>)-2-(Benzoylimino)-6-(chloromethyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)cyclohexanecarboxylate (<b>11</b>)</h3><div class="NLM_p last">To a solution of <b>10</b> (0.40 g, 0.98 mmol) in DCM (9.8 mL), cooled to 0 °C, was added thionyl chloride (1.43 mL, 19.6 mmol) dropwise. The reaction was stirred at 0 °C for 15 min and then stirred at ambient temperature for 30 min. The reaction mixture was then concentrated in vacuo to afford <b>11</b> as a white solid. LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 426.2 (M + H).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (1<i>s</i>,4<i>s</i>)-Methyl 4-((<i>E</i>)-2-(Benzoylimino)-6-(piperidin-1-ylmethyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)cyclohexanecarboxylate (<b>2</b>)</h3><div class="NLM_p last">To a solution of <b>11</b> (0.41 g, 0.96 mmol) in DMSO (4 mL) was added piperidine (0.97 mL, 9.8 mmol) dropwise. The reaction was stirred at ambient temperature for 1 h. The reaction mixture was then diluted with DCM and washed with water. The organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was triturated with 10% water in methanol to afford <b>2</b> (0.34 g, 75% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.80 (br s, 1 H), 8.11–8.21 (m, 2 H), 7.36–7.58 (m, 5 H), 7.13 (d, <i>J</i> = 8.03 Hz, 1 H), 4.62–4.88 (m, 1 H), 3.77 (s, 3H), 3.50 (br s, 2 H), 2.80–2.91 (m, 1 H), 2.53–2.71 (m, 2 H), 2.19–2.43 (m, 6 H), 1.62–1.93 (m, 4 H), 1.35–1.60 (m, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>28</sub>H<sub>35</sub>N<sub>4</sub>O<sub>3</sub>, 475.2704; found, 475.2705.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (1<i>s</i>,4<i>s</i>)-Ethyl 4-((<i>E</i>)-2-(Benzoylimino)-6-(piperidin-1-ylmethyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)cyclohexanecarboxylate (<b>14</b>)</h3><div class="NLM_p last">Compound <b>14</b> was prepared according to the reaction sequence described for the synthesis of <b>2</b>, substituting ethanol for methanol in the first step to afford the ethyl ester. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31–8.35 (m, 2 H), 7.35–7.68 (m, 6 H), 4.28 (q, <i>J</i> = 7.11 Hz, 2 H), 4.23–4.26 (m, 1 H), 3.38–3.55 (m, 2 H), 2.47–2.89 (m, 5 H), 2.24–2.44 (m, 4 H), 1.80–1.98 (m, 8 H), 1.58–1.70 (m, 2 H), 1.34 (t, <i>J</i> = 7.09 Hz, 3 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>29</sub>H<sub>37</sub>N<sub>4</sub>O<sub>3</sub>, 489.2860; found, 489.2867.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Preparation of <b>15</b>–<b>18</b>. General Procedure A</h3><div class="NLM_p">Step 1: To a suspension of <b>2</b> (0.23 g, 0.49 mmol) in methanol (7 mL) was added 1 N aqueous sodium hydroxide (7.3 mL, 7.3 mmol), and the resulting mixture was stirred at ambient temperature overnight. The reaction was neutralized with 1 N aqueous HCl and extracted with DCM (50 mL). The organic portion was dried over sodium sulfate, filtered, and concentrated to afford <b>12</b>.</div><div class="NLM_p last">Step 2: A suspension of <b>12</b> (50 mg, 0.11 mmol) in thionyl chloride (0.5 mL) was stirred at ambient temperature for 30 min. The reaction mixture was then concentrated in vacuo, and the residue was suspended in THF (1.1 mL), cooled to 0 °C, and treated with an amine (0.11 mmol). The resulting mixture was stirred at 0 °C for 30 min and then stirred at ambient temperature for 1 h. The reaction mixture was partitioned between water and DCM. The organic portion was dried over anhydrous sodium sulfate, filtered, and concentrated to afford the desired product.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>E</i>)-<i>N</i>-(1-((1<i>s</i>,4<i>s</i>)-4-(Ethylcarbamoyl)cyclohexyl)-6-(piperidin-1-ylmethyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>15</b>)</h3><div class="NLM_p last">General procedure A, with ethylamine, was used to produce <b>15</b> (40 mg, 76% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.98 (br s, 1 H), 8.23–8.31 (m, 2 H), 7.90 (s, 1 H) 7.83–7.88 (m, 1 H), 7.60 (d, <i>J</i> = 8.02 Hz, 1 H), 7.37–7.57 (m, 4 H), 4.58–4.83 (m, 1 H), 4.33 (m, 2 H), 3.38 (m, 2 H), 3.16–3.28 (m, 2 H), 2.69–2.97 (m, 4 H), 2.18 (m, 2 H), 1.59–1.88 (m, 9 H), 1.30–1.45 (m, 2 H), 1.07 (t, <i>J</i> = 7.19 Hz, 3 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>29</sub>H<sub>38</sub>N<sub>5</sub>O<sub>2</sub>, 488.3020; found, 488.3016.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>E</i>)-<i>N</i>-(1-((1<i>s</i>,4<i>s</i>)-4-(Diethylcarbamoyl)cyclohexyl)-6-(piperidin-1-ylmethyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>16</b>)</h3><div class="NLM_p last">General procedure A, with diethylamine, was used to produce <b>16</b> (35 mg, 63% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (br s, 1 H), 8.30 (m, 2 H), 7.76 (s, 1 H), 7.42–7.57 (m, 4 H), 7.09–7.20 (m, 1 H), 4.73–5.03 (m, 1 H), 3.44–3.59 (m, 1 H), 3.38 (m, 3 H), 2.95–3.01 (m, 2 H), 2.93 (q, <i>J</i> = 7.27 Hz, 4 H), 2.27–2.42 (m, 3 H), 1.89–2.05 (m, 2 H), 1.73–1.89 (m, 2 H), 1.47–1.70 (m, 6 H), 1.32–1.44 (m, 2 H), 1.17 (t, <i>J</i> = 7.28 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>31</sub>H<sub>42</sub>N<sub>5</sub>O<sub>2</sub>, 516.3333; found, 516.3329.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>E</i>)-<i>N</i>-(1-((1<i>s</i>,4<i>s</i>)-4-Carbamoylcyclohexyl)-6-(piperidin-1-ylmethyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>17</b>)</h3><div class="NLM_p last">General procedure A, with ammonia, was used to produce <b>17</b> (20 mg, 40% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (br s, 1 H), 8.17–8.30 (m, 2 H), 7.44–7.54 (m, 5 H), 7.17 (d, <i>J</i> = 8.31 Hz, 1 H), 6.86–6.93 (br s, 2 H), 4.63–4.98 (m, 1 H), 3.42–3.55 (m, 2 H), 2.66–2.84 (m, 2 H), 2.53–2.58 (m, 1H), 2.26–2.42 (m, 4 H), 2.12–2.25 (m, 2 H), 1.68–1.81 (m, 2 H), 1.59–1.68 (m, 2 H), 1.46–1.57 (m, 4 H), 1.34–1.44 (m, 2 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>27</sub>H<sub>34</sub>N<sub>5</sub>O<sub>2</sub>, 460.2707; found, 460.2712.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>E</i>)-<i>N</i>-(1-((1<i>s</i>,4<i>s</i>)-4-(Isopropylcarbamoyl)cyclohexyl)-6-(piperidin-1-ylmethyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>18</b>)</h3><div class="NLM_p last">General procedure A, with isopropylamine, was used to produce <b>18</b> (35 mg, 64% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.93 (s, 1 H), 8.25–8.31 (m, 2 H), 7.91 (s, 1 H) 7.66–7.73 (m, 1 H), 7.61 (d, <i>J</i> = 8.22 Hz, 1 H), 7.44–7.57 (m, 3 H), 7.36–7.43 (m, 1 H), 4.64–4.78 (m, 1 H), 4.28–4.38 (m, 3 H), 4.00–4.14 (m, 1 H), 3.31–3.45 (m, 2 H), 2.76–2.97 (m, 3 H), 2.53–2.61 (m, 1 H), 2.07–2.22 (m, 2 H), 1.75–1.90 (m, 2 H), 1.64–1.76 (m, 4 H), 1.17–1.32 (m, 2 H), 1.10 (d, <i>J</i> = 6.55 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>30</sub>H<sub>40</sub>N<sub>5</sub>O<sub>2</sub>, 502.3177; found, 502.3183.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (1<i>s</i>,4<i>s</i>)-4-((5-(Hydroxymethyl)-2-nitrophenyl)amino)-<i>N</i>-isopropylcyclohexanecarboxamide (<b>20</b>)</h3><div class="NLM_p last">To a suspension of <b>19</b> (7.09 g, 32.1 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (15.3 mL, 88 mmol) in acetonitrile (50 mL) was added <b>4</b> (5.0 g, 29.2 mmol), and the reaction was stirred overnight at 80 °C. After 16 h, the reaction mixture was cooled to ambient temperature and concentrated. The crude product was purified by column chromatography, eluting with 0–100% ethyl acetate in DCM to provide <b>20</b> (7.0 g, 71% yield) as an orange solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35 (d, <i>J</i> = 7.5 Hz, 1 H), 8.04 (d, <i>J</i> = 8.9 Hz, 1 H), 7.57 (d, <i>J</i> = 8.0 Hz, 1 H), 6.99 (s, 1 H), 6.62 (dd, <i>J</i> = 1.7 Hz, 8.9 Hz, 1 H), 5.41 (t, <i>J</i> = 5.8 Hz, 1 H), 4.51 (d, <i>J</i> = 5.5 Hz, 2 H), 3.89–3.96 (m, 1 H), 3.77–3.86 (m, 1 H), 2.16–2.25 (m, 1 H), 1.81–1.89 (m, 2 H), 1.57–1.74 (m, 6 H), 1.03 (d, <i>J</i> = 6.5 Hz, 6 H). LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 336.0 (M + H).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-Fluorobenzoyl Isothiocyanate (<b>21</b>)</h3><div class="NLM_p last">To a suspension of potassium thiocyanate (16.2 g, 167 mmol) in acetone (93 mL) was added 4-fluorobenzoyl chloride (16.4 mL, 139 mmol) dropwise, and the reaction was stirred for 7 h at 50 °C. After the reaction was complete, the reaction mixture was cooled to ambient temperature and filtered through a pad of Celite. The filtrate was concentrated, and the residue was dissolved in DCM (25 mL) and passed through a silica gel pad, eluting with 1:1 hexanes/DCM. The product fractions were combined and concentrated to produce <b>21</b> (11.1 g, 44% yield) as an orange liquid that solidified upon standing. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (dd, <i>J</i> = 5.3 Hz, 9.0 Hz, 2 H), 7.18 (dd, <i>J</i> = 8.2 Hz, 9.0 Hz, 2 H).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>E</i>)-4-Fluoro-<i>N</i>-(6-(hydroxymethyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>22</b>)</h3><div class="NLM_p">Step 1: To a solution of <b>20</b> (2.0 g, 5.96 mmol) in ethanol (25 mL) was added 10% (w/w) palladium on carbon (0.635 g, 0.596 mmol). A hydrogen balloon was installed, and the reaction was stirred under a hydrogen atmosphere for 3 h. After 3 h, the reaction mixture was filtered through a Celite pad and concentrated to produce (1<i>s</i>,4<i>s</i>)-4-(2-amino-5-(hydroxymethyl)phenylamino)-<i>N</i>-isopropylcyclohexanecarboxamide as a brown oil.</div><div class="NLM_p last">Step 2: To a solution of the crude (1<i>s</i>,4<i>s</i>)-4-(2-amino-5-(hydroxymethyl)phenylamino)-<i>N</i>-isopropylcyclohexanecarboxamide in tetrahydrofuran (30 mL) at 0 °C was added <b>21</b> (1.30 g, 7.15 mmol), and the reaction was stirred at 0 °C for 15 min. After 15 min, <i>N</i>,<i>N</i>-diisopropylethylamine (1.56 mL, 8.94 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.71 g, 8.94 mmol) were added, and the reaction was stirred for 2 h at 60 °C and then overnight at ambient temperature. The reaction mixture was concentrated, and the residue was partitioned between water and DCM. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated. The crude product was purified by column chromatography, eluting with 0–100% ethyl acetate in DCM, to produce <b>22</b> (2.14 g, 80% yield over two steps) as a tan solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.75 (s, 1 H), 8.33 (dd, <i>J</i> = 5.9 Hz, 8.8 Hz, 2 H), 7.63 (d, <i>J</i> = 7.9 Hz, 1 H), 7.58 (s, 1 H), 7.49 (d, <i>J</i> = 8.2 Hz, 1 H), 7.13–7.28 (m, 3 H), 5.20 (t, <i>J</i> = 5.6 Hz, 1 H), 4.75–4.86 (m, 1 H), 4.56 (d, <i>J</i> = 5.6 Hz, 2 H), 3.99–4.09 (m, 1 H), 2.71–2.84 (m, 2 H), 2.53–2.59 (m, 1 H), 2.10–2.20 (m, 2 H), 1.67–1.79 (m, 2 H), 1.57–1.67 (m, 2 H), 1.10 (d, <i>J</i> = 6.6 Hz, 6 H). LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 453.0 (M + H).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>E</i>)-4-Fluoro-<i>N</i>-(1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>24</b>)</h3><div class="NLM_p">Step 1: In an analogous sequence to the reactions described for <b>20</b>, <b>8</b>, and <b>9</b>, 4-chloro-2-fluoro-1-nitrobenzene (159 mg, 0.91 mmol) was converted to (1<i>s</i>,4<i>s</i>)-4-(2-amino-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-<i>N</i>-isopropylcyclohexanecarboxamide (162 mg, 60% yield for three steps). LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 300.9 (M + H).</div><div class="NLM_p last">Step 2: To a solution of (1<i>s</i>,4<i>s</i>)-4-(2-amino-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-<i>N</i>-isopropylcyclohexanecarboxamide (162 mg, 0.54 mmol) and pyridine (87 μL, 1.08 mmol) in DCM (5 mL) at 0 °C was added 4-fluorobenzoyl chloride (64 μL, 0.54 mmol). The reaction was allowed to warm to ambient temperature and stirred overnight. The reaction mixture was concentrated and purified by column chromatography, eluting with 20–100% ethyl acetate in hexanes, to produce <b>24</b> (62 mg, 27% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.79 (br s, 1 H), 8.28–8.35 (m, 2 H), 7.69 (d, <i>J</i> = 6.8 Hz, 2 H), 7.54–7.58 (m, 1 H), 7.18–7.28 (m, 4 H), 4.82–4.96 (m, 1 H), 3.95–4.06 (m, 1 H), 2.71–2.84 (m, 2 H), 2.52–2.57 (m, 1 H), 2.04–2.14 (m, 2 H), 1.67–1.79 (m, 2 H), 1.57–1.67 (m, 2 H), 1.10 (d, <i>J</i> = 6.5 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>24</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>2</sub>, 423.2191; found, 423.2193.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>E</i>)-4-Fluoro-<i>N</i>-(1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-6-(piperidin-1-ylmethyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>25</b>)</h3><div class="NLM_p last"><b>25</b> (40 mg, 73.7% yield) was prepared from <b>9</b> using the reaction sequence described for <b>18</b>, substituting 4-fluorobenzoyl chloride for benzoyl chloride. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.54 (s, 1 H), 8.32–8.47 (m, 2 H), 8.01 (s, 1 H), 7.76 (d, <i>J</i> = 7.73 Hz, 1 H), 7.64 (d, <i>J</i> = 8.22 Hz, 1 H), 7.47–7.53 (m, 1 H), 7.25–7.34 (m, 2 H), 4.63–4.82 (m, 1 H), 4.29–4.44 (m, 2 H), 4.05–4.19 (m, 1 H), 3.89–4.03 (m, 1 H), 3.33–3.47 (m, 2 H), 2.84–3.03 (m, 4 H), 2.59–2.64 (m, 1 H), 2.12–2.25 (m, 2 H), 1.81–1.89 (m, 3 H), 1.68–1.79 (m, 4 H), 1.27–1.34 (m, 2 H), 1.15 (d, <i>J</i> = 6.55 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>30</sub>H<sub>39</sub>FN<sub>5</sub>O<sub>2</sub>, 520.3082; found, 520.3084.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Preparation of <b>26</b>, <b>29</b>–<b>30</b>, and <b>34</b>–<b>40</b>. General Procedure B</h3><div class="NLM_p last">To a solution of <b>22</b> (100 mg, 0.221 mmol) in DCM (2.5 mL) at 0 °C was added thionyl chloride (81 μL, 1.11 mmol) dropwise, and the reaction was stirred at 0 °C for 30 min. After 30 min, the reaction mixture was concentrated and dried in vacuo. To a suspension of the crude intermediate in acetonitrile (2 mL) was added an amine, and the reaction was stirred overnight at ambient temperature. After 16 h, the reaction was concentrated and the crude product was purified by reverse-phase preparative HPLC using a gradient of 15–90% [0.1% TFA in acetonitrile] in [0.1% TFA in water], to provide the desired product.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>E</i>)-<i>N</i>-(6-((1,1-Dioxidothiomorpholino)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)-4-fluorobenzamide (<b>26</b>)</h3><div class="NLM_p last">General procedure B, with thiomorpholine 1,1-dioxide (TCI America, 299 mg, 2.21 mmol), was used to produce <b>26</b> (67 mg, 53.2% yield) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.75 (s, 1 H), 8.31 (dd, <i>J</i> = 6.2 Hz, 8.7 Hz, 2 H), 7.80 (s, 1 H), 7.68 (d, <i>J</i> = 7.8 Hz, 1 H), 7.49 (d, <i>J</i> = 8.2 Hz, 1 H), 7.25 (dd, <i>J</i> = 8.6 Hz, 8.6 Hz, 2 H), 7.13, (d, <i>J</i> = 8.6 Hz, 1 H), 4.86–4.97 (m, 1 H), 4.00–4.07 (m, 1 H), 3.76 (s, 2 H), 3.18–3.25 (m, 4 H), 2.88–2.96 (m, 4 H), 2.72–2.86 (m, 2 H), 2.53–2.60 (m, 1 H), 2.05–2.14 (m, 2 H), 1.69–1.79 (m, 2 H), 1.59–1.65 (m, 2 H), 1.21–1.30 (m, 1H), 1.11 (d, <i>J</i> = 6.6 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>29</sub>H<sub>37</sub>FN<sub>5</sub>O<sub>4</sub>S, 570.2545; found, 570.2545.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>E</i>)-<i>N</i>-(6-((1<i>H</i>-1,2,4-Triazol-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)-4-fluorobenzamide (<b>27</b>)</h3><div class="NLM_p last">To a solution of <b>22</b> (100 mg, 0.221 mmol) in DCM (2.5 mL) at 0 °C was added thionyl chloride (81 μL, 1.11 mmol) dropwise, and the reaction was stirred at 0 °C for 30 min. After 30 min, the reaction mixture was concentrated and dried in vacuo. The residue was suspended in acetonitrile (2 mL) and cooled to 0 °C. To the suspension were added 1,2,4-triazole (153 mg, 2.21 mmol), potassium carbonate (305 mg, 2.21 mmol), and sodium iodide (33.1 mg, 0.221 mmol), and the reaction was allowed to warm to ambient temperature. After 16 h, the reaction mixture was partitioned between water and DCM; the aqueous layer was acidified to pH 8 with 1 N aqueous HCl and extracted with DCM. The combined organic layers were concentrated, adsorbed onto a silica gel loading column, and purified by column chromatography, eluting with 0–10% methanol in DCM to produce <b>27</b> (35 mg, 31.5% yield) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.80 (s, 1 H), 8.69 (s, 1 H), 8.33 (dd, <i>J</i> = 6.0 Hz, 8.6 Hz, 2 H), 7.95 (s, 1 H), 7.76 (s, 1 H), 7.67 (d, <i>J</i> = 7.6 Hz, 1 H), 7.50 (d, <i>J</i> = 8.1 Hz, 1 H), 7.24 (dd, <i>J</i> = 8.8 Hz, 8.8 Hz, 2 H), 7.15 (d, <i>J</i> = 8.2 Hz, 1 H), 5.45 (s, 2 H), 4.72–4.84 (m, 1 H), 4.03–4.13 (m, 1 H), 2.71–2.87 (m, 2 H), 2.52–2.57 (m, 1 H), 2.06–2.17 (m, 2 H), 1.66–1.79 (m, 2 H), 1.55–1.65 (m, 2 H), 1.21–1.30 (m, 1H), 1.11 (d, <i>J</i> = 6.6 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>27</sub>H<sub>31</sub>FN<sub>7</sub>O<sub>2</sub>, 504.2518; found, 504.2517.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>E</i>)-4-Fluoro-<i>N</i>-(1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-6-(pyridin-2-yloxy)-1<i>H</i>-benzo[d]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>28</b>)</h3><div class="NLM_p">Step 1: To a solution of 3-fluoro-4-nitrophenol (2.96 g, 18.8 mmol) in DMF (18.8 mL) was added 1-(chloromethyl)-4-methoxybenzene (2.55 mL, 18.8 mmol) and potassium carbonate (5.20 g, 37.6 mmol), and the reaction was stirred overnight at ambient temperature. After 16 h, the reaction mixture was partitioned between water and ethyl acetate, and the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with 1 N aqueous sodium hydroxide and brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The residue was triturated with ether produce 2-fluoro-4-(4-methoxybenzyloxy)-1-nitrobenzene (4.39 g, 84% yield).</div><div class="NLM_p">Step 2: 2-Fluoro-4-(4-methoxybenzyloxy)-1-nitrobenzene (507 mg, 1.83 mmol) and <b>19</b> (404 mg, 1.83 mmol) were converted to (1<i>s</i>,4<i>s</i>)-<i>N</i>-isopropyl-4-((5-((4-methoxybenzyl)oxy)-2-nitrophenyl)amino)cyclohexanecarboxamide (476 mg, 59.0% yield) as described for <b>20</b>. LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 442.2 (M + H).</div><div class="NLM_p">Step 3: To a solution of (1<i>s</i>,4<i>s</i>)-<i>N</i>-isopropyl-4-((5-((4-methoxybenzyl)oxy)-2-nitrophenyl)amino)cyclohexanecarboxamide (452 mg, 1.02 mmol) in methanol (5.1 mL) was added acetic acid (0.29 mL, 5.12 mmol) and zinc (669 mg, 10.2 mmol), and the mixture was stirred at ambient temperature for 3 h. The reaction was filtered through a pad of Celite, and the filtrate was concentrated to produce (1<i>s</i>,4<i>s</i>)-4-(2-amino-5-(4-methoxybenzyloxy)phenylamino)-<i>N</i>-isopropylcyclohexanecarboxamide (421 mg, quantitative yield). LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 412.2 (M + H).</div><div class="NLM_p">Step 4: To a solution of (1<i>s</i>,4<i>s</i>)-4-(2-amino-5-(4-methoxybenzyloxy)phenylamino)-<i>N</i>-isopropylcyclohexanecarboxamide (400 mg, 0.97 mmol) in ethanol (4.9 mL) was added cyanogen bromide (165 mg, 1.55 mmol), and the reaction was stirred at ambient temperature for 2 h. The reaction mixture was concentrated, and the residue was redissolved in DCM (10 mL), washed with water, 1 N aqueous sodium hydroxide, and brine. The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated to produce (1<i>s</i>,4<i>s</i>)-4-(2-amino-6-((4-methoxybenzyloxy)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-<i>N</i>-isopropylcyclohexanecarboxamide. LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 437.2 (M + H).</div><div class="NLM_p">Step 5: To a solution of (1<i>s</i>,4<i>s</i>)-4-(2-amino-6-((4-methoxybenzyloxy)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-<i>N</i>-isopropylcyclohexanecarboxamide (424 mg, 0.97 mmol) and 4-fluorobenzoyl chloride (0.17 mL, 1.46 mmol) in DCM was added triethylamine (0.27 mL, 1.94 mmol), and the reaction was stirred at ambient temperature for 10 min. The reaction mixture was then diluted with DCM, washed with water and brine, and concentrated. After column chromatography, eluting with 0–10% methanol in DCM, a mixture of the mono- and bis-acylated products, in an approximately 2:1 ratio, was obtained.</div><div class="NLM_p">The mixture of products was redissolved in methanol (3.25 mL) and 1,4-dioxane (3.25 mL) and treated with sodium hydroxide (47 mg, 1.17 mmol). After 1 h, the reaction mixture was diluted with DCM, washed with 1 N aqueous sodium hydroxide and brine, and concentrated. The residue was purified by column chromatography, eluting with 0–50% ethyl acetate in hexanes, to produce (<i>E</i>)-4-fluoro-<i>N</i>-(1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-6-((4-methoxybenzyl)oxy)-1<i>H</i>-benzo[d]imidazol-2(3<i>H</i>)-ylidene)benzamide (275 mg, 51% yield). LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 559.2 (M + H).</div><div class="NLM_p">Step 6: To a solution of (<i>E</i>)-4-fluoro-<i>N</i>-(1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-6-((4-methoxybenzyl)oxy)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (232 mg, 0.42 mmol) in DCM was added trifluoroacetic acid (96 μL, 1.25 mmol), and the reaction was stirred at ambient temperature for 90 min. Another portion of trifluoroacetic acid (96 μL, 1.25 mmol) was added, and the reaction was stirred at ambient temperature for an additional hour. The reaction was then partitioned between DCM and 1 N aqueous sodium hydroxide. The aqueous layer was washed with DCM, and the pH was adjusted to about 8 with 6 N aqueous HCl and saturated aqueous ammonium chloride. The resulting precipitate was collected by vacuum filtration, washed with water, and dried in vacuo to produce (<i>E</i>)-4-fluoro-<i>N</i>-(6-hydroxy-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[d]imidazol-2(3<i>H</i>)-ylidene)benzamide. LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 439.2 (M + H).</div><div class="NLM_p last">To a solution of (<i>E</i>)-4-fluoro-<i>N</i>-(6-hydroxy-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide and cesium carbonate (166 mg, 0.511 mmol) in NMP (0.6 mL) in a microwave vial was added 2-chloropyridine (0.036 mL,0.383 mmol), and the reaction was irradiated for 6 h at 160 °C in a Biotage Initiator microwave. The reaction mixture was partitioned between water and ethyl acetate, and the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product was purified by preparative HPLC, using a gradient of 10–90% [0.1% TFA in acetonitrile] in [0.1% TFA in water]. The product fractions were partitioned between saturated aqueous sodium bicarbonate and 5% 2-propanol in DCM. The organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated to produce <b>28</b> (32 mg, 35% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.81 (s, 1 H), 8.27–8.38 (m, 2 H), 8.07–8.19 (m, 1 H), 7.80–7.90 (m, 1 H), 7.51–7.62 (m, 2 H), 7.48 (d, <i>J</i> = 2.05 Hz, 1 H), 7.20–7.29 (m, 2 H), 7.00–7.18 (m, 1 H), 6.97 (dd, <i>J</i> = 8.56 Hz, 2.10 Hz, 1 H), 6.95–7.10 (m, 1 H), 4.80–4.95 (m, 1 H), 3.75–3.93 (m, 1 H), 2.56–2.77 (m, 2 H), 2.42–2.56 (m, 1 H), 2.01–2.14 (m, 2 H), 1.54–1.82 (m, 4 H), 0.98 (d, <i>J</i> = 8.00 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>29</sub>H<sub>31</sub>FN<sub>5</sub>O<sub>3</sub>, 516.2405; found, 516.2410.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>E</i>)-4-Fluoro-<i>N</i>-(1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-6-(piperazin-1-ylmethyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>29</b>)</h3><div class="NLM_p last">General procedure B, with piperazine (190 mg, 2.21 mmol), was used to produce <b>29</b> (58 mg, 50.4% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.30 (dd, <i>J</i> = 5.8 Hz, 8.8 Hz, 2 H), 7.67 (d, <i>J</i> = 7.9 Hz, 1 H), 7.61 (s, 1 H), 7.48 (d, <i>J</i> = 8.2 Hz, 1 H), 7.24 (dd, <i>J</i> = 8.8 Hz, 9.0 Hz, 2 H), 7.15 (d, <i>J</i> = 8.1 Hz, 1 H), 4.79–4.92 (m, 1 H), 3.98–4.10 (m, 1 H), 3.55 (s, 2 H), 2.80–2.91 (m, 2 H), 2.64–2.79 (m, 2 H), 2.53–2.57 (m, 1 H), 2.34–2.44 (m, 4 H), 2.09–2.19 (m, 2 H), 1.55–1.79 (m, 4 H), 1.21–1.30 (m, 1 H), 1.11 (d, <i>J</i> = 6.6 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>29</sub>H<sub>38</sub>FN<sub>6</sub>O<sub>2</sub>, 521.3035; found, 521.3034.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>E</i>)-4-Fluoro-<i>N</i>-(1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-6-((3-oxopiperazin-1-yl)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>30</b>)</h3><div class="NLM_p last">General procedure B, with piperazin-2-one (221 mg, 2.21 mmol), was used to produce <b>30</b> (72 mg, 50.3% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.79 (br, 1 H), 8.26–8.38 (m, 2 H), 7.65 (d, <i>J</i> = 7.5 Hz, 1 H), 7.69–7.82 (m, 1 H), 7.49–7.60 (m, 2 H), 7.13–7.30 (m, 3 H), 4.73–4.91 (m, 1 H), 3.98–4.10 (m, 1 H), 3.54–3.63 (m, 2 H), 3.12–3.26 (m, 2 H), 2.65–3.03 (m, 4 H), 2.53–2.61 (m, 1 H), 2.09–2.20 (m, 2 H), 1.57–1.79 (m, 4 H), 1.11 (d, <i>J</i> = 6.7 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>29</sub>H<sub>36</sub>FN<sub>6</sub>O<sub>3</sub>, 535.2827; found, 535.2827.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>E</i>)-<i>N</i>-(6-((4-(Aminomethyl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)-4-fluorobenzamide (<b>31</b>)</h3><div class="NLM_p">Step 1: Using the reaction sequence described for the synthesis of <b>25</b>, substituting <i>tert</i>-butyl piperidine-4-ylcarbamate (Matrix Scientific) for piperidine, <b>9</b> (400 mg, 0.94 mmol) was converted to <i>tert</i>-butyl ((1-(((<i>E</i>)-2-((4-fluorobenzoyl)imino)-3-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)methyl)piperidin-4-yl)methyl)carbamate.</div><div class="NLM_p last">Step 2: The <i>tert</i>-butyl ((1-(((<i>E</i>)-2-((4-fluorobenzoyl)imino)-3-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)methyl)piperidin-4-yl)methyl)carbamate was suspended in a solution of 4 M HCl in 1,4-dioxane (23.5 mL. 94 mmol), and the reaction was stirred at ambient temperature overnight. After 16 h, the reaction mixture was concentrated. The residue was resuspended in DCM, washed with aqueous sodium bicarbonate, and concentrated. The crude product was purified by column chromatography, eluting with 10–100% [9:1 DCM/methanol with 1% ammonium hydroxide] in [0.1% ammonium hydroxide in DCM] to produce <b>31</b> (300 mg, 58% yield over two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31 (dd, <i>J</i> = 4.9 Hz, 8.9 Hz, 2 H), 7.64 (d, <i>J</i> = 7.4 Hz, 1 H), 7.58 (s, 1 H), 7.47 (d, <i>J</i> = 8.1 Hz, 1 H), 7.24 (dd, <i>J</i> = 8.9 Hz, 8.9 Hz, 2 H), 7.14 (dd, <i>J</i> = 1.2 Hz, 8.2 Hz, 1 H), 4.79–4.92 (m, 1 H), 3.80–4.09 (m, 1 H), 3.51 (s, 2 H), 2.65–2.88 (m, 4 H), 2.52–2.56 (m, 1 H), 2.45 (d, <i>J</i> = 5.9 Hz, 1 H), 2.09–2.19 (m, 2 H), 1.84–1.93 (m, 2 H), 1.54–1.78 (m, 6 H), 1.13–1.35 (m, 5 H), 1.11 (d, <i>J</i> = 6.7 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>31</sub>H<sub>42</sub>FN<sub>6</sub>O<sub>2</sub>, 549.3348; found, 549.3352.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-(((<i>E</i>)-2-((4-Fluorobenzoyl)imino)-3-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)methyl)piperidine-2-carboxylic acid hydrochloride (<b>32</b>)</h3><div class="NLM_p">Step 1: To a suspension of <i>tert</i>-butyl piperidine-2-carboxylate hydrochloride (AstaTech, Inc., 229 mg, 1.38 mmol) in DCM (5 mL) was added 1 N aqueous sodium hydroxide (1.38 mL, 1.38 mmol), and the mixture was shaken. The layers were separated, and the organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated to produce <i>tert</i>-butyl piperidine-2-carboxylate.</div><div class="NLM_p last">Step 2: To a suspension of <b>22</b> (0.042 g, 0.093 mmol) in DCM (1 mL) at 0 °C was added thionyl chloride (0.11 g, 0.93 mmol), and the reaction was stirred at ambient temperature for 30 min. After 30 min, the reaction mixture was concentrated and dried in vacuo. The residue was suspended in DMSO (2 mL), and <i>tert</i>-butyl piperidine-2-carboxylate (100 mg, 0.538 mmol) was added. The reaction was stirred at ambient temperature for 2 h, diluted with water (2 mL), and extracted with DCM (10 mL). The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated. The crude ester was purified by preparative HPLC, using a gradient of 10–70% [0.1% TFA in acetonitrile] in [0.1% TFA in water]. The product fractions were combined and concentrated to produce <i>tert</i>-butyl 1-(((<i>E</i>)-2-((4-fluorobenzoyl)imino)-3-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)methyl)piperidine-2-carboxylate, which was then dissolved in 4 M HCl in 1,4-dioxane (1.16 mL, 4.64 mmol) and stirred for 16 h at ambient temperature. The reaction mixture was concentrated and dried in vacuo to produce <b>32</b> (20 mg, 35.9% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.09 (br s, 1 H), 8.34 (dd, <i>J</i> = 5.9 Hz, 8.6 Hz, 2 H), 7.82 (s, 1 H), 7.72 (d, <i>J</i> = 7.5 Hz, 1 H), 7.61 (d, <i>J</i> = 8.3 Hz, 1 H), 7.21–7.34 (m, 3 H), 4.62–4.77 (m, 1 H), 4.41–4.59 (m, 1 H), 4.20–4.30 (m, 3 H), 3.97–4.11 (m, 1 H), 3.35–3.44 (m, 1 H), 3.00–3.13 (m, 1 H), 2.78–2.96 (m, 2 H), 2.53–2.59 (m, 1 H), 2.06–2.27 (m, 3 H), 1.59–1.85 (m, 8 H), 1.42–1.59 (m, 1 H), 1.09 (d, <i>J</i> = 6.6 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>31</sub>H<sub>39</sub>FN<sub>5</sub>O<sub>4</sub>, 564.2981; found, 564.2978.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-(((<i>E</i>)-2-((4-Fluorobenzoyl)imino)-3-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)methyl)piperidine-4-carboxylic acid hydrochloride (<b>33</b>)</h3><div class="NLM_p last"><b>33</b> (20 mg, 24.3% yield) was prepared according to the procedures in <b>32</b>, substituting <i>tert</i>-butyl piperidine-4-carboxylate hydrochloride (0.229 g, 1.38 mmol) for <i>tert</i>-butyl piperidine-2-carboxylate hydrochloride. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.05 (br s, 1 H), 8.31–8.38 (m, 2 H), 7.78–7.93 (m, 1 H), 7.69 (d, <i>J</i> = 7.5 Hz, 1 H), 7.59 (d, <i>J</i> = 8.2 Hz, 1 H), 7.24 (dd, <i>J</i> = 8.7 Hz, 8.7 Hz, 2 H), 4.62–4.75 (m, 1 H), 4.30–4.41 (m, 2 H), 4.00–4.10 (m, 1 H), 3.65–3.74 (m, 1 H), 3.41–3.50 (m, 1 H), 2.82–3.05 (m, 3 H), 2.56–2.62 (m, 1 H), 1.93–2.18 (m, 4 H), 1.54–1.89 (m, 4 H), 1.19–1.32 (m, 2 H), 1.09 (d, <i>J</i> = 6.6 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>31</sub>H<sub>39</sub>FN<sub>5</sub>O<sub>4</sub>, 564.2981; found, 564.2985.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-(((<i>E</i>)-2-((4-Fluorobenzoyl)imino)-3-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)methyl)piperidine-4-carboxamide (<b>34</b>)</h3><div class="NLM_p last">General procedure B, with piperidine-4-carboxamide (283 mg, 2.21 mmol), was used to produce <b>34</b> (57 mg, 46.0% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.96 (br s, 1 H), 8.32 (dd, <i>J</i> = 6.1 Hz, 14.2 Hz, 2 H), 8.10 (d, <i>J</i> = 6.8 Hz, 1 H), 7.54–7.70 (m, 2 H), 7.37–7.47 (m, 1 H), 7.26 (dd, <i>J</i> = 6.7 Hz, 8.8 Hz, 2 H), 4.72–4.97 (m, 3 H), 3.59–3.72 (m, 2 H), 3.37–3.52 (m, 2 H), 3.16–3.27 (m, 1 H), 2.71–2.94 (m, 2 H), 2.41–2.48 (m, 1 H), 2.21–2.35 (m, 2 H), 1.89–2.02 (m, 2 H), 1.53–1.80 (m, 5 H), 1.07–1.15 (m, 3 H), 0.75–0.89 (m, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>31</sub>H<sub>40</sub>FN<sub>6</sub>O<sub>3</sub>, 563.3140; found, 563.3144.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>S</i>)-1-(((<i>E</i>)-2-((4-Fluorobenzoyl)imino)-3-((1<i>s</i>,4<i>R</i>)-4-(isopropylcarbamoyl)cyclohexyl)-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)methyl)pyrrolidine-2-carboxamide (<b>35</b>)</h3><div class="NLM_p last">General procedure B, with (<i>S</i>)-pyrrolidine-2-carboxamide (Bachem AG, 252 mg, 2.21 mmol), was used to produce <b>35</b> (41 mg, 33.9% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.73 (br s, 1 H), 8.31 (dd, <i>J</i> = 5.8 Hz, 8.8 Hz, 2 H), 7.92 (s, 1 H), 7.74 (d, <i>J</i> = 7.7 Hz, 1 H), 7.25 (dd, <i>J</i> = 8.9 Hz, 8.9 Hz, 2 H), 7.43–7.53 (m, 2 H), 7.14 (d, <i>J</i> = 8.2 Hz, 1 H), 7.01–7.07 (m, 1 H), 4.87–4.99 (m, 1 H), 3.92–4.06 (m, 2 H), 3.42–3.49 (m, 1 H), 2.87–3.00 (m, 2 H), 2.65–2.79 (m, 1 H), 2.53–2.59 (m, 1 H), 2.01–2.27 (m, 4 H), 1.56–1.83 (m, 8 H), 1.07–1.13 (m, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>30</sub>H<sub>37</sub>FN<sub>6</sub>O<sub>3</sub>, 549.2984; found, 549.2982.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>E</i>)-4-Fluoro-<i>N</i>-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>36</b>)</h3><div class="NLM_p last">General procedure B, with <b>23</b> (TCI America, 200 mg, 1.39 mmol), was used to produce <b>36</b> (77 mg, 60.3% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.75 (br s, 1 H), 8.32 (dd, <i>J</i> = 6.0 Hz, 8.6 Hz, 2 H), 7.63 (d, <i>J</i> = 7.7 Hz, 1 H), 7.57 (s, 1 H), 7.48 (d, <i>J</i> = 7.9 Hz, 1 H), 7.24 (dd, <i>J</i> = 8.8 Hz, 8.8 Hz, 2 H), 7.16 (d, <i>J</i> = 7.8 Hz, 1 H), 4.76–4.91 (m, 1 H), 4.00–4.08 (m, 2 H), 3.43–3.58 (m, 2 H), 2.82–2.98 (m, 2 H), 2.65–2.80 (m, 2 H), 2.54–2.57 (m, 1 H), 2.11–2.20 (m, 2 H), 1.78–1.90 (m, 2 H), 1.59–1.78 (m, 6 H), 1.18–1.33 (m, 3 H), 1.11 (d, <i>J</i> = 6.6 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>33</sub>H<sub>45</sub>FN<sub>5</sub>O<sub>3</sub>, 578.3428; found, 578.3493.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>E</i>)-4-Fluoro-<i>N</i>-(6-(((<i>S</i>)-2-(2-hydroxypropan-2-yl)pyrrolidin-1-yl)methyl)-1-((1<i>s</i>,4<i>R</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>37</b>)</h3><div class="NLM_p last">General procedure B, with a premixed solution of (<i>S</i>)-2-(pyrrolidin-2-yl)propan-2-ol hydrochloride<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (183 mg, 1.11 mmol) and sodium hydride (60% dispersion in mineral oil, 44 mg, 1.11 mmol) in acetonitrile (2 mL), was used to produce <b>37</b> (44 mg, 35.3% yield) as a dark solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.71 (s, 1 H), 8.30 (dd, <i>J</i> = 5.9 Hz, 8.9 Hz, 2 H), 7.79 (s, 1 H), 7.70 (d, <i>J</i> = 8.0 Hz, 1 H), 7.46 (d, <i>J</i> = 8.0 Hz, 1 H), 7.22–7.29 (m, 2 H), 7.18 (d, <i>J</i> = 8.0 Hz, 1 H), 4.86–4.96 (m, 1 H), 4.36 (d, <i>J</i> = 13.3 Hz, 1 H), 4.14 (s, 1 H), 3.98–4.09 (m, 1 H), 3.51 (d, <i>J</i> = 14.4 Hz, 1 H), 2.76–2.90 (m, 3 H), 2.62–2.68 (m, 1 H), 2.52–2.57 (m, 1 H), 2.19–2.28 (m, 1 H), 2.07–2.13 (m, 2 H), 1.55–1.81 (m, 8 H), 1.14 (s, 6 H), 1.09 (d, <i>J</i> = 6.6 Hz, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>32</sub>H<sub>42</sub>FN<sub>5</sub>O<sub>3</sub>, 564.3344; found, 564.3342.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>E</i>)-4-Fluoro-<i>N</i>-(6-((3-(2-hydroxypropan-2-yl)pyrrolidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>38</b>)</h3><div class="NLM_p last">General procedure B, with 2-(pyrrolidin-3-yl)propan-2-ol hydrochloride<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (110 mg, 0.66 mmol) and triethylamine (0.15 mL, 1.11 mmol), was used to produce <b>38</b> (65 mg, 52.2% yield) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.74 (br s, 1 H), 8.32 (dd, <i>J</i> = 6.0 Hz, 8.7 Hz, 2 H), 7.55–7.66 (m, 2 H), 7.48 (d, <i>J</i> = 8.0 Hz, 1 H), 7.24 (dd, <i>J</i> = 8.9 Hz, 8.9 Hz, 2 H), 7.14–7.19 (m, 1 H), 4.75–4.90 (m, 1 H), 3.99–4.10 (m, 2 H), 3.45–3.77 (m, 2 H), 2.69–2.84 (m, 2 H), 2.52–2.63 (m, 2 H), 2.25–2.41 (m, 2 H), 2.09–2.19 (m, 2 H), 1.54–1.79 (m, 8 H), 1.11 (d, <i>J</i> = 6.7 Hz, 6 H), 1.03 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>32</sub>H<sub>43</sub>FN<sub>5</sub>O<sub>3</sub>, 564.3344; found, 564.3346.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>E</i>)-4-Fluoro-<i>N</i>-(6-(((2-hydroxy-2-methylpropyl)amino)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>39</b>)</h3><div class="NLM_p last">General procedure B, with 1-amino-2-methylpropan-2-ol (Tyger Scientific, 197 mg, 2.21 mmol), was used to produce <b>39</b> (24 mg, 17.1% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.75 (br s, 1 H), 8.32 (dd, <i>J</i> = 5.8 Hz, 8.6 Hz, 2 H), 7.60–7.70 (m, 2 H), 7.49 (d, <i>J</i> = 8.2 Hz, 1 H), 7.19–7.28 (m, 3 H), 4.75–4.88 (m, 1 H), 2.72–2.87 (m, 2 H), 3.99–4.10 (m, 1 H), 3.79–3.93 (m, 2 H), 2.52–2.57 (m, 1 H), 2.40–2.48 (m, 1 H), 2.09–2.17 (m, 2 H), 1.56–1.79 (m, 4 H), 1.23–1.28 (m, 2 H), 1.06–1.15 (m, 12 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>29</sub>H<sub>39</sub>FN<sub>5</sub>O<sub>3</sub>, 524.3031; found, 524.3032.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>E</i>)-4-Fluoro-<i>N</i>-(6-((3-(2-hydroxypropan-2-yl)azetidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>40</b>)</h3><div class="NLM_p last">General Procedure B, with 2-(azetidin-3-yl)propan-2-ol hydrochloride<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (101 mg, 0.66 mmol) and DBU (0.10 mL, 0.66 mmol), was used to produce <b>40</b> (26 mg, 21.4% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (br s, 1 H), 8.27–8.36 (m, 2 H), 7.55–7.70 (m, 2H), 7.50 (d, <i>J</i> = 5.9 Hz, 1 H), 7.24 (dd, <i>J</i> = 8.9 Hz, 8.9 Hz, 2 H), 7.12–7.20 (m, 1 H), 4.76–4.89 (m, 1 H), 4.01–4.11 (m, 1 H), 3.29 (s, 2 H), 2.70–2.85 (m, 2 H), 2.52–2.57 (m, 1 H), 2.09–2.19 (m, 2 H), 1.67–1.79 (m, 2 H), 1.57–1.67 (m, 2 H), 1.21–1.30 (m, 2 H), 1.11 (d, <i>J</i> = 6.6 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>31</sub>H<sub>41</sub>FN<sub>5</sub>O<sub>3</sub>, 550.3188; found, 550.3192.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-(1-(3-Fluoro-4-nitrobenzyl)piperidin-4-yl)propan-2-ol (<b>42</b>)</h3><div class="NLM_p last">To a solution of 3-fluoro-4-nitrobenzenecarbaldehyde (Bionet Research, 5.50 g, 32.5 mmol) in DCM (100 mL) was added acetic acid (0.17 mL). The reaction was cooled in an ice–water bath to 5 °C, and then <b>23</b> (4.66 g, 32.5 mmol) was added, followed by sodium triacetoxyborohydride (7.10 g, 33.5 mmol) and additional DCM (50 mL). The reaction was stirred at 5 °C for 45 min, allowed to warm to ambient temperature, and stirred at ambient temperature for 1 h. The reaction mixture was concentrated, and the residue was diluted with ethyl acetate and washed with saturated aqueous sodium bicarbonate and brine. The organic phase was concentrated, adsorbed onto a silica-gel loading column, and purified by chromatography, eluting with 50–100% ethyl acetate in hexanes, to afford <b>42</b> (8.48 g, 88% yield) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.02 (t, <i>J</i> = 8.0 Hz, 1 H), 7.34 (d, <i>J</i> = 8.1 Hz, 1 H), 7.27 (br s, 1 H), 3.55 (br s, 2 H), 2.87–2.98 (m, 2 H), 1.95–2.07 (m, 2 H), 1.53–1.87 (m, 2 H), 1.37–1.50 (m, 2 H), 1.29–1.35 (m, 1 H), 1.20 (s, 6 H). LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 297.2 (M + H).</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (1<i>s</i>,4<i>s</i>)-4-((5-((4-(2-Hydroxypropan-2-yl)piperidin-1-yl)methyl)-2-nitrophenyl)amino)-<i>N</i>-isopropylcyclohexanecarboxamide (<b>43</b>)</h3><div class="NLM_p last">To a solution of <b>42</b> (8.48 g, 28.6 mmol) in acetonitrile (50 mL) was added <b>19</b> (7.10 g, 32.2 mmol), followed by <i>N</i>,<i>N</i>-diisopropylethylamine (14.9 mL, 86 mmol). The reaction was stirred for 15 min at ambient temperature and then at 80 °C for 24 h. After cooling to ambient temperature, the reaction mixture was concentrated in vacuo, and the residue was partitioned between ethyl acetate and aqueous potassium carbonate. The aqueous layer was extracted with ethyl acetate three times; the combined organic phases were washed with brine and concentrated. The crude product was adsorbed onto a silica gel pad and eluted with ethyl acetate, followed by 90:10:1 DCM:methanol:ammonium hydroxide when the product began to elute. The product fractions were combined and concentrated; the residue was recrystallized from hot toluene/hexanes to afford <b>43</b> (9.62 g, 73% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.28 (d, <i>J</i> = 7.5 Hz, 1 H), 8.03 (d, <i>J</i> = 8.9 Hz, 1 H), 7.54 (d, <i>J</i> = 7.7 Hz, 1 H), 6.97 (s, 1 H), 6.65 (dd, <i>J</i> = 1.5 Hz, 8.9 Hz, 1 H), 4.01 (s, 1 H), 3.88–3.95 (m, 1 H), 3.77–3.87 (m, 1 H), 3.43 (s, 2 H), 2.70–2.98 (m, 2 H), 2.17–2.25 (m, 1 H), 1.79–1.92 (m, 4 H), 1.58–1.74 (m, 8 H), 1.10–1.30 (m, 3 H), 1.03 (d, <i>J</i> = 6.5 Hz, 6 H), 1.03 (s, 6 H). LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 461.2 (M + H).</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (1<i>s</i>,4<i>s</i>)-4-((2-Amino-5-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)phenyl)amino)-<i>N</i>-isopropylcyclohexanecarboxamide (<b>44</b>)</h3><div class="NLM_p last">To a slurry of 5% palladium on carbon (1.42 g, 0.667 mmol) in water (10 mL), under an argon atmosphere, was added ethanol (100 mL), followed by <b>43</b> (9.62 g, 20.9 mmol). The reaction was cooled in an ice–water bath, and ammonium formate (13.2 g, 209 mmol), and ethanol (20 mL) were added. The reaction was stirred at 5 °C for 135 min. The reaction was filtered through a Celite pad, and the filter cake was rinsed with ethanol and DCM. The combined filtrates were concentrated and partitioned between DCM and water. The aqueous layer was extracted twice with 1-butanol; the combined organic layers were washed with brine and concentrated. The crude product was adsorbed onto a silica gel pad and eluted with ethyl acetate, followed by 90:10:1 DCM:methanol:ammonium hydroxide when the product began to elute. The product-containing filtrate was concentrated; the resulting foam was recrystallized from toluene/hexanes to afford <b>44</b> (8.98 g, 100% yield) as a red solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.68 (d, <i>J</i> = 1.4 Hz, 1 H), 6.66 (d, <i>J</i> = 7.8 Hz, 1 H), 6.58 (dd, <i>J</i> = 1.7 Hz, 7.8 Hz, 1 H), 5.28 (d, <i>J</i> = 7.7 Hz, 1 H), 4.05–4.18 (m, 1 H), 3.57–3.63 (m, 1 H), 3.54 (s, 2 H), 2.97–3.21 (m, 2 H), 2.13–2.21 (m, 1 H), 1.98–2.07 (m, 2 H), 1.82–1.92 (m, 3 H), 1.66–1.77 (m, 6 H), 1.45–1.56 (m, 2 H), 1.26–1.35 (m, 1 H), 1.18 (s, 6 H), 1.16 (d, <i>J</i> = 6.6 Hz, 6 H).</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 3,5-Difluorobenzoyl Isothiocyanate (<b>45</b>)</h3><div class="NLM_p last">To a solution of potassium thiocyanate (5.65 mL, 111 mmol) in acetonitrile (65 mL) was added 3,5-difluorobenzoyl chloride (16.3 g, 92 mmol) dropwise via syringe, and the reaction was stirred for 2 h at 50 °C. After the reaction was complete, the reaction mixture was cooled to ambient temperature and the precipitated solids were removed by filtration. The filtrate was concentrated, and the residue was triturated with benzene. The precipitated solids were again removed by filtration, and the filtrate was concentrated. The residue was triturated with 3:2 benzene/hexanes, and the precipitated solids were again removed by filtration. The filtrate was concentrated in vacuo to generate <b>45</b> (10.9 g, 59% yield) as a light-orange liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56–7.62 (m, 2 H), 7.12 (tt, <i>J</i> = 2.4 Hz, 8.3 Hz, 1 H).</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (1<i>s</i>,4<i>s</i>)-4-(2-Amino-6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-<i>N</i>-isopropylcyclohexanecarboxamide (<b>46</b>)</h3><div class="NLM_p">Step 1: To a solution of <b>44</b> (1.86 g, 4.32 mmol) in 1,4-dioxane (22 mL) was added acetyl isothiocyanate (0.379 mL, 4.32 mmol), and the reaction was stirred at 100 °C for 5 min. After the reaction had cooled to ambient temperature, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.48 g, 13.0 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (2.72 mL, 15.6 mmol) were added, and the reaction was stirred at 60 °C for 1 h. The reaction mixture was then concentrated onto silica gel and purified by column chromatography, eluting with 90:10:1 DCM:methanol:ammonium hydroxide. The product fractions were combined and concentrated to produce (1<i>s</i>,4<i>s</i>)-4-(2-acetamido-6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-<i>N</i>-isopropylcyclohexanecarboxamide as an orange solid. LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 498.2 (M + H).</div><div class="NLM_p last">Step 2: A solution of (1<i>s</i>,4<i>s</i>)-4-(2-acetamido-6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-<i>N</i>-isopropylcyclohexanecarboxamide (2.16 g, 4.34 mmol) in 2 N aqueous HCl (33 mL) was stirred at 50 °C for 24 h. After concentrating the reaction mixture in vacuo, the crude product was adsorbed onto a silica gel loading column and purified by column chromatography, eluting with a gradient of 0–100% [9:1 DCM/methanol with 1% ammonium hydroxide] in DCM. The product fractions were combined and concentrated to produce <b>46</b> (1.63 g, 82% yield over two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.60 (d, <i>J</i> = 7.6 Hz, 1 H), 7.20 (s, 1 H), 7.02 (d, <i>J</i> = 8.0 Hz, 1 H), 6.84 (d, <i>J</i> = 8.0 Hz, 1 H), 6.19 (s, 2 H), 4.19 (br s, 1 H), 3.93–4.03 (m, 2 H), 3.40 (s, 2 H), 2.75–2.99 (m, 2 H), 2.41–2.47 (m, 2 H), 1.95–2.25 (m, 2 H), 1.78 (br s, 2 H), 1.50–1.65 (m, 6 H), 1.16–1.28 (m, 4 H), 1.12 (d, <i>J</i> = 6.5 Hz, 6 H), 1.01 (s, 6 H). LC/MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 456.2 (M + H).</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Preparation of <b>47</b>–<b>48</b> and <b>50</b>–<b>59</b>. General Procedure C</h3><div class="NLM_p last">To a solution of <b>46</b> (100 mg, 0.219 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.063 g, 0.329 mmol), <i>N</i>-hydroxybenzotriazole (0.034 g, 0.219 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (0.153 mL, 0.878 mmol) in DMF (0.439 mL) was added a benzoic acid (0.219 mmol). The reaction was stirred at 50 °C for 2 h and then stirred at ambient temperature overnight. The reaction mixture was diluted with ethyl acetate and washed with water and brine; the organic layer was dried over sodium sulfate, filtered, and concentrated. The crude product was purified via reverse-phase preparative HPLC to provide the desired product.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>E</i>)-<i>N</i>-(6-((4-(2-Hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>47</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using benzoic acid. The crude product was purified using a gradient of 20–80% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>47</b> (27 mg, 22.3% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.75 (br s, 1 H), 8.26 (d, <i>J</i> = 7.2 Hz, 2 H), 7.63 (d, <i>J</i> = 7.6 Hz, 1 H), 7.56 (s, 1 H), 7.43–7.53 (m, 4 H), 7.15 (d, <i>J</i> = 8.1 Hz, 1 H), 4.79–4.93 (m, 1 H), 4.03–4.12 (m, 1 H), 4.01 (s, 1 H), 3.51 (s, 2 H), 2.82–2.96 (m, 2 H), 2.65–2.78 (m, 2 H), 2.51–2.56 (m, 1 H), 2.11–2.21 (m, 2 H), 1.78–1.93 (m, 2 H), 1.55–1.78 (m, 6 H), 1.20–1.32 (m, 2 H), 1.13–1.18 (m, 1 H), 1.11 (d, <i>J</i> = 6.6 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>33</sub>H<sub>46</sub>N<sub>5</sub>O<sub>3</sub>, 560.3595; found, 560.3598.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>E</i>)-3-Fluoro-<i>N</i>-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>48</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using 3-fluorobenzoic acid. The crude product was purified using a gradient of 20–80% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>48</b> (33 mg, 39.5% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.80 (br s, 1 H), 8.11 (d, <i>J</i> = 7.8 Hz, 1 H), 7.94 (d, <i>J</i> = 9.9 Hz, 1 H), 7.43–7.69 (m, 4 H), 7.29–7.39 (m, 1 H), 7.11–7.23 (m, 1 H), 4.80–4.92 (m, 1 H), 3.94–4.13 (m, 2 H), 3.44–3.58 (m, 2 H), 2.81–2.96 (m, 2 H), 2.64–2.80 (m, 2 H), 2.51–2.56 (m, 1 H), 2.09–2.21 (m, 2 H), 1.54–1.92 (m, 8 H), 1.20–1.37 (m, 2 H), 1.13–1.19 (m, 1 H), 1.10 (d, <i>J</i> = 6.6 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>33</sub>H<sub>45</sub>FN<sub>5</sub>O<sub>3</sub>, 578.3501; found, 578.3500.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>E</i>)-3,5-Difluoro-<i>N</i>-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>49</b>)</h3><div class="NLM_p">To a solution of <b>44</b> (8.98 g, 20.9 mmol) in THF (80 mL) at 0 °C was added a solution of <b>45</b> (4.57 g, 22.9 mmol) in THF. The reaction was stirred at 0 °C for 30 min and then warmed to 20 °C and stirred for 1.5 h to form the thiourea intermediate.</div><div class="NLM_p last">To the reaction mixture were added <i>N</i>,<i>N</i>-diisopropylethylamine (4.37 mL, 25.02 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (4.80 g, 25.02 mmol), and the reaction was stirred at 60 °C for 1 h. The reaction mixture was diluted with ethyl acetate, washed with water and brine, and concentrated. The crude product was adsorbed onto a silica gel loading column and purified by column chromatography, eluting with 1:1 ethyl acetate/hexanes, followed by 5–10% [9:1 DCM/methanol with 1% ammonium hydroxide] in DCM. The product fractions were combined and concentrated; the residue was recrystallized from acetonitrile to produce <b>49</b> (8.95 g, 72% yield) as an off-white crystalline solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.81 (s, 1 H), 7.85 (dd, <i>J</i> = 2.3 Hz, 8.4 Hz, 2 H), 7.56–7.64 (m, 2 H), 7.50 (d, <i>J</i> = 8.2 Hz, 1 H), 7.38 (tt, <i>J</i> = 9.0 Hz, 2.4 Hz, 1 H), 7.18 (dd, <i>J</i> = 8.2 Hz, 8.2 Hz, 1 H), 4.78–4.90 (m, 1 H), 4.00–4.11 (m, 1 H), 3.99 (s, 1 H), 3.50 (s, 2 H), 2.85–2.92 (m, 2 H), 2.63–2.82 (m, 2 H), 2.51–2.56 (m, 1 H), 2.06–2.19 (m, 2 H), 1.69–1.91 (m, 4 H), 1.56–1.69 (m, 4 H), 1.18–1.35 (m, 2 H), 1.12–1.18 (m, 1 H), 1.09 (d, <i>J</i> = 3.6 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>33</sub>H<sub>43</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>, 596.3407; found, 596.3409.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>E</i>)-<i>N</i>-(6-((4-(2-Hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)isonicotinamide (<b>50</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using isonicotinic acid. The crude product was purified using a gradient of 15–75% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>50</b> (27 mg, 21.3% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.83 (s, 1 H), 8.70 (dd, <i>J</i> = 1.5 Hz, 4.5 Hz, 2H), 8.11 (dd, <i>J</i> = 1.5 Hz, 4.5 Hz, 2 H), 7.63 (d, <i>J</i> = 7.6 Hz, 1 H), 7.58 (s, 1 H), 7.50 (d, <i>J</i> = 8.1 Hz, 1 H), 7.18 (d, <i>J</i> = 8.1 Hz, 1 H), 4.80–4.91 (m, 1 H), 4.02–4.11 (m, 1 H), 4.00 (s, 1 H), 3.50 (s, 2 H), 2.85–2.93 (m, 2 H), 2.69–2.81 (m, 2 H), 2.52–2.56 (m, 1 H), 2.12–2.20 (m, 2 H), 1.79–1.88 (m, 2 H), 1.68–1.79 (m, 2 H), 1.58–1.68 (m, 4 H), 1.20–1.31 (m, 2 H), 1.12–1.18 (m, 1 H), 1.10 (d, <i>J</i> = 6.5 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>32</sub>H<sub>45</sub>N<sub>6</sub>O<sub>3</sub>, 561.3548; found, 561.3548.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>E</i>)-4-Cyano-<i>N</i>-(6-((4-(2-Hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>51</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using 4-cyanobenzoic acid. The crude product was purified using a gradient of 20–80% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>51</b> (32 mg, 20.5% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.83 (br s, 1 H), 8.41 (d, <i>J</i> = 8.4 Hz, 2 H), 7.91 (d, <i>J</i> = 8.4 Hz, 2 H), 7.64 (d, <i>J</i> = 7.6 Hz, 1 H), 7.58 (s, 1 H), 7.50 (d, <i>J</i> = 8.1 Hz, 1 H), 7.18 (d, <i>J</i> = 8.2 Hz, 1 H), 4.81–4.92 (m, 1 H), 4.01–4.09 (m, 1 H), 4.00 (s, 1 H), 3.50 (s, 2 H), 2.83–2.93 (m, 2 H), 2.66–2.80 (m, 2 H), 2.52–2.56 (m, 1 H), 2.10–2.19 (m, 2 H), 1.79–1.89 (m, 2 H), 1.68–1.79 (m, 2 H), 1.58–1.67 (m, 4 H), 1.18–1.31 (m, 2 H), 1.13–1.17 (m, 1 H), 1.11 (d, <i>J</i> = 6.5 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>34</sub>H<sub>45</sub>N<sub>6</sub>O<sub>3</sub>, 585.3548; found, 585.3549.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>E</i>)-<i>N</i>-(6-((4-(2-Hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)nicotinamide (<b>52</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using nicotinic acid. The crude product was purified using a gradient of 15–75% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>52</b> (27 mg, 23.2% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.79 (s, 1 H), 9.36 (d, <i>J</i> = 1.4 Hz, 1 H), 8.69 (dd, <i>J</i> = 1.7 Hz, 4.7 Hz, 1 H), 8.56 (d, <i>J</i> = 7.8 Hz, 1 H), 7.63 (d, <i>J</i> = 7.6 Hz, 1 H), 7.58 (s, 1 H), 7.46–7.53 (m, 2 H), 7.18 (d, <i>J</i> = 8.2 Hz, 1 H), 4.85–4.94 (m, 1 H), 4.02–4.11 (m, 1 H), 4.01 (s, 1 H), 3.50 (s, 2 H), 2.83–2.93 (m, 2 H), 2.66–2.77 (m, 2 H), 2.51–2.56 (m, 1 H), 2.12–2.19 (m, 2 H), 1.80–1.88 (m, 2 H), 1.69–1.80 (m, 2 H), 1.58–1.69 (m, 4 H), 1.20–1.32 (m, 2 H), 1.13–1.17 (m, 1 H), 1.11 (d, <i>J</i> = 6.5 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>32</sub>H<sub>45</sub>N<sub>6</sub>O<sub>3</sub>, 561.3548; found, 561.3552.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>E</i>)-3,4-Difluoro-<i>N</i>-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>53</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using 3,4-difluorobenzoic acid. The crude product was purified using a gradient of 30–90% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>53</b> (35 mg, 16.4% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (s, 1 H), 8.15–8.22 (m, 1 H), 8.09–8.15 (m, 1 H), 7.63 (d, <i>J</i> = 7.7 Hz, 1 H), 7.56 (s, 1 H), 7.44–7.52 (m, 2 H), 7.16 (d, <i>J</i> = 8.3 Hz, 1 H), 4.77–4.88 (m, 1 H), 4.01–4.10 (m, 1 H), 4.00 (s, 1 H), 3.49 (s, 2 H), 2.84–2.93 (m, 2 H), 2.68–2.80 (m, 2 H), 2.51–2.56 (m, 1 H), 2.07–2.18 (m, 2 H), 1.79–1.88 (m, 2 H), 1.68–1.79 (m, 2 H), 1.55–1.68 (m, 4 H), 1.20–1.32 (m, 2 H), 1.12–1.17 (m, 1 H), 1.10 (d, <i>J</i> = 6.6 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>33</sub>H<sub>44</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>, 596.3407; found, 596.3406.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (<i>E</i>)-3-Cyano-5-fluoro-<i>N</i>-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>54</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using 3-cyano-5-fluorobenzoic acid. The crude product was purified using a gradient of 30–90% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>54</b> (36 mg, 17.6% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.87 (br s, 1 H), 8.43 (s, 1 H), 8.32 (d, <i>J</i> = 1.0 Hz, 1 H), 7.96–8.03 (m, 1 H), 7.58–7.65 (m, 2 H), 7.52 (d, <i>J</i> = 8.1 Hz, 1 H), 7.19 (d, <i>J</i> = 8.2 Hz, 1 H), 4.78–4.90 (m, 1 H), 4.02–4.13 (m, 1 H), 4.00 (s, 1 H), 3.50 (s, 2 H), 2.85–2.92 (m, 2 H), 2.72–2.84 (m, 2 H), 2.52–2.57 (m, 1 H), 2.06–2.15 (m, 2 H), 1.68–1.90 (m, 4 H), 1.58–1.67 (m, 4 H), 1.19–1.31 (m, 2 H), 1.11–1.18 (m, 1 H), 1.08 (d, <i>J</i> = 6.5 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>34</sub>H<sub>44</sub>FN<sub>6</sub>O<sub>3</sub>, 603.3453; found, 603.3452.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (<i>E</i>)-3-Cyano-<i>N</i>-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>55</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using 3-cyanobenzoic acid. The crude product was purified using a gradient of 20–80% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>55</b> (32 mg, 20.2% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.83 (br s, 1 H), 8.60 (d, <i>J</i> = 7.9 Hz, 1 H), 8.56 (s, 1 H), 7.98 (dd, <i>J</i> = 1.3 Hz, 7.7 Hz, 1 H), 7.68 (dd, <i>J</i> = 7.7 Hz, 7.7 Hz, 1 H), 7.63 (d, <i>J</i> = 7.6 Hz, 1 H), 7.58 (s, 1 H), 7.51 (d, <i>J</i> = 8.2 Hz, 1 H), 7.17 (d, <i>J</i> = 8.1 Hz, 1 H), 4.80–4.91 (m, 1 H), 4.03–4.13 (m, 1 H), 4.00 (s, 1 H), 3.50 (s, 2 H), 2.83–2.93 (m, 2 H), 2.69–2.83 (m, 2 H), 2.51–2.56 (m, 1 H), 2.08–2.19 (m, 2 H), 1.69–1.90 (m, 4 H), 1.55–1.69 (m, 4 H), 1.18–1.31 (m, 2 H), 1.12–1.18 (m, 1 H), 1.10 (d, <i>J</i> = 6.5 Hz, 6 H), 1.01 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>34</sub>H<sub>45</sub>N<sub>6</sub>O<sub>3</sub>, 585.3548; found, 585.3548.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>E</i>)-3-Chloro-5-fluoro-<i>N</i>-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>56</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using 3-chloro-5-fluorobenzoic acid. The crude product was purified using a gradient of 30–90% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>56</b> (38 mg, 21.4% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.82 (br s, 1 H), 7.96–8.05 (m, 2 H), 7.54–7.66 (m, 3 H), 7.51 (d, <i>J</i> = 8.1 Hz, 1 H), 7.18 (d, <i>J</i> = 8.1 Hz, 1 H), 4.80–4.91 (m, 1 H), 4.01–4.10 (m, 1 H), 4.00 (s, 1 H), 3.50 (s, 2 H), 2.84–2.92 (m, 2 H), 2.64–2.79 (m, 2 H), 2.51–2.56 (m, 1 H), 2.05–2.19 (m, 2 H), 1.79–1.89 (m, 2 H), 1.67–1.79 (m, 2 H), 1.59–1.67 (m, 4 H), 1.12–1.31 (m, 3 H), 1.10 (d, <i>J</i> = 6.5 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>33</sub>H<sub>44</sub>ClFN<sub>5</sub>O<sub>3</sub>, 612.3111; found, 612.3116.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (<i>E</i>)-3-Chloro-<i>N</i>-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>57</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using 3-chlorobenzoic acid. The crude product was purified using a gradient of 30–90% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>57</b> (34 mg, 21.4% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.82 (br s, 1 H), 7.96–8.05 (m, 2 H), 7.54–7.66 (m, 3 H), 7.51 (d, <i>J</i> = 8.1 Hz, 1 H), 7.18 (d, <i>J</i> = 8.1 Hz, 1 H), 4.80–4.91 (m, 1 H), 4.01–4.10 (m, 1 H), 4.00 (s, 1 H), 3.50 (s, 2 H), 2.84–2.92 (m, 2 H), 2.64–2.79 (m, 2 H), 2.51–2.56 (m, 1 H), 2.05–2.19 (m, 2 H), 1.79–1.89 (m, 2 H), 1.67–1.79 (m, 2 H), 1.59–1.67 (m, 4 H), 1.18–1.31 (m, 2 H), 1.14–1.17 (m, 1 H), 1.10 (d, <i>J</i> = 6.5 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>33</sub>H<sub>45</sub>ClN<sub>5</sub>O<sub>3</sub>, 594.3205; found, 594.3204.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (<i>E</i>)-3-Chloro-4-fluoro-<i>N</i>-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>58</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using 3-chloro-4-fluorobenzoic acid. The crude product was purified using a gradient of 30–90% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>58</b> (38 mg, 21.4% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (br s, 1 H), 8.27–8.34 (m, 2 H), 7.63 (d, <i>J</i> = 7.6 Hz, 1 H), 7.57 (s, 1 H), 7.43–7.54 (m, 2 H), 7.16 (d, <i>J</i> = 8.2 Hz, 1 H), 4.80–4.90 (m, 1 H), 4.02–4.11 (m, 1 H), 4.00 (s, 1 H), 3.49 (s, 2 H), 2.84–2.92 (m, 2 H), 2.66–2.79 (m, 2 H), 2.51–2.57 (m, 1 H), 2.09–2.18 (m, 2 H), 1.78–1.88 (m, 2 H), 1.67–1.78 (m, 2 H), 1.55–1.67 (m, 4 H), 1.20–1.30 (m, 2 H), 1.12–1.17 (m, 1 H), 1.11 (d, <i>J</i> = 6.5 Hz, 6 H), 1.01 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>33</sub>H<sub>44</sub>ClFN<sub>5</sub>O<sub>3</sub>, 612.3111; found, 612.3111.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (<i>E</i>)-4-Cyano-3-fluoro-<i>N</i>-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1<i>s</i>,4<i>s</i>)-4-(isopropylcarbamoyl)cyclohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ylidene)benzamide (<b>59</b>)</h3><div class="NLM_p last">The title compound was prepared by general procedure C using 4-cyano-3-fluorobenzoic acid. The crude product was purified using a gradient of 30–90% [0.1% TFA in acetonitrile] in [0.1% TFA in water] to produce <b>59</b> (36 mg, 21.5% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.87 (br s, 1 H), 8.20–8.27 (m, 2 H), 7.96–8.02 (m, 1 H), 7.57–7.67 (m, 2 H), 7.52 (d, <i>J</i> = 8.2 Hz, 1 H), 7.19 (d, <i>J</i> = 8.1 Hz, 1 H), 4.79–4.90 (m, 1 H), 4.01–4.10 (m, 1 H), 4.00 (s, 1 H), 3.50 (s, 2 H), 2.83–2.93 (m, 2 H), 2.70–2.82 (m, 2 H), 2.51–2.56 (m, 1 H), 2.08–2.16 (m, 2 H), 1.69–1.89 (m, 4 H), 1.59–1.67 (m, 4 H), 1.19–1.31 (m, 2 H), 1.12–1.18 (m, 1 H), 1.10 (d, <i>J</i> = 6.6 Hz, 6 H), 1.02 (s, 6 H). HRMS (<i>m</i>/<i>z</i>): [MH<sup>+</sup>] calcd for C<sub>34</sub>H<sub>44</sub>FN<sub>6</sub>O<sub>3</sub>, 603.3453; found, 603.3450.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67"><a href="/doi/suppl/10.1021/jm3005866">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35840" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35840" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">IC<sub>50</sub> data from which the selectivity ratios are derived for the off-target kinases, together with protocols for in vitro selectivity assays, xenograft study, and X-ray crystallography.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3005866/suppl_file/jm3005866_si_001.pdf">jm3005866_si_001.pdf (201.34 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3005866" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard T. Lewis</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#26544f454e475442084a43514f5566474b4143480845494b"><span class="__cf_email__" data-cfemail="93e1faf0fbf2e1f7bdfff6e4fae0d3f2fef4f6fdbdf0fcfe">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christiane M. Bode</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah M. Choquette</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michele Potashman</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karina Romero</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John C. Stellwagen</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yohannes Teffera</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Earl Moore</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas A. Whittington</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hao Chen</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linda F. Epstein</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Renee Emkey</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul S. Andrews</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Violeta L. Yu</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas C. Saffran</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Man Xu</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allison Drew</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia Merkel</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Szilvassy</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachael L. Brake</span> - <span class="hlFld-Affiliation affiliation">Amgen Inc., 360 Binney Street, Cambridge Massachusetts 02142, United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s):The authors are employees of Amgen Inc.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1828e5533-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Kavita Shah and Roman Shimanovich are thanked for their assistance with formulation of compounds for in vivo studies. Jingzhou Liu, Loren Berry, Samer A. Al-Assaad, and James Mann are thanked for their assistance with in vitro screening assays. Alan Cheng is thanked for stimulating discussions and in-silico modeling assistance. Keith Wilcoxen of TESARO is thanked for helpful discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i69" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i69"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i70" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i70"> Abbreviations Used</h2><tr><td class="NLM_term">ALK</td><td class="NLM_def"><p class="first last">anaplastic lymphoma kinase</p></td></tr><tr><td class="NLM_term">ALCL</td><td class="NLM_def"><p class="first last">anaplastic large-cell lymphoma</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">c-Met</td><td class="NLM_def"><p class="first last">hepatocyte growth factor receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">DCE</td><td class="NLM_def"><p class="first last">dichloroethane</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DFG</td><td class="NLM_def"><p class="first last">Asp-Phe-Gly sequence in ATP binding site</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">EML4-ALK</td><td class="NLM_def"><p class="first last">echinoderm microtubule-associated protein-like 4-ALK fusion protein</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">2-(7-Aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">IGF1R</td><td class="NLM_def"><p class="first last">insulin-like growth factor-1 receptor</p></td></tr><tr><td class="NLM_term">INSR</td><td class="NLM_def"><p class="first last">insulin receptor</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">janus kinase</p></td></tr><tr><td class="NLM_term">NPM-ALK</td><td class="NLM_def"><p class="first last">nucleophosmin-ALK fusion protein</p></td></tr><tr><td class="NLM_term">pALK IC<sub>50</sub></td><td class="NLM_def"><p class="first last">inhibition of phosphorylation of ALK</p></td></tr><tr><td class="NLM_term">pINSR IC<sub>50</sub></td><td class="NLM_def"><p class="first last">inhibition of phosphorylation of INSR</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamic</p></td></tr><tr><td class="NLM_term">PDB ID</td><td class="NLM_def"><p class="first last">Protein Data Bank identity number</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">POC</td><td class="NLM_def"><p class="first last">percent of control</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">SRC</td><td class="NLM_def"><p class="first last">sarcoma kinase</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetra <i>n</i>-butylammonium fluoride</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TIPS</td><td class="NLM_def"><p class="first last">triisopropylsilyl</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved-fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">XDFG</td><td class="NLM_def"><p class="first last">amio acid residue which preceedes the Asp-Phe-Gly sequence in ATP binding site</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froehling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, W.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrady, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A.</span><span> </span><span class="NLM_article-title">Activating mutations in ALK provide a therapeutic target in neuroblastoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=975-978&author=R.+E.+Georgeauthor=T.+Sandaauthor=M.+Hannaauthor=S.+Froehlingauthor=W.+Lutherauthor=J.+Zhangauthor=Y.+Ahnauthor=W+Zhouauthor=W.+B.+Londonauthor=P.+McGradyauthor=L.+Xueauthor=S.+Zozulyaauthor=V.+E.+Gregorauthor=T.+R.+Webbauthor=N.+S.+Grayauthor=D.+G.+Gillilandauthor=L.+Dillerauthor=H.+Greulichauthor=S.+W.+Morrisauthor=M.+Meyersonauthor=A.+Look&title=Activating+mutations+in+ALK+provide+a+therapeutic+target+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DSanda%26aufirst%3DT.%26aulast%3DHanna%26aufirst%3DM.%26aulast%3DFroehling%26aufirst%3DS.%26aulast%3DLuther%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DW%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DMcGrady%26aufirst%3DP.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZozulya%26aufirst%3DS.%26aulast%3DGregor%26aufirst%3DV.%2BE.%26aulast%3DWebb%26aufirst%3DT.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DDiller%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DLook%26aufirst%3DA.%26atitle%3DActivating%2520mutations%2520in%2520ALK%2520provide%2520a%2520therapeutic%2520target%2520in%2520neuroblastoma%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D975%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmer, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=1281-1284&author=S.+W.+Morrisauthor=M.+N.+Kirsteinauthor=M.+B.+Valentineauthor=K.+G.+Dittmerauthor=D.+N.+Shapiroauthor=D.+L.+Saltmanauthor=A.+T.+Look&title=Fusion+of+a+kinase+gene%2C+ALK%2C+to+a+nucleolar+protein+gene%2C+NPM%2C+in+non-Hodgkin%E2%80%99s+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DValentine%26aufirst%3DM.%2BB.%26aulast%3DDittmer%26aufirst%3DK.%2BG.%26aulast%3DShapiro%26aufirst%3DD.%2BN.%26aulast%3DSaltman%26aufirst%3DD.%2BL.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DFusion%2520of%2520a%2520kinase%2520gene%252C%2520ALK%252C%2520to%2520a%2520nucleolar%2520protein%2520gene%252C%2520NPM%252C%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurashina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Identification of the transforming <i>EML4–ALK</i> fusion gene in non-small-cell lung cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=561-566&author=M.+Sodaauthor=Y.+L.+Choiauthor=M.+Enomotoauthor=S.+Takadaauthor=Y.+Yamashitaauthor=S.+Ishikawaauthor=S.-I.+Fujiwaraauthor=H.+Watanabeauthor=K.+Kurashinaauthor=H.+Hatanakaauthor=M.+Bandoauthor=S.+Ohnoauthor=Y.+Ishikawaauthor=H.+Aburataniauthor=T.+Nikiauthor=Y.+Soharaauthor=Y.+Sugiyamaauthor=H.+Mano&title=Identification+of+the+transforming+EML4%E2%80%93ALK+fusion+gene+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DEnomoto%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DS.-I.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKurashina%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520the%2520transforming%2520EML4%25E2%2580%2593ALK%2520fusion%2520gene%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><a href="http://www.cancer.gov/cancertopics/druginfo/fda-crizotinib" class="extLink">http://www.cancer.gov/cancertopics/druginfo/fda-crizotinib</a>; see also <span class="NLM_contrib-group">Shaw, A. T.; Yasothan, U.; Kirkpatrick, P.; crizotinib.</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span>),  <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span>, <div class="note"><p class="first last">see also ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fdruginfo%2Ffda-crizotinib%3B+see+also+Shaw%2C+A.+T.%3B+Yasothan%2C+U.%3B+Kirkpatrick%2C+P.%3B+crizotinib.Nature+Rev.+Drug+Discovery%2C+2011%2C+10+%2812%29%2C+897%E2%80%93898%2C+see+also+ref+9."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D12%26spage%3D897%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bresler, S. C.; Wood, A. C.; Haglund, E. A.; Courtright, J.; Belcastro, L. T.; Plegaria, J. S.; Cole, K.; Toporovskaya, Y.; Zhao, H.; Carpenter, E. L.; Christensen, J. G.; Maris, J. M.; Lemmon, M. A.; Mossé, Y. P.</span><span> </span><span class="NLM_article-title">Differential Inhibitor Sensitivity of Anaplastic Lymphoma Kinase Variants Found in Neuroblastoma</span>.  <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span>),  <span class="NLM_fpage">108ra114</span>, DOI: <span class="refDoi"> DOI: 10.1126/scitranslmed.3002950.</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm3005866&amp;key=10.1126%2Fscitranslmed.3002950." title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=108ra114&issue=3&author=S.+C.+Bresler&author=A.+C.+Wood&author=E.+A.+Haglund&author=J.+Courtright&author=L.+T.+Belcastro&author=J.+S.+Plegaria&author=K.+Cole&author=Y.+Toporovskaya&author=H.+Zhao&author=E.+L.+Carpenter&author=J.+G.+Christensen&author=J.+M.+Maris&author=M.+A.+Lemmon&author=Y.+P.+Moss%C3%A9&title=Differential+Inhibitor+Sensitivity+of+Anaplastic+Lymphoma+Kinase+Variants+Found+in+Neuroblastoma&doi=10.1126%2Fscitranslmed.3002950."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3002950.&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3002950.%26sid%3Dliteratum%253Aachs%26aulast%3DBresler%26aufirst%3DS.%2BC.%26atitle%3DDifferential%2520Inhibitor%2520Sensitivity%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520Variants%2520Found%2520in%2520Neuroblastoma%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D108%26issue%3D3%26spage%3D108ra114%26doi%3D10.1126%2Fscitranslmed.3002950." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">See also</p></div><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butrynski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span> </span><span class="NLM_article-title">The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">10038</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10038-43&issue=24&author=T.+Sasakiauthor=K.+Okudaauthor=W.+Zhengauthor=J.+Butrynskiauthor=M.+Capellettiauthor=L.+Wangauthor=N.+S.+Grayauthor=K.+Wilnerauthor=J.+G.+Christensenauthor=G.+Demetriauthor=G.+I.+Shapiroauthor=S.+J.+Rodigauthor=M.+J.+Eckauthor=P.+A.+J%C3%A4nne&title=The+neuroblastoma-associated+F1174L+ALK+mutation+causes+resistance+to+an+ALK+kinase+inhibitor+in+ALK-translocated+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DOkuda%26aufirst%3DK.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DButrynski%26aufirst%3DJ.%26aulast%3DCapelletti%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWilner%26aufirst%3DK.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DDemetri%26aufirst%3DG.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26atitle%3DThe%2520neuroblastoma-associated%2520F1174L%2520ALK%2520mutation%2520causes%2520resistance%2520to%2520an%2520ALK%2520kinase%2520inhibitor%2520in%2520ALK-translocated%2520cancers%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D24%26spage%3D10038%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">See also</p></div><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haruta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsudomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanio, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">EML4-ALK Mutations in Lung cancer that confer resistance to ALK inhibitors</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">1734</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm3005866&amp;key=10.1056%2FNEJMoa1007478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm3005866&amp;key=20979473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm3005866&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1734-1739&issue=18&author=Y.+L.+Choiauthor=M.+Sodaauthor=Y.+Yamashitaauthor=T.+Uenoauthor=J.+Takashimaauthor=T.+Nakajimaauthor=Y.+Yatabeauthor=K.+Takeuchiauthor=T.+Hamadaauthor=H.+Harutaauthor=Y.+Ishikawaauthor=H.+Kimuraauthor=T.+Mitsudomiauthor=Y.+Tanioauthor=H.+Mano&title=EML4-ALK+Mutations+in+Lung+cancer+that+confer+resistance+to+ALK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors</span></div><div class="casAuthors">Choi, Young Lim; Soda, Manabu; Yamashita, Yoshihiro; Ueno, Toshihide; Takashima, Junpei; Nakajima, Takahiro; Yatabe, Yasushi; Takeuchi, Kengo; Hamada, Toru; Haruta, Hidenori; Ishikawa, Yuichi; Kimura, Hideki; Mitsudomi, Tetsuya; Tanio, Yoshiro; Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1734-1739</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The EML4 (echinoderm microtubule-assocd. protein-like 4)-ALK (anaplastic lymphoma kinase) fusion-type tyrosine kinase is an oncoprotein found in 4% to 5% of non-small-cell lung cancers, and clin. trials of specific inhibitors of ALK for the treatment of such tumors are currently under way.  Here, we report the discovery of two secondary mutations within the kinase domain of EML4-ALK in tumor cells isolated from a patient during the relapse phase of treatment with an ALK inhibitor.  Each mutation developed independently in subclones of the tumor and conferred marked resistance to two different ALK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCIrEIBi5MjrVg90H21EOLACvtfcHk0lhH44JXvmASoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FJ&md5=d903151706575c159b7abcdc8999281c</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1007478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1007478%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DTakashima%26aufirst%3DJ.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DYatabe%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DHamada%26aufirst%3DT.%26aulast%3DHaruta%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DMitsudomi%26aufirst%3DT.%26aulast%3DTanio%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DEML4-ALK%2520Mutations%2520in%2520Lung%2520cancer%2520that%2520confer%2520resistance%2520to%2520ALK%2520inhibitors%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26issue%3D18%26spage%3D1734%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">See also</p></div><span class="NLM_contrib-group">Heuckmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heynck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balke-Want, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovly, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruetter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. K.</span><span> </span><span class="NLM_article-title">ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">7394</span><span class="NLM_x">–</span> <span class="NLM_lpage">7401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm3005866&amp;key=10.1158%2F1078-0432.CCR-11-1648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm3005866&amp;key=21948233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm3005866&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCmtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=7394-7401&issue=23&author=J.+M.+Heuckmannauthor=M.+Hoelzelauthor=M.+L.+Sosauthor=S.+Heynckauthor=H.+Balke-Wantauthor=M.+Kokerauthor=M.+Peiferauthor=J.+Weissauthor=C.+M.+Lovlyauthor=C.+Gruetterauthor=D.+Rauhauthor=W.+Paoauthor=R.+K.+Thomas&title=ALK+Mutations+Conferring+Differential+Resistance+to+Structurally+Diverse+ALK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors</span></div><div class="casAuthors">Heuckmann, Johannes M.; Hoelzel, Michael; Sos, Martin L.; Heynck, Stefanie; Balke-Want, Hyatt; Koker, Mirjam; Peifer, Martin; Weiss, Jonathan; Lovly, Christine M.; Gruetter, Christian; Rauh, Daniel; Pao, William; Thomas, Roman K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7394-7401</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE:EML4-ALK fusions define a subset of lung cancers that can be effectively treated with anaplastic lymphoma kinase (ALK) inhibitors.  Unfortunately, the duration of response is heterogeneous and acquired resistance limits their ultimate efficacy.  Thus, a better understanding of resistance mechanisms will help to enhance tumor control in EML4-ALK-pos. tumors.  Exptl. Design: By applying orthogonal functional mutagenesis screening approaches, we screened for mutations inducing resistance to the aminopyridine PF02341066 (crizotinib) and/or the diaminopyrimidine TAE684.  RESULTS: Here, we show that the resistance mutation, L1196M, as well as other crizotinib resistance mutations (F1174L and G1269S), are highly sensitive to the structurally unrelated ALK inhibitor TAE684.  In addn., we identified two novel EML4-ALK resistance mutations (L1198P and D1203N), which unlike previously reported mutations, induced resistance to both ALK inhibitors.  An independent resistance screen in ALK-mutant neuroblastoma cells yielded the same L1198P resistance mutation but defined two addnl. mutations conferring resistance to TAE684 but not to PF02341066.  CONCLUSIONS: Our results show that different ALK resistance mutations as well as different ALK inhibitors impact the therapeutic efficacy in the setting of EML4-ALK fusions and ALK mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo4XRKE2WO0bVg90H21EOLACvtfcHk0lhH44JXvmASoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCmtrnK&md5=11592d3e0280edc60fabc02419f00496</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1648%26sid%3Dliteratum%253Aachs%26aulast%3DHeuckmann%26aufirst%3DJ.%2BM.%26aulast%3DHoelzel%26aufirst%3DM.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DHeynck%26aufirst%3DS.%26aulast%3DBalke-Want%26aufirst%3DH.%26aulast%3DKoker%26aufirst%3DM.%26aulast%3DPeifer%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DJ.%26aulast%3DLovly%26aufirst%3DC.%2BM.%26aulast%3DGruetter%26aufirst%3DC.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26atitle%3DALK%2520Mutations%2520Conferring%2520Differential%2520Resistance%2520to%2520Structurally%2520Diverse%2520ALK%2520Inhibitors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26issue%3D23%26spage%3D7394%26epage%3D7401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><div class="note"><p class="first last">ALK, JAK2<sup>13</sup> and SRC are related in that they share a common downstream signaling pathway via Stat3. For details of the JAK kinase enzyme assays; see</p></div><span class="NLM_contrib-group">Laurie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S.</span><span> </span><span class="NLM_article-title">Discovery of Potent and Highly Selective Thienopyridine Janus Kinase 2 Inhibitors</span> <span class="citation_source-journal"> J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">8440</span><span class="NLM_x">–</span> <span class="NLM_lpage">8450</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8440-8450&issue=24&author=B.+Laurieauthor=L.+B.+Schenkelauthor=X.+Huangauthor=A.+Chengauthor=H.+L.+Deakauthor=E.+Dohertyauthor=R.+Emkeyauthor=Y.+Guauthor=H.+Gunaydinauthor=J.+L.+Kimauthor=J.+Leeauthor=R.+Lobergauthor=P.+Olivieriauthor=J.+Pistilloauthor=J.+Tangauthor=Q.+Wanauthor=H.-L.+Wangauthor=S.-W.+Wangauthor=M.+C.+Wellsauthor=B.+Wuauthor=V.+Yuauthor=L.+Liuauthor=S.+Geuns-Meyer&title=Discovery+of+Potent+and+Highly+Selective+Thienopyridine+Janus+Kinase+2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaurie%26aufirst%3DB.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DDoherty%26aufirst%3DE.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLoberg%26aufirst%3DR.%26aulast%3DOlivieri%26aufirst%3DP.%26aulast%3DPistillo%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.-L.%26aulast%3DWang%26aufirst%3DS.-W.%26aulast%3DWells%26aufirst%3DM.%2BC.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Highly%2520Selective%2520Thienopyridine%2520Janus%2520Kinase%25202%2520Inhibitors%26jtitle%3D%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D24%26spage%3D8440%26epage%3D8450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><div class="note"><p class="first last">For details of the ALK kinase enzyme and cellular screens, see</p></div><span class="NLM_contrib-group">Drew, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Assaad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szilvassy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brake, R. L.</span><span> </span><span class="NLM_article-title">Comparison of 2 Cell-Based Phosphoprotein Assays to Support Screening and D evelopment of an ALK Inhibitor</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><div class="note"><p class="first last">Details of the IGF1R and SRC enzyme assays and INSR cellular assay are reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3005866&amp;key=10.1177%2F1087057110394657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3005866&amp;key=21297104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3005866&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVGlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-173&issue=2&author=A.+E.+Drewauthor=S.+Al-Assaadauthor=V.+Yuauthor=P.+Andrewsauthor=P.+Merkelauthor=S.+Szilvassyauthor=R.+Emkeyauthor=R.+Lewisauthor=R.+L.+Brake&title=Comparison+of+2+Cell-Based+Phosphoprotein+Assays+to+Support+Screening+and+D+evelopment+of+an+ALK+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of 2 cell-based phosphoprotein assays to support screening and development of an ALK inhibitor</span></div><div class="casAuthors">Drew, Allison E.; Al-Assaad, Samer; Yu, Violeta; Andrews, Paul; Merkel, Patricia; Szilvassy, Stephen; Emkey, Renee; Lewis, Richard; Brake, Rachael L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-173</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) when expressed as a fusion protein with nucleophosmin (NPM) has been implicated as a driving oncogene in a subset of lymphomas.  Recent reports of ALK expression in a no. of other cancers have raised the possibility that an ALK inhibitor may benefit patients with these diseases as well.  In a campaign to identify and develop a selective ALK inhibitor, 2 assays were devised to measure the phosphorylation of tyrosine residue 1604 of ALK (pY1604 ALK).  Amplified Luminescent Proximity Homogeneous Assay (AlphaScreen) and phosflow platforms were used to detect modulation of pY1604 ALK to det. the relative potency of a set of small-mol. inhibitors.  Prior to making use of these assays in diverse settings, the authors attempted to ensure their equivalence with a direct comparison of their performance.  The pY1604 ALK assays correlated well both with each other and with assays of ALK enzyme activity or ALK-dependent cell proliferation.  The AlphaScreen assay was amenable to automation and enabled rapid, high-throughput compd. assessment in an NPM-ALK-driven cell line, whereas the phosflow assay enabled the authors to characterize the activity of compds. with respect to their impact on targeted enzymes and pathways.  Results show that both AlphaScreen and phosflow ALK assays exhibited diverse characteristics that made them desirable for different applications but were detd. to be equally sensitive and robust in the detection of inhibition of pY1604 ALK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5MH7yS6GGhbVg90H21EOLACvtfcHk0lgsbpE_Tt4VsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVGlurs%253D&md5=31212fb7129ded1aeb1395b2407c5e23</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1177%2F1087057110394657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057110394657%26sid%3Dliteratum%253Aachs%26aulast%3DDrew%26aufirst%3DA.%2BE.%26aulast%3DAl-Assaad%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DAndrews%26aufirst%3DP.%26aulast%3DMerkel%26aufirst%3DP.%26aulast%3DSzilvassy%26aufirst%3DS.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DBrake%26aufirst%3DR.%2BL.%26atitle%3DComparison%2520of%25202%2520Cell-Based%2520Phosphoprotein%2520Assays%2520to%2520Support%2520Screening%2520and%2520D%2520evelopment%2520of%2520an%2520ALK%2520Inhibitor%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2011%26volume%3D16%26issue%3D2%26spage%3D164%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="note"><p class="first last">IC<sub>50</sub> data from which these selectivity ratios are derived for the off-target kinases is included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S3">Supporting Information, Table S3</a>, together with assay protocols (see also refs <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and <a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a>). All IC<sub>50</sub> values are derived from 22 point dose–response curves and are reported as a mean (±) SD where two or more independent determinations were performed. ND = not determined.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&issue=18&author=J.+J.+Cuiauthor=M.+Tran-Dubeauthor=H.+Shenauthor=M.+Nambuauthor=P.-P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+Based+Drug+Design+of+Crizotinib+%28PF-02341066%29%2C+a+Potent+and+Selective+Dual+Inhibitor+of+Mesenchymal%E2%80%93Epithelial+Transition+Factor+%28c-MET%29+Kinase+and+Anaplastic+Lymphoma+Kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520Based%2520Drug%2520Design%2520of%2520Crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520Potent%2520and%2520Selective%2520Dual%2520Inhibitor%2520of%2520Mesenchymal%25E2%2580%2593Epithelial%2520Transition%2520Factor%2520%2528c-MET%2529%2520Kinase%2520and%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D18%26spage%3D6342%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">There is evidence of a close association between the benzimidazole nitrogen and the backbone carbonyl of Met1199 in all of the co-crystal structures that we have obtained for this class of ALK inhibitors. For compound <b>36</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), the N-to-O distance is measured at 2.9 Å, which is consistent with an intermolecular hydrogen bond between these two centers. The interatomic distance between the benzoyl carbonyl oxygen of the inhibitor and the backbone NH of Met199 measures 3.0 Å in this structure. These interatomic distances are compatible with this class of compounds adopting an exocyclic acylimine tautomer, which is best able to satisfy the observed hydrogen-bonding pattern.</p></div><span class="NLM_contrib-group">Riether, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zindell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lombaert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugler, S. Z.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, K. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labissiere, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">5-Aminomethylbenzimdazoles as potent ITK antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1588</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1588-1591&author=D.+Rietherauthor=R.+Zindellauthor=J.+A.+Kowalskiauthor=B.+N.+Cookauthor=J.+Bentzienauthor=S.+De+Lombaertauthor=D.+Thomsonauthor=S.+Z.+Kuglerauthor=D.+Skowauthor=L.+S.+Martinauthor=E.+L.+Raymondauthor=H+H.+Khineauthor=K.+O%E2%80%99Sheaauthor=J.+R.+Woskaauthor=D.+Jeanfavreauthor=R.+Sellatiauthor=K.+L.+M.+Ralphauthor=J.+Ahlbergauthor=G.+Labissiereauthor=M.+A.+Kashemauthor=S.+S.+Pullenauthor=H.+Takahashi&title=5-Aminomethylbenzimdazoles+as+potent+ITK+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiether%26aufirst%3DD.%26aulast%3DZindell%26aufirst%3DR.%26aulast%3DKowalski%26aufirst%3DJ.%2BA.%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DBentzien%26aufirst%3DJ.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26aulast%3DThomson%26aufirst%3DD.%26aulast%3DKugler%26aufirst%3DS.%2BZ.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DL.%2BS.%26aulast%3DRaymond%26aufirst%3DE.%2BL.%26aulast%3DKhine%26aufirst%3DH%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DK.%26aulast%3DWoska%26aufirst%3DJ.%2BR.%26aulast%3DJeanfavre%26aufirst%3DD.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DRalph%26aufirst%3DK.%2BL.%2BM.%26aulast%3DAhlberg%26aufirst%3DJ.%26aulast%3DLabissiere%26aufirst%3DG.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3D5-Aminomethylbenzimdazoles%2520as%2520potent%2520ITK%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1588%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">See also</p></div><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleymanzadeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugler, S. Z.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lombaert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=773-777&author=B.+N.+Cookauthor=J.+Bentzienauthor=A.+Whiteauthor=P.+A.+Nemotoauthor=J.+Wangauthor=C.+C.+Manauthor=F.+Soleymanzadehauthor=H.+H.+Khineauthor=M.+A.+Kashemauthor=S.+Z.+Kuglerauthor=J.+P.+Wolakauthor=G.+P.+Rothauthor=S.+De+Lombaertauthor=S.+S.+Pullenauthor=H.+Takahashi&title=Discovery+of+potent+inhibitors+of+interleukin-2+inducible+T-cell+kinase+%28ITK%29+through+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DBentzien%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DNemoto%26aufirst%3DP.%2BA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMan%26aufirst%3DC.%2BC.%26aulast%3DSoleymanzadeh%26aufirst%3DF.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DKugler%26aufirst%3DS.%2BZ.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520of%2520interleukin-2%2520inducible%2520T-cell%2520kinase%2520%2528ITK%2529%2520through%2520structure-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D773%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">For a discussion of acyliminobenzimidazole tautomerism, see</p></div><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywardane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarko, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolaka, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span> </span><span class="NLM_article-title">Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3660</span><span class="NLM_x">–</span> <span class="NLM_lpage">3665</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3660-3665&author=R.+J.+Snowauthor=A.+Abeywardaneauthor=S.+Campbellauthor=J.+Lordauthor=M.+A.+Kashemauthor=H.+H.+Khineauthor=J.+Kingauthor=J.+A.+Kowalskiauthor=S.+S.+Pullenauthor=T.+Romaauthor=G.+P.+Rothauthor=C.+R.+Sarkoauthor=N.+S.+Wilsonauthor=M.+P.+Wintersauthor=J.+P.+Wolakaauthor=C.+L.+Cywin&title=Hit-to-lead+studies+on+benzimidazole+inhibitors+of+ITK%3A+discovery+of+a+novel+class+of+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DAbeywardane%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DLord%26aufirst%3DJ.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DKing%26aufirst%3DJ.%26aulast%3DKowalski%26aufirst%3DJ.%2BA.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DRoma%26aufirst%3DT.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DSarko%26aufirst%3DC.%2BR.%26aulast%3DWilson%26aufirst%3DN.%2BS.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DWolaka%26aufirst%3DJ.%2BP.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26atitle%3DHit-to-lead%2520studies%2520on%2520benzimidazole%2520inhibitors%2520of%2520ITK%253A%2520discovery%2520of%2520a%2520novel%2520class%2520of%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3660%26epage%3D3665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">See also</p></div><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N. P. C.</span><span> </span><span class="NLM_article-title">Crystal Structures of IRAK-4 Kinase in Complex with Inhibitors: A Serine/Threonine Kinase with Tyrosine as a Gatekeeper</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1835</span><span class="NLM_x">–</span> <span class="NLM_lpage">1844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1835-1844&author=Z.+Wangauthor=J.+Liuauthor=S.+Sudomauthor=M.+Ayresauthor=S.+Liauthor=H.+Wescheauthor=J.+P.+Powersauthor=N.+P.+C.+Walker&title=Crystal+Structures+of+IRAK-4+Kinase+in+Complex+with+Inhibitors%3A+A+Serine%2FThreonine+Kinase+with+Tyrosine+as+a+Gatekeeper"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSudom%26aufirst%3DS.%26aulast%3DAyres%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DWalker%26aufirst%3DN.%2BP.%2BC.%26atitle%3DCrystal%2520Structures%2520of%2520IRAK-4%2520Kinase%2520in%2520Complex%2520with%2520Inhibitors%253A%2520A%2520Serine%252FThreonine%2520Kinase%2520with%2520Tyrosine%2520as%2520a%2520Gatekeeper%26jtitle%3DStructure%26date%3D2006%26volume%3D14%26spage%3D1835%26epage%3D1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="note"><p class="first last">Data collection and refinement statistics are included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S4">Supporting Information, Table S4</a>, along with crystallographic experimental procedures. The cocrystal structures of <b>1</b> and <b>2</b> in ALK have PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOB">4FOB</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOC">4FOC</a>, respectively; <b>3</b>, PF-02341066, hydrogen-bonds to the linker region of ALK through its pyridine nitrogen atom and the adjacent amine. The pyrazole ring and solubilizing group face solvent and the O-linked benzyl ring sits in the lipophilic pocket defined largely by Leu1256, Gly1269 (the X-DFG residue), and the backbone atoms of Arg1253/Asn1254 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2">2XP2</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">SAR of the sulfonamide side chain of <b>1</b> or ester moiety of <b>2</b> indicated that the cost of not occupying this lipophilic pocket amounted to an order of magnitude loss in binding affinity. Unpublished observations.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">Activity against JAK1, 2, and 3 and TYK2 were routinely monitored,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and selectivity over JAK2 was the highest hurdle for this structural class. Selected data for compounds <b>14</b>, <b>1</b>, and <b>36</b>, typical for this class, is included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S1">Supporting Information, Table S1</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Bode, C. M.; Cheng, A. C.; Choquette, D.; Lewis, Richard, T.; Potashman, M. H.; Romero, K.; Stellwagen, J. C.; Whittington, D. A.</span><span> </span><span class="NLM_article-title">Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase</span>. PCT Int. Appl. WO 2012018668,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+M.+Bode&author=A.+C.+Cheng&author=D.+Choquette&author=T.+Lewis+Richard&author=M.+H.+Potashman&author=K.+Romero&author=J.+C.+Stellwagen&author=D.+A.+Whittington&title=Benzimidazole+and+azabenzimidazole+compounds+that+inhibit+anaplastic+lymphoma+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DC.%2BM.%26atitle%3DBenzimidazole%2520and%2520azabenzimidazole%2520compounds%2520that%2520inhibit%2520anaplastic%2520lymphoma%2520kinase%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">Point changes with respect to the residues which flank the benzamide moiety are summarized for closely related kinases in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information in Table S2">Supporting Information in Table S2</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">Microsomal turnover protocol: 0.5 mg/mL of protein, 1 μM substrate, 1 mM NADPH, 30 min incubation, pH 7.4, and 37 °C.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><div class="note"><p class="first last">Screen was performed by KINOMEscan, a division of DiscoveRx, 11180 Roselle Street, San Diego. CA 92121 USA; <a href="http://kinomescan.com/" class="extLink">http://kinomescan.com/</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Screen+was+performed+by+KINOMEscan%2C+a+division+of+DiscoveRx%2C+11180+Roselle+Street%2C+San+Diego.+CA+92121+USA%3B+http%3A%2F%2Fkinomescan.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for assay protocol.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><div class="note"><p class="first last">Screen was performed by Carna Biosciences. <a href="https://www.carnabio.com/english/product/search.cgi?mode=profiling" class="extLink">https://www.carnabio.com/english/product/search.cgi?mode=profiling</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Screen+was+performed+by+Carna+Biosciences.+https%3A%2F%2Fwww.carnabio.com%2Fenglish%2Fproduct%2Fsearch.cgi%3Fmode%3Dprofiling."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">Douglas C. Saffran unpublished results. See <a class="ref internalNav" href="#notes-1" aria-label="Figure S1 in the Supporting Information">Figure S1 in the Supporting Information</a> for body weight data associated with the Karpass299 xenograft study.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">Yohannes Teffera unpublished results.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>Details of additional studies will be reported elsewhere. In March 2011, Tesaro, Inc. signed an agreement with Amgen granting Tesaro exclusive worldwide rights for the development, manufacture, commercialization, and distribution of small molecule inhibitors of ALK. For more information, please contact Dr. Mary Lynne Hedley: <a href="http://MLHedley@tesarobio.com" class="extLink"><span class="__cf_email__" data-cfemail="cb868783aeafa7aeb28bbfaeb8aab9a4a9a2a4e5a8a4a6">[email protected]</span></a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Details+of+additional+studies+will+be+reported+elsewhere.+In+March+2011%2C+Tesaro%2C+Inc.+signed+an+agreement+with+Amgen+granting+Tesaro+exclusive+worldwide+rights+for+the+development%2C+manufacture%2C+commercialization%2C+and+distribution+of+small+molecule+inhibitors+of+ALK.+For+more+information%2C+please+contact+Dr.+Mary+Lynne+Hedley%3A+MLHedley%40tesarobio.com"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Allen, J. R.; Bourbeau, M. P.; Chen, N.; He, E.; Kunz, R.; Rumfelt, S.</span><span> </span><span class="NLM_article-title">Pyrazine compounds as phosphodiesterase 10 inhibitors and their preparation and use in the treatment of diseases</span>. WO 2010/057121,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+R.+Allen&author=M.+P.+Bourbeau&author=N.+Chen&author=E.+He&author=R.+Kunz&author=S.+Rumfelt&title=Pyrazine+compounds+as+phosphodiesterase+10+inhibitors+and+their+preparation+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DPyrazine%2520compounds%2520as%2520phosphodiesterase%252010%2520inhibitors%2520and%2520their%2520preparation%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Allen, J. R.; Chen, N.; Falsey, J. R.; Frohn, M.; Harrington, P.; He, E.; Kaller, M. R.; Kunz, R.; Mercede, S. J.; Nguyen, T. T.; Pickrell, A. J.; Reichelt, A.; Rumfelt, S.; Rzasa, R. M.; Sham, K.; Siegmund, A. C.; Tegley, C. M.; Yao, G.</span><span> </span><span class="NLM_article-title">Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors</span>. U.S. Patent US 2010/0160280,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+R.+Allen&author=N.+Chen&author=J.+R.+Falsey&author=M.+Frohn&author=P.+Harrington&author=E.+He&author=M.+R.+Kaller&author=R.+Kunz&author=S.+J.+Mercede&author=T.+T.+Nguyen&author=A.+J.+Pickrell&author=A.+Reichelt&author=S.+Rumfelt&author=R.+M.+Rzasa&author=K.+Sham&author=A.+C.+Siegmund&author=C.+M.+Tegley&author=G.+Yao&title=Aminopyridine+and+carboxypyridine+compounds+as+phosphodiesterase+10+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DAminopyridine%2520and%2520carboxypyridine%2520compounds%2520as%2520phosphodiesterase%252010%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Castanedo, G.; Chan, B.; Goldstein, D. M.; Kondru, R. K.; Lucas, M. C.; Palmer, W. S.; Price, S.; Safina, B.; Savy, P. P. A.; Seward, E. M.; Sutherlin, D. P.; Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Preparation of bicyclic pyrimidines as selective inhibitors of the p110 delta isoform of PI3K for treating inflammation, immune diseases, and cancers</span>. WO 2010/138589,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=G.+Castanedo&author=B.+Chan&author=D.+M.+Goldstein&author=R.+K.+Kondru&author=M.+C.+Lucas&author=W.+S.+Palmer&author=S.+Price&author=B.+Safina&author=P.+P.+A.+Savy&author=E.+M.+Seward&author=D.+P.+Sutherlin&author=Z.+K.+Sweeney&title=Preparation+of+bicyclic+pyrimidines+as+selective+inhibitors+of+the+p110+delta+isoform+of+PI3K+for+treating+inflammation%2C+immune+diseases%2C+and+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%26atitle%3DPreparation%2520of%2520bicyclic%2520pyrimidines%2520as%2520selective%2520inhibitors%2520of%2520the%2520p110%2520delta%2520isoform%2520of%2520PI3K%2520for%2520treating%2520inflammation%252C%2520immune%2520diseases%252C%2520and%2520cancers%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6'],'ref7':['cit7'],'ref8':[],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c','cit10d'],'ref11':[],'ref12':[],'ref13':[],'ref14':['cit14'],'ref15':[],'ref16':[],'ref17':['cit17'],'ref18':[],'ref19':['cit19'],'ref20':[],'ref21':[],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jianyong Chen, Yunlong Zhou, Xuyuan Dong, Liu Liu, Longchuan Bai, Donna McEachern, Sally Przybranowski, Chao-Yie Yang, Jeanne Stuckey, Xiaoqin Li, Bo Wen, Ting Zhao, Siwei Sun, Duxin Sun, Lingling Jiao, Yu Jing, Ming Guo, Dajun Yang, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of CJ-2360 as a Potent and Orally Active Inhibitor of Anaplastic Lymphoma Kinase Capable of Achieving Complete Tumor Regression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13994-14016. <a href="https://doi.org/10.1021/acs.jmedchem.0c01550" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01550%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BCJ-2360%252Bas%252Ba%252BPotent%252Band%252BOrally%252BActive%252BInhibitor%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252BCapable%252Bof%252BAchieving%252BComplete%252BTumor%252BRegression%26aulast%3DChen%26aufirst%3DJianyong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D04092020%26date%3D13112020%26volume%3D63%26issue%3D22%26spage%3D13994%26epage%3D14016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaotian Kong, Peichen Pan, Huiyong Sun, Hongguang Xia, Xuwen Wang, Youyong Li, <span class="NLM_string-name hlFld-ContribAuthor">Tingjun Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery Targeting Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 10927-10954. <a href="https://doi.org/10.1021/acs.jmedchem.9b00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252BDiscovery%252BTargeting%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DKong%26aufirst%3DXiaotian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14032019%26date%3D26082019%26date%3D16082019%26volume%3D62%26issue%3D24%26spage%3D10927%26epage%3D10954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, Massimo Santoro, Neil Q. McDonald, Fengping Lv, Naresh Gunaganti, Brendan Frett, <span class="NLM_string-name hlFld-ContribAuthor">Hong-yu Li</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1731-1760. <a href="https://doi.org/10.1021/acs.jmedchem.8b01092" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01092%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInsights%252Binto%252BCurrent%252BTropomyosin%252BReceptor%252BKinase%252B%252528TRK%252529%252BInhibitors%25253A%252BDevelopment%252Band%252BClinical%252BApplication%26aulast%3DYan%26aufirst%3DWei%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D11072018%26date%3D19092018%26date%3D06092018%26volume%3D62%26issue%3D4%26spage%3D1731%26epage%3D1760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gydo C.
P. van Zundert, Brandi M. Hudson, Saulo H. P. de Oliveira, Daniel A. Keedy, Rasmus Fonseca, Amelie Heliou, Pooja Suresh, Kenneth Borrelli, Tyler Day, James S. Fraser, <span class="NLM_string-name hlFld-ContribAuthor">Henry van den Bedem</span>. </span><span class="cited-content_cbyCitation_article-title">qFit-ligand Reveals Widespread Conformational Heterogeneity of Drug-Like Molecules in X-Ray Electron Density Maps. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (24)
                                     , 11183-11198. <a href="https://doi.org/10.1021/acs.jmedchem.8b01292" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01292</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01292%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DqFit-ligand%252BReveals%252BWidespread%252BConformational%252BHeterogeneity%252Bof%252BDrug-Like%252BMolecules%252Bin%252BX-Ray%252BElectron%252BDensity%252BMaps%26aulast%3Dvan%2BZundert%26aufirst%3DGydo%2BC.%2BP.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15082018%26date%3D06122018%26date%3D20112018%26volume%3D61%26issue%3D24%26spage%3D11183%26epage%3D11198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Sheng  Huang</span>, <span class="hlFld-ContribAuthor ">Shuangying  Liu</span>, <span class="hlFld-ContribAuthor ">Dong  Zou</span>, <span class="hlFld-ContribAuthor ">Mathew  Thomas</span>, <span class="hlFld-ContribAuthor ">Yihan  Wang</span>, <span class="hlFld-ContribAuthor ">Tianjun  Zhou</span>, <span class="hlFld-ContribAuthor ">Jan  Romero</span>, <span class="hlFld-ContribAuthor ">Anna  Kohlmann</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Jiwei  Qi</span>, <span class="hlFld-ContribAuthor ">Lisi  Cai</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Dwight</span>, <span class="hlFld-ContribAuthor ">Yongjin  Xu</span>, <span class="hlFld-ContribAuthor ">Rongsong  Xu</span>, <span class="hlFld-ContribAuthor ">Rory  Dodd</span>, <span class="hlFld-ContribAuthor ">Angela  Toms</span>, <span class="hlFld-ContribAuthor ">Lois  Parillon</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Lu</span>, <span class="hlFld-ContribAuthor ">Rana  Anjum</span>, <span class="hlFld-ContribAuthor ">Sen  Zhang</span>, <span class="hlFld-ContribAuthor ">Frank  Wang</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Keats</span>, <span class="hlFld-ContribAuthor ">Scott D.  Wardwell</span>, <span class="hlFld-ContribAuthor ">Yaoyu  Ning</span>, <span class="hlFld-ContribAuthor ">Qihong  Xu</span>, <span class="hlFld-ContribAuthor ">Lauren E.  Moran</span>, <span class="hlFld-ContribAuthor ">Qurish K.  Mohemmad</span>, <span class="hlFld-ContribAuthor ">Hyun Gyung  Jang</span>, <span class="hlFld-ContribAuthor ">Tim  Clackson</span>, <span class="hlFld-ContribAuthor ">Narayana I.  Narasimhan</span>, <span class="hlFld-ContribAuthor ">Victor M.  Rivera</span>, <span class="hlFld-ContribAuthor ">Xiaotian  Zhu</span>, <span class="hlFld-ContribAuthor ">David  Dalgarno</span>, and <span class="hlFld-ContribAuthor ">William C.  Shakespeare</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4948-4964. <a href="https://doi.org/10.1021/acs.jmedchem.6b00306" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00306%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBrigatinib%252B%252528AP26113%252529%25252C%252Ba%252BPhosphine%252BOxide-Containing%25252C%252BPotent%25252C%252BOrally%252BActive%252BInhibitor%252Bof%252BAnaplastic%252BLymphoma%252BKinase%26aulast%3DHuang%26aufirst%3DWei-Sheng%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26022016%26date%3D12052016%26date%3D26052016%26date%3D04052016%26volume%3D59%26issue%3D10%26spage%3D4948%26epage%3D4964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saemina  Shin</span>, <span class="hlFld-ContribAuthor ">Shinmee  Mah</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>, and <span class="hlFld-ContribAuthor ">Hwangseo  Park</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Low Micromolar Dual Inhibitors for Wild Type and L1196M Mutant of Anaplastic Lymphoma Kinase through Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (4)
                                     , 802-810. <a href="https://doi.org/10.1021/acs.jcim.6b00026" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00026%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BLow%252BMicromolar%252BDual%252BInhibitors%252Bfor%252BWild%252BType%252Band%252BL1196M%252BMutant%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252Bthrough%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DShin%26aufirst%3DSaemina%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D20012016%26date%3D04042016%26date%3D25042016%26date%3D25032016%26volume%3D56%26issue%3D4%26spage%3D802%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng  Tian</span>, <span class="hlFld-ContribAuthor ">Huiyong  Sun</span>, <span class="hlFld-ContribAuthor ">Peichen  Pan</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Xuechu  Zhen</span>, <span class="hlFld-ContribAuthor ">Youyong  Li</span>, and <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>  . </span><span class="cited-content_cbyCitation_article-title">Assessing an Ensemble Docking-Based Virtual Screening Strategy for Kinase Targets by Considering Protein Flexibility. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (10)
                                     , 2664-2679. <a href="https://doi.org/10.1021/ci500414b" title="DOI URL">https://doi.org/10.1021/ci500414b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500414b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500414b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAssessing%252Ban%252BEnsemble%252BDocking-Based%252BVirtual%252BScreening%252BStrategy%252Bfor%252BKinase%252BTargets%252Bby%252BConsidering%252BProtein%252BFlexibility%26aulast%3DTian%26aufirst%3DSheng%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13072014%26date%3D29092014%26date%3D27102014%26date%3D18092014%26volume%3D54%26issue%3D10%26spage%3D2664%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas H.  Marsilje</span>, <span class="hlFld-ContribAuthor ">Wei  Pei</span>, <span class="hlFld-ContribAuthor ">Bei  Chen</span>, <span class="hlFld-ContribAuthor ">Wenshuo  Lu</span>, <span class="hlFld-ContribAuthor ">Tetsuo  Uno</span>, <span class="hlFld-ContribAuthor ">Yunho  Jin</span>, <span class="hlFld-ContribAuthor ">Tao  Jiang</span>, <span class="hlFld-ContribAuthor ">Sungjoon  Kim</span>, <span class="hlFld-ContribAuthor ">Nanxin  Li</span>, <span class="hlFld-ContribAuthor ">Markus  Warmuth</span>, <span class="hlFld-ContribAuthor ">Yelena  Sarkisova</span>, <span class="hlFld-ContribAuthor ">Frank  Sun</span>, <span class="hlFld-ContribAuthor ">Auzon  Steffy</span>, <span class="hlFld-ContribAuthor ">AnneMarie C.  Pferdekamper</span>, <span class="hlFld-ContribAuthor ">Allen G.  Li</span>, <span class="hlFld-ContribAuthor ">Sean B.  Joseph</span>, <span class="hlFld-ContribAuthor ">Young  Kim</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Tove  Tuntland</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Cui</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Ruo  Steensma</span>, <span class="hlFld-ContribAuthor ">Yongqin  Wan</span>, <span class="hlFld-ContribAuthor ">Jiqing  Jiang</span>, <span class="hlFld-ContribAuthor ">Greg  Chopiuk</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">W. Perry  Gordon</span>, <span class="hlFld-ContribAuthor ">Wendy  Richmond</span>, <span class="hlFld-ContribAuthor ">Kevin  Johnson</span>, <span class="hlFld-ContribAuthor ">Jonathan  Chang</span>, <span class="hlFld-ContribAuthor ">Todd  Groessl</span>, <span class="hlFld-ContribAuthor ">You-Qun  He</span>, <span class="hlFld-ContribAuthor ">Andrew  Phimister</span>, <span class="hlFld-ContribAuthor ">Alex  Aycinena</span>, <span class="hlFld-ContribAuthor ">Christian C.  Lee</span>, <span class="hlFld-ContribAuthor ">Badry  Bursulaya</span>, <span class="hlFld-ContribAuthor ">Donald S.  Karanewsky</span>, <span class="hlFld-ContribAuthor ">H. Martin  Seidel</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Harris</span>, and <span class="hlFld-ContribAuthor ">Pierre-Yves  Michellys</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (14)
                                     , 5675-5690. <a href="https://doi.org/10.1021/jm400402q" title="DOI URL">https://doi.org/10.1021/jm400402q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400402q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400402q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BStructure%2525E2%252580%252593Activity%252BRelationships%25252C%252Band%252Bin%252BVivo%252BEfficacy%252Bof%252Bthe%252BNovel%252BPotent%252Band%252BSelective%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252BInhibitor%252B5-Chloro-N2-%2525282-isopropoxy-5-methyl-4-%252528piperidin-4-yl%252529phenyl%252529-N4-%2525282-%252528isopropylsulfonyl%252529phenyl%252529pyrimidine-2%25252C4-diamine%252B%252528LDK378%252529%252BCurrently%252Bin%252BPhase%252B1%252Band%252BPhase%252B2%252BClinical%252BTrials%26aulast%3DMarsilje%26aufirst%3DThomas%2BH.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D19032013%26date%3D26062013%26date%3D25072013%26date%3D06062013%26volume%3D56%26issue%3D14%26spage%3D5675%26epage%3D5690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingting  Jiang</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Yao  Liu</span>, <span class="hlFld-ContribAuthor ">Lu  Feng</span>, <span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 355-372. <a href="https://doi.org/10.1016/j.apsb.2020.05.004" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDevelopment%252Bof%252Bsmall-molecule%252Btropomyosin%252Breceptor%252Bkinase%252B%252528TRK%252529%252Binhibitors%252Bfor%252BNTRK%252Bfusion%252Bcancers%26aulast%3DJiang%26aufirst%3DTingting%26date%3D2021%26volume%3D11%26issue%3D2%26spage%3D355%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Mologni</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance mechanisms to ALK TKIs in tumors other than lung cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 101-121. <a href="https://doi.org/10.1016/B978-0-12-821774-0.00005-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-821774-0.00005-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-821774-0.00005-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-821774-0.00005-X%26sid%3Dliteratum%253Aachs%26atitle%3DResistance%252Bmechanisms%252Bto%252BALK%252BTKIs%252Bin%252Btumors%252Bother%252Bthan%252Blung%252Bcancer%26aulast%3DMologni%26aufirst%3DLuca%26date%3D2021%26spage%3D101%26epage%3D121%26pub%3DElsevier%26atitle%3DTherapeutic%252BStrategies%252Bto%252BOvercome%252BALK%252BResistance%252Bin%252BCancer%26date%3D2021%26volume%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinxin  Che</span>, <span class="hlFld-ContribAuthor ">Ruiwei  Feng</span>, <span class="hlFld-ContribAuthor ">Jian  Gao</span>, <span class="hlFld-ContribAuthor ">Hongyun  Yu</span>, <span class="hlFld-ContribAuthor ">Qinjie  Weng</span>, <span class="hlFld-ContribAuthor ">Qiaojun  He</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jian  Wu</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Artificial Intelligence in Participating Structure-Based Virtual Screening for Identifying Novel Interleukin-1 Receptor Associated Kinase-1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.01769" title="DOI URL">https://doi.org/10.3389/fonc.2020.01769</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.01769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.01769%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DEvaluation%252Bof%252BArtificial%252BIntelligence%252Bin%252BParticipating%252BStructure-Based%252BVirtual%252BScreening%252Bfor%252BIdentifying%252BNovel%252BInterleukin-1%252BReceptor%252BAssociated%252BKinase-1%252BInhibitors%26aulast%3DChe%26aufirst%3DJinxin%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ulviye Acar  Çevik</span>, <span class="hlFld-ContribAuthor ">Derya  Osmaniye</span>, <span class="hlFld-ContribAuthor ">Betül Kaya  Çavuşoğlu</span>, <span class="hlFld-ContribAuthor ">Begüm Nurpelin  Sağlik</span>, <span class="hlFld-ContribAuthor ">Serkan  Levent</span>, <span class="hlFld-ContribAuthor ">Sinem  Ilgin</span>, <span class="hlFld-ContribAuthor ">Nafiz Öncü  Can</span>, <span class="hlFld-ContribAuthor ">Yusuf  Özkay</span>, <span class="hlFld-ContribAuthor ">Zafer Asım  Kaplancikli</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel benzimidazole–oxadiazole derivatives as potent anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (12)
                                     , 2252-2261. <a href="https://doi.org/10.1007/s00044-019-02451-0" title="DOI URL">https://doi.org/10.1007/s00044-019-02451-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02451-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02451-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Bof%252Bnovel%252Bbenzimidazole%2525E2%252580%252593oxadiazole%252Bderivatives%252Bas%252Bpotent%252Banticancer%252Bactivity%26aulast%3D%25C3%2587evik%26aufirst%3DUlviye%2BAcar%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D12%26spage%3D2252%26epage%3D2261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changwei  Chen</span>, <span class="hlFld-ContribAuthor ">Peichen  Pan</span>, <span class="hlFld-ContribAuthor ">Ziyang  Deng</span>, <span class="hlFld-ContribAuthor ">Dahai  Wang</span>, <span class="hlFld-ContribAuthor ">Qifan  Wu</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>, <span class="hlFld-ContribAuthor ">Sunliang  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3,6-diaryl-1H-pyrazolo[3,4-b]pyridines as potent anaplastic lymphoma kinase (ALK) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (7)
                                     , 912-916. <a href="https://doi.org/10.1016/j.bmcl.2019.01.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.01.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.01.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3%25252C6-diaryl-1H-pyrazolo%25255B3%25252C4-b%25255Dpyridines%252Bas%252Bpotent%252Banaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Binhibitors%26aulast%3DChen%26aufirst%3DChangwei%26date%3D2019%26volume%3D29%26issue%3D7%26spage%3D912%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre-Yves  Michellys</span>. </span><span class="cited-content_cbyCitation_article-title">Ceritinib: A Potent ALK Inhibitor for the Treatment of Crizotinib-Resistant Non-Small Cell Lung Cancer Tumors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 131-152. <a href="https://doi.org/10.1002/9783527808694.ch6" title="DOI URL">https://doi.org/10.1002/9783527808694.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527808694.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527808694.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DCeritinib%25253A%252BA%252BPotent%252BALK%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BCrizotinib-Resistant%252BNon-Small%252BCell%252BLung%252BCancer%252BTumors%26aulast%3DMichellys%26aufirst%3DPierre-Yves%26date%3D2018%26date%3D2018%26spage%3D131%26epage%3D152%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2018%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Kristen  Farrell</span>, <span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>. </span><span class="cited-content_cbyCitation_article-title">Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 –
              Part II. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (7)
                                     , 831-849. <a href="https://doi.org/10.1080/13543776.2017.1297797" title="DOI URL">https://doi.org/10.1080/13543776.2017.1297797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1297797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1297797%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTropomyosin%252Breceptor%252Bkinase%252Binhibitors%25253A%252Ban%252Bupdated%252Bpatent%252Breview%252Bfor%252B2010-2016%252B%2525E2%252580%252593%252BPart%252BII%26aulast%3DBailey%26aufirst%3DJustin%2BJ.%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D7%26spage%3D831%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Kristen  Farrell</span>, <span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>. </span><span class="cited-content_cbyCitation_article-title">Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 –
              Part I. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 733-751. <a href="https://doi.org/10.1080/13543776.2017.1297796" title="DOI URL">https://doi.org/10.1080/13543776.2017.1297796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1297796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1297796%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTropomyosin%252Breceptor%252Bkinase%252Binhibitors%25253A%252Ban%252Bupdated%252Bpatent%252Breview%252Bfor%252B2010-2016%252B%2525E2%252580%252593%252BPart%252BI%26aulast%3DBailey%26aufirst%3DJustin%2BJ.%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D733%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolong  Jiang</span>, <span class="hlFld-ContribAuthor ">Ji  Zhou</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Li  Xing</span>, <span class="hlFld-ContribAuthor ">Yong  Xi</span>, <span class="hlFld-ContribAuthor ">Junfeng  Guo</span>, <span class="hlFld-ContribAuthor ">Qizheng  Yao</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: Design, synthesis, and structure—activity relationship study. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>105 </em>, 39-56. <a href="https://doi.org/10.1016/j.ejmech.2015.10.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Btetracyclic%252Bbenzo%25255Bb%25255Dcarbazolones%252Bas%252Bhighly%252Bpotent%252Band%252Borally%252Bbioavailable%252BALK%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bstructure%2525E2%252580%252594activity%252Brelationship%252Bstudy%26aulast%3DJiang%26aufirst%3DXiaolong%26date%3D2015%26volume%3D105%26spage%3D39%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangappa S.  Keri</span>, <span class="hlFld-ContribAuthor ">Asha  Hiremathad</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Budagumpi</span>, <span class="hlFld-ContribAuthor ">Bhari Mallanna  Nagaraja</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive Review in Current Developments of Benzimidazole-Based Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (1)
                                     , 19-65. <a href="https://doi.org/10.1111/cbdd.12462" title="DOI URL">https://doi.org/10.1111/cbdd.12462</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12462%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DComprehensive%252BReview%252Bin%252BCurrent%252BDevelopments%252Bof%252BBenzimidazole-Based%252BMedicinal%252BChemistry%26aulast%3DKeri%26aufirst%3DRangappa%2BS.%26date%3D2015%26date%3D2014%26volume%3D86%26issue%3D1%26spage%3D19%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dandan  Wang</span>, <span class="hlFld-ContribAuthor ">Daixi  Li</span>, <span class="hlFld-ContribAuthor ">Guangrong  Qin</span>, <span class="hlFld-ContribAuthor ">Wen  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Ouyang</span>, <span class="hlFld-ContribAuthor ">Menghuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Lu  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">The Structural Characterization of Tumor Fusion Genes and Proteins. </span><span class="cited-content_cbyCitation_journal-name">Computational and Mathematical Methods in Medicine</span><span> <strong>2015,</strong> <em>2015 </em>, 1-9. <a href="https://doi.org/10.1155/2015/912742" title="DOI URL">https://doi.org/10.1155/2015/912742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2015/912742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2015%2F912742%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Mathematical%2520Methods%2520in%2520Medicine%26atitle%3DThe%252BStructural%252BCharacterization%252Bof%252BTumor%252BFusion%252BGenes%252Band%252BProteins%26aulast%3DWang%26aufirst%3DDandan%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clive  McCarthy</span>, <span class="hlFld-ContribAuthor ">Edward  Walker</span>. </span><span class="cited-content_cbyCitation_article-title">Tropomyosin receptor kinase inhibitors: a patent update 2009 – 2013. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (7)
                                     , 731-744. <a href="https://doi.org/10.1517/13543776.2014.910195" title="DOI URL">https://doi.org/10.1517/13543776.2014.910195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.910195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.910195%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTropomyosin%252Breceptor%252Bkinase%252Binhibitors%25253A%252Ba%252Bpatent%252Bupdate%252B2009%252B%2525E2%252580%252593%252B2013%26aulast%3DMcCarthy%26aufirst%3DClive%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D7%26spage%3D731%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipeng  Ke</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Haichun  Liu</span>, <span class="hlFld-ContribAuthor ">Haoliang  Yuan</span>, <span class="hlFld-ContribAuthor ">Ting  Ran</span>, <span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Sihui  Yao</span>, <span class="hlFld-ContribAuthor ">Xiao  Xiong</span>, <span class="hlFld-ContribAuthor ">Jinxing  Xu</span>, <span class="hlFld-ContribAuthor ">Anyang  Xu</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and molecular fragment replacement study on diaminopyrimidine and pyrrolotriazine ALK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2014,</strong> <em>1067 </em>, 127-137. <a href="https://doi.org/10.1016/j.molstruc.2014.03.036" title="DOI URL">https://doi.org/10.1016/j.molstruc.2014.03.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2014.03.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2014.03.036%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3D3D-QSAR%252Band%252Bmolecular%252Bfragment%252Breplacement%252Bstudy%252Bon%252Bdiaminopyrimidine%252Band%252Bpyrrolotriazine%252BALK%252Binhibitors%26aulast%3DKe%26aufirst%3DZhipeng%26date%3D2014%26volume%3D1067%26spage%3D127%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugen F  Mesaros</span>, <span class="hlFld-ContribAuthor ">Gregory R  Ott</span>, <span class="hlFld-ContribAuthor ">Bruce D  Dorsey</span>. </span><span class="cited-content_cbyCitation_article-title">Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (4)
                                     , 417-442. <a href="https://doi.org/10.1517/13543776.2014.877890" title="DOI URL">https://doi.org/10.1517/13543776.2014.877890</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.877890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.877890%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DAnaplastic%252Blymphoma%252Bkinase%252Binhibitors%252Bas%252Banticancer%252Btherapeutics%25253A%252Ba%252Bpatent%252Breview%26aulast%3DMesaros%26aufirst%3DEugen%2BF%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D4%26spage%3D417%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek K.  Vyas</span>, <span class="hlFld-ContribAuthor ">Ajay  Patel</span>, <span class="hlFld-ContribAuthor ">Nirzari  Gupta</span>, <span class="hlFld-ContribAuthor ">Manjunath  Ghate</span>. </span><span class="cited-content_cbyCitation_article-title">Design of novel anaplastic lymphoma kinase (ALK) inhibitors based on predictive 3D QSAR models using different alignment strategies. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (2)
                                     , 603-617. <a href="https://doi.org/10.1007/s00044-013-0662-9" title="DOI URL">https://doi.org/10.1007/s00044-013-0662-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-013-0662-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-013-0662-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDesign%252Bof%252Bnovel%252Banaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Binhibitors%252Bbased%252Bon%252Bpredictive%252B3D%252BQSAR%252Bmodels%252Busing%252Bdifferent%252Balignment%252Bstrategies%26aulast%3DVyas%26aufirst%3DVivek%2BK.%26date%3D2014%26date%3D2013%26volume%3D23%26issue%3D2%26spage%3D603%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiyong  Sun</span>, <span class="hlFld-ContribAuthor ">Youyong  Li</span>, <span class="hlFld-ContribAuthor ">Mingyun  Shen</span>, <span class="hlFld-ContribAuthor ">Sheng  Tian</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Peichen  Pan</span>, <span class="hlFld-ContribAuthor ">Yan  Guan</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring. </span><span class="cited-content_cbyCitation_journal-name">Phys. Chem. Chem. Phys.</span><span> <strong>2014,</strong> <em>16 </em>
                                    (40)
                                     , 22035-22045. <a href="https://doi.org/10.1039/C4CP03179B" title="DOI URL">https://doi.org/10.1039/C4CP03179B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4CP03179B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4CP03179B%26sid%3Dliteratum%253Aachs%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26atitle%3DAssessing%252Bthe%252Bperformance%252Bof%252BMM%25252FPBSA%252Band%252BMM%25252FGBSA%252Bmethods.%252B5.%252BImproved%252Bdocking%252Bperformance%252Busing%252Bhigh%252Bsolute%252Bdielectric%252Bconstant%252BMM%25252FGBSA%252Band%252BMM%25252FPBSA%252Brescoring%26aulast%3DSun%26aufirst%3DHuiyong%26date%3D2014%26date%3D2014%26volume%3D16%26issue%3D40%26spage%3D22035%26epage%3D22045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ran  Friedman</span>, . </span><span class="cited-content_cbyCitation_article-title">Drug Resistance Missense Mutations in Cancer Are Subject to Evolutionary Constraints. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (12)
                                     , e82059. <a href="https://doi.org/10.1371/journal.pone.0082059" title="DOI URL">https://doi.org/10.1371/journal.pone.0082059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0082059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0082059%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DDrug%252BResistance%252BMissense%252BMutations%252Bin%252BCancer%252BAre%252BSubject%252Bto%252BEvolutionary%252BConstraints%26aulast%3DFriedman%26aufirst%3DRan%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D12%26spage%3De82059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeep  Kumar</span>, <span class="hlFld-ContribAuthor ">Nikhil  Kumar</span>, <span class="hlFld-ContribAuthor ">Partha  Roy</span>, <span class="hlFld-ContribAuthor ">Sham M.  Sondhi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, anti-inflammatory, and antiproliferative activity evaluation of isoindole, pyrrolopyrazine, benzimidazoisoindole, and benzimidazopyrrolopyrazine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2013,</strong> <em>17 </em>
                                    (4)
                                     , 753-766. <a href="https://doi.org/10.1007/s11030-013-9472-8" title="DOI URL">https://doi.org/10.1007/s11030-013-9472-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-013-9472-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-013-9472-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DSynthesis%25252C%252Banti-inflammatory%25252C%252Band%252Bantiproliferative%252Bactivity%252Bevaluation%252Bof%252Bisoindole%25252C%252Bpyrrolopyrazine%25252C%252Bbenzimidazoisoindole%25252C%252Band%252Bbenzimidazopyrrolopyrazine%252Bderivatives%26aulast%3DKumar%26aufirst%3DSandeep%26date%3D2013%26date%3D2013%26volume%3D17%26issue%3D4%26spage%3D753%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric J.  Lowe</span>, <span class="hlFld-ContribAuthor ">Megan S.  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Therapies for Anaplastic Lymphoma Kinase-Driven Tumors in Children: Progress to Date. </span><span class="cited-content_cbyCitation_journal-name">Pediatric Drugs</span><span> <strong>2013,</strong> <em>15 </em>
                                    (3)
                                     , 163-169. <a href="https://doi.org/10.1007/s40272-013-0027-3" title="DOI URL">https://doi.org/10.1007/s40272-013-0027-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40272-013-0027-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40272-013-0027-3%26sid%3Dliteratum%253Aachs%26jtitle%3DPediatric%2520Drugs%26atitle%3DPotential%252BTherapies%252Bfor%252BAnaplastic%252BLymphoma%252BKinase-Driven%252BTumors%252Bin%252BChildren%25253A%252BProgress%252Bto%252BDate%26aulast%3DLowe%26aufirst%3DEric%2BJ.%26date%3D2013%26date%3D2013%26volume%3D15%26issue%3D3%26spage%3D163%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2013,</strong> <em>68 </em>
                                    (1)
                                     , 68-94. <a href="https://doi.org/10.1016/j.phrs.2012.11.007" title="DOI URL">https://doi.org/10.1016/j.phrs.2012.11.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2012.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2012.11.007%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DAnaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%25253A%252BStructure%25252C%252Boncogenic%252Bactivation%25252C%252Band%252Bpharmacological%252Binhibition%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2013%26volume%3D68%26issue%3D1%26spage%3D68%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yohannes  Teffera</span>, <span class="hlFld-ContribAuthor ">Loren M.  Berry</span>, <span class="hlFld-ContribAuthor ">Rachael L.  Brake</span>, <span class="hlFld-ContribAuthor ">Richard T.  Lewis</span>, <span class="hlFld-ContribAuthor ">Douglas C.  Saffran</span>, <span class="hlFld-ContribAuthor ">Earl  Moore</span>, <span class="hlFld-ContribAuthor ">Jingzhou  Liu</span>, <span class="hlFld-ContribAuthor ">Zhiyang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Hydrolysis-Mediated Clearance on the Pharmacokinetics of Novel Anaplastic Lymphoma Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2013,</strong> <em>41 </em>
                                    (1)
                                     , 238-247. <a href="https://doi.org/10.1124/dmd.112.047993" title="DOI URL">https://doi.org/10.1124/dmd.112.047993</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.112.047993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.112.047993%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DImpact%252Bof%252BHydrolysis-Mediated%252BClearance%252Bon%252Bthe%252BPharmacokinetics%252Bof%252BNovel%252BAnaplastic%252BLymphoma%252BKinase%252BInhibitors%26aulast%3DTeffera%26aufirst%3DYohannes%26date%3D2013%26date%3D2012%26volume%3D41%26issue%3D1%26spage%3D238%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linda F.  Epstein</span>, <span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Renee  Emkey</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>. </span><span class="cited-content_cbyCitation_article-title">The R1275Q Neuroblastoma Mutant and Certain ATP-competitive Inhibitors Stabilize Alternative Activation Loop Conformations of Anaplastic Lymphoma Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2012,</strong> <em>287 </em>
                                    (44)
                                     , 37447-37457. <a href="https://doi.org/10.1074/jbc.M112.391425" title="DOI URL">https://doi.org/10.1074/jbc.M112.391425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M112.391425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M112.391425%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DThe%252BR1275Q%252BNeuroblastoma%252BMutant%252Band%252BCertain%252BATP-competitive%252BInhibitors%252BStabilize%252BAlternative%252BActivation%252BLoop%252BConformations%252Bof%252BAnaplastic%252BLymphoma%252BKinase%26aulast%3DEpstein%26aufirst%3DLinda%2BF.%26date%3D2012%26volume%3D287%26issue%3D44%26spage%3D37447%26epage%3D37457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overlay of cocrystal structures of <b>1</b> (purple) and <b>2</b> (green) in the ATP binding pocket of the ALK kinase domain. Dashed lines indicate hydrogen bonds and the red sphere denotes an ordered water molecule associated with <b>1</b>. PDB codes: <b>1</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOB">4FOB</a>; <b>2</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOC">4FOC</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. A comparison of the binding modes of compounds <b>1</b> and <b>2</b>, cocrystallized with ALK (left panel) and superimposed onto a JAK2 crystal structure (right panel). A comparison of the binding modes of compound <b>1</b> (purple) and <b>2</b> (green), cocrystallized with ALK (left panel; PBB = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOB">4FOB</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOC">4FOC</a>) and superimposed onto a JAK2 crystal structure (right panel; PDB = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LPB">3LPB</a>). The surfaces of residues Leu855 and Gly856 in JAK2 are colored yellow. Both proteins are shown at the same scale and relative orientation to illustrate differences in the dimensions of their ATP binding pockets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,6-lutidine, TIPSOTf, DCM, 99%; (b) DIPEA, CH<sub>3</sub>CN, 50 °C, 60%; (c) NH<sub>4</sub>HCO<sub>2</sub>, 10% Pd/C, EtOH, 100%; (d) CNBr, EtOH, 25 °C, 92%; (e) (i) PhCOCl, Et<sub>3</sub>N, DCM, 0 °C, (ii) TBAF, THF, 0–25 °C, 63%; (f) (i) SOCl<sub>2</sub>, 0 °C, (ii) piperidine, DMSO, 25°, 75%; (g) NaOH, MeOH, 95%; (h) (i) SOCl<sub>2</sub>, neat, 0 °C, (ii) EtNH<sub>2</sub>, THF 0–25 °C, 90%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup>i</sup>Pr<sub>2</sub>EtN, CH<sub>3</sub>CN, 50 °C, 71%; (b) (i) H<sub>2</sub>/10% Pd/C, EtOH, (ii) <b>21</b>, THF, (iii) EDCI, <sup>i</sup>Pr<sub>2</sub>EtN, 80% overall; (c) (i) SOCl<sub>2</sub>, 0 °C, (ii) <b>23</b>, DCM, 25 °C; 56% overall.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Na(AcO)<sub>3</sub>BH, DCM, 88%; (b) <sup>i</sup>Pr<sub>2</sub>EtN, CH<sub>3</sub>CN, 50 °C, 73%; (c) NH<sub>4</sub>HCO<sub>2</sub>, Pd/C, EtOH, 100%; (d) <sup>i</sup>Pr<sub>2</sub>EtN/EDCI, 72%; (e) (i) MeCONCS, dioxan, 100 °C, (ii) EDCI, <sup>i</sup>Pr<sub>2</sub>EtN, 60 °C, HCl aq (2N), 50 °C, 82% overall; (f) ArCO<sub>2</sub>H, EDCI, HOBt, <sup>i</sup>Pr<sub>2</sub>EtN, DMF, 50 °C, 15–24%</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Co-crystal structure of ALK with compound <b>36</b>. The solubilizing group is observed to adopt two possible orientations (A or B). Dashed lines indicate hydrogen bonds. PDB code is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOD">4FOD</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. AMBIT kinome screening at 1 μM, annotated on (<i>n</i> = 442) enzymes in the human <b>36</b> and <b>49</b> with hits showing % control at 1 μM (i.e., 0%, largest spot is most active) overlaid on the kinome phylogenetic tree.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/medium/jm-2012-005866_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>49</b> dosed (10, 30, 60 mpk, po, qd) in SCID-beige mice bearing Karpas-299 xenografts. **After 15 days of treatment with <b>49</b> at the 60 mpk dose, the tumors in 6 of the 10 animals had completely regressed. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure S1">Supporting Information Figure S1</a> for body weight data from this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3005866/production/images/large/jm-2012-005866_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005866&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froehling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, W.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrady, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A.</span><span> </span><span class="NLM_article-title">Activating mutations in ALK provide a therapeutic target in neuroblastoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=975-978&author=R.+E.+Georgeauthor=T.+Sandaauthor=M.+Hannaauthor=S.+Froehlingauthor=W.+Lutherauthor=J.+Zhangauthor=Y.+Ahnauthor=W+Zhouauthor=W.+B.+Londonauthor=P.+McGradyauthor=L.+Xueauthor=S.+Zozulyaauthor=V.+E.+Gregorauthor=T.+R.+Webbauthor=N.+S.+Grayauthor=D.+G.+Gillilandauthor=L.+Dillerauthor=H.+Greulichauthor=S.+W.+Morrisauthor=M.+Meyersonauthor=A.+Look&title=Activating+mutations+in+ALK+provide+a+therapeutic+target+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DSanda%26aufirst%3DT.%26aulast%3DHanna%26aufirst%3DM.%26aulast%3DFroehling%26aufirst%3DS.%26aulast%3DLuther%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DW%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DMcGrady%26aufirst%3DP.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZozulya%26aufirst%3DS.%26aulast%3DGregor%26aufirst%3DV.%2BE.%26aulast%3DWebb%26aufirst%3DT.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DDiller%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DLook%26aufirst%3DA.%26atitle%3DActivating%2520mutations%2520in%2520ALK%2520provide%2520a%2520therapeutic%2520target%2520in%2520neuroblastoma%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D975%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmer, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=1281-1284&author=S.+W.+Morrisauthor=M.+N.+Kirsteinauthor=M.+B.+Valentineauthor=K.+G.+Dittmerauthor=D.+N.+Shapiroauthor=D.+L.+Saltmanauthor=A.+T.+Look&title=Fusion+of+a+kinase+gene%2C+ALK%2C+to+a+nucleolar+protein+gene%2C+NPM%2C+in+non-Hodgkin%E2%80%99s+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DValentine%26aufirst%3DM.%2BB.%26aulast%3DDittmer%26aufirst%3DK.%2BG.%26aulast%3DShapiro%26aufirst%3DD.%2BN.%26aulast%3DSaltman%26aufirst%3DD.%2BL.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DFusion%2520of%2520a%2520kinase%2520gene%252C%2520ALK%252C%2520to%2520a%2520nucleolar%2520protein%2520gene%252C%2520NPM%252C%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurashina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Identification of the transforming <i>EML4–ALK</i> fusion gene in non-small-cell lung cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=561-566&author=M.+Sodaauthor=Y.+L.+Choiauthor=M.+Enomotoauthor=S.+Takadaauthor=Y.+Yamashitaauthor=S.+Ishikawaauthor=S.-I.+Fujiwaraauthor=H.+Watanabeauthor=K.+Kurashinaauthor=H.+Hatanakaauthor=M.+Bandoauthor=S.+Ohnoauthor=Y.+Ishikawaauthor=H.+Aburataniauthor=T.+Nikiauthor=Y.+Soharaauthor=Y.+Sugiyamaauthor=H.+Mano&title=Identification+of+the+transforming+EML4%E2%80%93ALK+fusion+gene+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DEnomoto%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DS.-I.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKurashina%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520the%2520transforming%2520EML4%25E2%2580%2593ALK%2520fusion%2520gene%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><a href="http://www.cancer.gov/cancertopics/druginfo/fda-crizotinib" class="extLink">http://www.cancer.gov/cancertopics/druginfo/fda-crizotinib</a>; see also <span class="NLM_contrib-group">Shaw, A. T.; Yasothan, U.; Kirkpatrick, P.; crizotinib.</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span>),  <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span>, <div class="note"><p class="first last">see also ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fdruginfo%2Ffda-crizotinib%3B+see+also+Shaw%2C+A.+T.%3B+Yasothan%2C+U.%3B+Kirkpatrick%2C+P.%3B+crizotinib.Nature+Rev.+Drug+Discovery%2C+2011%2C+10+%2812%29%2C+897%E2%80%93898%2C+see+also+ref+9."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D12%26spage%3D897%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bresler, S. C.; Wood, A. C.; Haglund, E. A.; Courtright, J.; Belcastro, L. T.; Plegaria, J. S.; Cole, K.; Toporovskaya, Y.; Zhao, H.; Carpenter, E. L.; Christensen, J. G.; Maris, J. M.; Lemmon, M. A.; Mossé, Y. P.</span><span> </span><span class="NLM_article-title">Differential Inhibitor Sensitivity of Anaplastic Lymphoma Kinase Variants Found in Neuroblastoma</span>.  <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span>),  <span class="NLM_fpage">108ra114</span>, DOI: <span class="refDoi"> DOI: 10.1126/scitranslmed.3002950.</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm3005866&amp;key=10.1126%2Fscitranslmed.3002950." title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=108ra114&issue=3&author=S.+C.+Bresler&author=A.+C.+Wood&author=E.+A.+Haglund&author=J.+Courtright&author=L.+T.+Belcastro&author=J.+S.+Plegaria&author=K.+Cole&author=Y.+Toporovskaya&author=H.+Zhao&author=E.+L.+Carpenter&author=J.+G.+Christensen&author=J.+M.+Maris&author=M.+A.+Lemmon&author=Y.+P.+Moss%C3%A9&title=Differential+Inhibitor+Sensitivity+of+Anaplastic+Lymphoma+Kinase+Variants+Found+in+Neuroblastoma&doi=10.1126%2Fscitranslmed.3002950."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3002950.&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3002950.%26sid%3Dliteratum%253Aachs%26aulast%3DBresler%26aufirst%3DS.%2BC.%26atitle%3DDifferential%2520Inhibitor%2520Sensitivity%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520Variants%2520Found%2520in%2520Neuroblastoma%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D108%26issue%3D3%26spage%3D108ra114%26doi%3D10.1126%2Fscitranslmed.3002950." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">See also</p></div><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butrynski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span> </span><span class="NLM_article-title">The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">10038</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10038-43&issue=24&author=T.+Sasakiauthor=K.+Okudaauthor=W.+Zhengauthor=J.+Butrynskiauthor=M.+Capellettiauthor=L.+Wangauthor=N.+S.+Grayauthor=K.+Wilnerauthor=J.+G.+Christensenauthor=G.+Demetriauthor=G.+I.+Shapiroauthor=S.+J.+Rodigauthor=M.+J.+Eckauthor=P.+A.+J%C3%A4nne&title=The+neuroblastoma-associated+F1174L+ALK+mutation+causes+resistance+to+an+ALK+kinase+inhibitor+in+ALK-translocated+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DOkuda%26aufirst%3DK.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DButrynski%26aufirst%3DJ.%26aulast%3DCapelletti%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWilner%26aufirst%3DK.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DDemetri%26aufirst%3DG.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26atitle%3DThe%2520neuroblastoma-associated%2520F1174L%2520ALK%2520mutation%2520causes%2520resistance%2520to%2520an%2520ALK%2520kinase%2520inhibitor%2520in%2520ALK-translocated%2520cancers%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D24%26spage%3D10038%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">See also</p></div><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haruta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsudomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanio, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">EML4-ALK Mutations in Lung cancer that confer resistance to ALK inhibitors</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">1734</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm3005866&amp;key=10.1056%2FNEJMoa1007478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm3005866&amp;key=20979473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm3005866&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1734-1739&issue=18&author=Y.+L.+Choiauthor=M.+Sodaauthor=Y.+Yamashitaauthor=T.+Uenoauthor=J.+Takashimaauthor=T.+Nakajimaauthor=Y.+Yatabeauthor=K.+Takeuchiauthor=T.+Hamadaauthor=H.+Harutaauthor=Y.+Ishikawaauthor=H.+Kimuraauthor=T.+Mitsudomiauthor=Y.+Tanioauthor=H.+Mano&title=EML4-ALK+Mutations+in+Lung+cancer+that+confer+resistance+to+ALK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors</span></div><div class="casAuthors">Choi, Young Lim; Soda, Manabu; Yamashita, Yoshihiro; Ueno, Toshihide; Takashima, Junpei; Nakajima, Takahiro; Yatabe, Yasushi; Takeuchi, Kengo; Hamada, Toru; Haruta, Hidenori; Ishikawa, Yuichi; Kimura, Hideki; Mitsudomi, Tetsuya; Tanio, Yoshiro; Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1734-1739</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The EML4 (echinoderm microtubule-assocd. protein-like 4)-ALK (anaplastic lymphoma kinase) fusion-type tyrosine kinase is an oncoprotein found in 4% to 5% of non-small-cell lung cancers, and clin. trials of specific inhibitors of ALK for the treatment of such tumors are currently under way.  Here, we report the discovery of two secondary mutations within the kinase domain of EML4-ALK in tumor cells isolated from a patient during the relapse phase of treatment with an ALK inhibitor.  Each mutation developed independently in subclones of the tumor and conferred marked resistance to two different ALK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCIrEIBi5MjrVg90H21EOLACvtfcHk0ljOOvkUhFUslg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FJ&md5=d903151706575c159b7abcdc8999281c</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1007478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1007478%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DTakashima%26aufirst%3DJ.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DYatabe%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DHamada%26aufirst%3DT.%26aulast%3DHaruta%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DMitsudomi%26aufirst%3DT.%26aulast%3DTanio%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DEML4-ALK%2520Mutations%2520in%2520Lung%2520cancer%2520that%2520confer%2520resistance%2520to%2520ALK%2520inhibitors%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26issue%3D18%26spage%3D1734%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">See also</p></div><span class="NLM_contrib-group">Heuckmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heynck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balke-Want, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovly, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruetter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. K.</span><span> </span><span class="NLM_article-title">ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">7394</span><span class="NLM_x">–</span> <span class="NLM_lpage">7401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm3005866&amp;key=10.1158%2F1078-0432.CCR-11-1648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm3005866&amp;key=21948233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm3005866&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCmtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=7394-7401&issue=23&author=J.+M.+Heuckmannauthor=M.+Hoelzelauthor=M.+L.+Sosauthor=S.+Heynckauthor=H.+Balke-Wantauthor=M.+Kokerauthor=M.+Peiferauthor=J.+Weissauthor=C.+M.+Lovlyauthor=C.+Gruetterauthor=D.+Rauhauthor=W.+Paoauthor=R.+K.+Thomas&title=ALK+Mutations+Conferring+Differential+Resistance+to+Structurally+Diverse+ALK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors</span></div><div class="casAuthors">Heuckmann, Johannes M.; Hoelzel, Michael; Sos, Martin L.; Heynck, Stefanie; Balke-Want, Hyatt; Koker, Mirjam; Peifer, Martin; Weiss, Jonathan; Lovly, Christine M.; Gruetter, Christian; Rauh, Daniel; Pao, William; Thomas, Roman K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7394-7401</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE:EML4-ALK fusions define a subset of lung cancers that can be effectively treated with anaplastic lymphoma kinase (ALK) inhibitors.  Unfortunately, the duration of response is heterogeneous and acquired resistance limits their ultimate efficacy.  Thus, a better understanding of resistance mechanisms will help to enhance tumor control in EML4-ALK-pos. tumors.  Exptl. Design: By applying orthogonal functional mutagenesis screening approaches, we screened for mutations inducing resistance to the aminopyridine PF02341066 (crizotinib) and/or the diaminopyrimidine TAE684.  RESULTS: Here, we show that the resistance mutation, L1196M, as well as other crizotinib resistance mutations (F1174L and G1269S), are highly sensitive to the structurally unrelated ALK inhibitor TAE684.  In addn., we identified two novel EML4-ALK resistance mutations (L1198P and D1203N), which unlike previously reported mutations, induced resistance to both ALK inhibitors.  An independent resistance screen in ALK-mutant neuroblastoma cells yielded the same L1198P resistance mutation but defined two addnl. mutations conferring resistance to TAE684 but not to PF02341066.  CONCLUSIONS: Our results show that different ALK resistance mutations as well as different ALK inhibitors impact the therapeutic efficacy in the setting of EML4-ALK fusions and ALK mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo4XRKE2WO0bVg90H21EOLACvtfcHk0lg4iToKPgBeUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCmtrnK&md5=11592d3e0280edc60fabc02419f00496</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1648%26sid%3Dliteratum%253Aachs%26aulast%3DHeuckmann%26aufirst%3DJ.%2BM.%26aulast%3DHoelzel%26aufirst%3DM.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DHeynck%26aufirst%3DS.%26aulast%3DBalke-Want%26aufirst%3DH.%26aulast%3DKoker%26aufirst%3DM.%26aulast%3DPeifer%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DJ.%26aulast%3DLovly%26aufirst%3DC.%2BM.%26aulast%3DGruetter%26aufirst%3DC.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26atitle%3DALK%2520Mutations%2520Conferring%2520Differential%2520Resistance%2520to%2520Structurally%2520Diverse%2520ALK%2520Inhibitors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26issue%3D23%26spage%3D7394%26epage%3D7401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><div class="note"><p class="first last">ALK, JAK2<sup>13</sup> and SRC are related in that they share a common downstream signaling pathway via Stat3. For details of the JAK kinase enzyme assays; see</p></div><span class="NLM_contrib-group">Laurie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S.</span><span> </span><span class="NLM_article-title">Discovery of Potent and Highly Selective Thienopyridine Janus Kinase 2 Inhibitors</span> <span class="citation_source-journal"> J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">8440</span><span class="NLM_x">–</span> <span class="NLM_lpage">8450</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8440-8450&issue=24&author=B.+Laurieauthor=L.+B.+Schenkelauthor=X.+Huangauthor=A.+Chengauthor=H.+L.+Deakauthor=E.+Dohertyauthor=R.+Emkeyauthor=Y.+Guauthor=H.+Gunaydinauthor=J.+L.+Kimauthor=J.+Leeauthor=R.+Lobergauthor=P.+Olivieriauthor=J.+Pistilloauthor=J.+Tangauthor=Q.+Wanauthor=H.-L.+Wangauthor=S.-W.+Wangauthor=M.+C.+Wellsauthor=B.+Wuauthor=V.+Yuauthor=L.+Liuauthor=S.+Geuns-Meyer&title=Discovery+of+Potent+and+Highly+Selective+Thienopyridine+Janus+Kinase+2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaurie%26aufirst%3DB.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DDoherty%26aufirst%3DE.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLoberg%26aufirst%3DR.%26aulast%3DOlivieri%26aufirst%3DP.%26aulast%3DPistillo%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.-L.%26aulast%3DWang%26aufirst%3DS.-W.%26aulast%3DWells%26aufirst%3DM.%2BC.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Highly%2520Selective%2520Thienopyridine%2520Janus%2520Kinase%25202%2520Inhibitors%26jtitle%3D%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D24%26spage%3D8440%26epage%3D8450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><div class="note"><p class="first last">For details of the ALK kinase enzyme and cellular screens, see</p></div><span class="NLM_contrib-group">Drew, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Assaad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szilvassy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brake, R. L.</span><span> </span><span class="NLM_article-title">Comparison of 2 Cell-Based Phosphoprotein Assays to Support Screening and D evelopment of an ALK Inhibitor</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><div class="note"><p class="first last">Details of the IGF1R and SRC enzyme assays and INSR cellular assay are reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3005866&amp;key=10.1177%2F1087057110394657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3005866&amp;key=21297104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3005866&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVGlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-173&issue=2&author=A.+E.+Drewauthor=S.+Al-Assaadauthor=V.+Yuauthor=P.+Andrewsauthor=P.+Merkelauthor=S.+Szilvassyauthor=R.+Emkeyauthor=R.+Lewisauthor=R.+L.+Brake&title=Comparison+of+2+Cell-Based+Phosphoprotein+Assays+to+Support+Screening+and+D+evelopment+of+an+ALK+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of 2 cell-based phosphoprotein assays to support screening and development of an ALK inhibitor</span></div><div class="casAuthors">Drew, Allison E.; Al-Assaad, Samer; Yu, Violeta; Andrews, Paul; Merkel, Patricia; Szilvassy, Stephen; Emkey, Renee; Lewis, Richard; Brake, Rachael L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-173</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) when expressed as a fusion protein with nucleophosmin (NPM) has been implicated as a driving oncogene in a subset of lymphomas.  Recent reports of ALK expression in a no. of other cancers have raised the possibility that an ALK inhibitor may benefit patients with these diseases as well.  In a campaign to identify and develop a selective ALK inhibitor, 2 assays were devised to measure the phosphorylation of tyrosine residue 1604 of ALK (pY1604 ALK).  Amplified Luminescent Proximity Homogeneous Assay (AlphaScreen) and phosflow platforms were used to detect modulation of pY1604 ALK to det. the relative potency of a set of small-mol. inhibitors.  Prior to making use of these assays in diverse settings, the authors attempted to ensure their equivalence with a direct comparison of their performance.  The pY1604 ALK assays correlated well both with each other and with assays of ALK enzyme activity or ALK-dependent cell proliferation.  The AlphaScreen assay was amenable to automation and enabled rapid, high-throughput compd. assessment in an NPM-ALK-driven cell line, whereas the phosflow assay enabled the authors to characterize the activity of compds. with respect to their impact on targeted enzymes and pathways.  Results show that both AlphaScreen and phosflow ALK assays exhibited diverse characteristics that made them desirable for different applications but were detd. to be equally sensitive and robust in the detection of inhibition of pY1604 ALK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5MH7yS6GGhbVg90H21EOLACvtfcHk0lg4iToKPgBeUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVGlurs%253D&md5=31212fb7129ded1aeb1395b2407c5e23</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1177%2F1087057110394657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057110394657%26sid%3Dliteratum%253Aachs%26aulast%3DDrew%26aufirst%3DA.%2BE.%26aulast%3DAl-Assaad%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DAndrews%26aufirst%3DP.%26aulast%3DMerkel%26aufirst%3DP.%26aulast%3DSzilvassy%26aufirst%3DS.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DBrake%26aufirst%3DR.%2BL.%26atitle%3DComparison%2520of%25202%2520Cell-Based%2520Phosphoprotein%2520Assays%2520to%2520Support%2520Screening%2520and%2520D%2520evelopment%2520of%2520an%2520ALK%2520Inhibitor%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2011%26volume%3D16%26issue%3D2%26spage%3D164%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="note"><p class="first last">IC<sub>50</sub> data from which these selectivity ratios are derived for the off-target kinases is included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S3">Supporting Information, Table S3</a>, together with assay protocols (see also refs <a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and <a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a>). All IC<sub>50</sub> values are derived from 22 point dose–response curves and are reported as a mean (±) SD where two or more independent determinations were performed. ND = not determined.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&issue=18&author=J.+J.+Cuiauthor=M.+Tran-Dubeauthor=H.+Shenauthor=M.+Nambuauthor=P.-P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+Based+Drug+Design+of+Crizotinib+%28PF-02341066%29%2C+a+Potent+and+Selective+Dual+Inhibitor+of+Mesenchymal%E2%80%93Epithelial+Transition+Factor+%28c-MET%29+Kinase+and+Anaplastic+Lymphoma+Kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520Based%2520Drug%2520Design%2520of%2520Crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520Potent%2520and%2520Selective%2520Dual%2520Inhibitor%2520of%2520Mesenchymal%25E2%2580%2593Epithelial%2520Transition%2520Factor%2520%2528c-MET%2529%2520Kinase%2520and%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D18%26spage%3D6342%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">There is evidence of a close association between the benzimidazole nitrogen and the backbone carbonyl of Met1199 in all of the co-crystal structures that we have obtained for this class of ALK inhibitors. For compound <b>36</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), the N-to-O distance is measured at 2.9 Å, which is consistent with an intermolecular hydrogen bond between these two centers. The interatomic distance between the benzoyl carbonyl oxygen of the inhibitor and the backbone NH of Met199 measures 3.0 Å in this structure. These interatomic distances are compatible with this class of compounds adopting an exocyclic acylimine tautomer, which is best able to satisfy the observed hydrogen-bonding pattern.</p></div><span class="NLM_contrib-group">Riether, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zindell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lombaert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugler, S. Z.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, K. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labissiere, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">5-Aminomethylbenzimdazoles as potent ITK antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1588</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1588-1591&author=D.+Rietherauthor=R.+Zindellauthor=J.+A.+Kowalskiauthor=B.+N.+Cookauthor=J.+Bentzienauthor=S.+De+Lombaertauthor=D.+Thomsonauthor=S.+Z.+Kuglerauthor=D.+Skowauthor=L.+S.+Martinauthor=E.+L.+Raymondauthor=H+H.+Khineauthor=K.+O%E2%80%99Sheaauthor=J.+R.+Woskaauthor=D.+Jeanfavreauthor=R.+Sellatiauthor=K.+L.+M.+Ralphauthor=J.+Ahlbergauthor=G.+Labissiereauthor=M.+A.+Kashemauthor=S.+S.+Pullenauthor=H.+Takahashi&title=5-Aminomethylbenzimdazoles+as+potent+ITK+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiether%26aufirst%3DD.%26aulast%3DZindell%26aufirst%3DR.%26aulast%3DKowalski%26aufirst%3DJ.%2BA.%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DBentzien%26aufirst%3DJ.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26aulast%3DThomson%26aufirst%3DD.%26aulast%3DKugler%26aufirst%3DS.%2BZ.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DL.%2BS.%26aulast%3DRaymond%26aufirst%3DE.%2BL.%26aulast%3DKhine%26aufirst%3DH%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DK.%26aulast%3DWoska%26aufirst%3DJ.%2BR.%26aulast%3DJeanfavre%26aufirst%3DD.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DRalph%26aufirst%3DK.%2BL.%2BM.%26aulast%3DAhlberg%26aufirst%3DJ.%26aulast%3DLabissiere%26aufirst%3DG.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3D5-Aminomethylbenzimdazoles%2520as%2520potent%2520ITK%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1588%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">See also</p></div><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleymanzadeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugler, S. Z.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lombaert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=773-777&author=B.+N.+Cookauthor=J.+Bentzienauthor=A.+Whiteauthor=P.+A.+Nemotoauthor=J.+Wangauthor=C.+C.+Manauthor=F.+Soleymanzadehauthor=H.+H.+Khineauthor=M.+A.+Kashemauthor=S.+Z.+Kuglerauthor=J.+P.+Wolakauthor=G.+P.+Rothauthor=S.+De+Lombaertauthor=S.+S.+Pullenauthor=H.+Takahashi&title=Discovery+of+potent+inhibitors+of+interleukin-2+inducible+T-cell+kinase+%28ITK%29+through+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DBentzien%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DNemoto%26aufirst%3DP.%2BA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMan%26aufirst%3DC.%2BC.%26aulast%3DSoleymanzadeh%26aufirst%3DF.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DKugler%26aufirst%3DS.%2BZ.%26aulast%3DWolak%26aufirst%3DJ.%2BP.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520of%2520interleukin-2%2520inducible%2520T-cell%2520kinase%2520%2528ITK%2529%2520through%2520structure-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D773%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">For a discussion of acyliminobenzimidazole tautomerism, see</p></div><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywardane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khine, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarko, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolaka, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span> </span><span class="NLM_article-title">Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3660</span><span class="NLM_x">–</span> <span class="NLM_lpage">3665</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3660-3665&author=R.+J.+Snowauthor=A.+Abeywardaneauthor=S.+Campbellauthor=J.+Lordauthor=M.+A.+Kashemauthor=H.+H.+Khineauthor=J.+Kingauthor=J.+A.+Kowalskiauthor=S.+S.+Pullenauthor=T.+Romaauthor=G.+P.+Rothauthor=C.+R.+Sarkoauthor=N.+S.+Wilsonauthor=M.+P.+Wintersauthor=J.+P.+Wolakaauthor=C.+L.+Cywin&title=Hit-to-lead+studies+on+benzimidazole+inhibitors+of+ITK%3A+discovery+of+a+novel+class+of+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DAbeywardane%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DLord%26aufirst%3DJ.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DKhine%26aufirst%3DH.%2BH.%26aulast%3DKing%26aufirst%3DJ.%26aulast%3DKowalski%26aufirst%3DJ.%2BA.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26aulast%3DRoma%26aufirst%3DT.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DSarko%26aufirst%3DC.%2BR.%26aulast%3DWilson%26aufirst%3DN.%2BS.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DWolaka%26aufirst%3DJ.%2BP.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26atitle%3DHit-to-lead%2520studies%2520on%2520benzimidazole%2520inhibitors%2520of%2520ITK%253A%2520discovery%2520of%2520a%2520novel%2520class%2520of%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3660%26epage%3D3665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">See also</p></div><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N. P. C.</span><span> </span><span class="NLM_article-title">Crystal Structures of IRAK-4 Kinase in Complex with Inhibitors: A Serine/Threonine Kinase with Tyrosine as a Gatekeeper</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1835</span><span class="NLM_x">–</span> <span class="NLM_lpage">1844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1835-1844&author=Z.+Wangauthor=J.+Liuauthor=S.+Sudomauthor=M.+Ayresauthor=S.+Liauthor=H.+Wescheauthor=J.+P.+Powersauthor=N.+P.+C.+Walker&title=Crystal+Structures+of+IRAK-4+Kinase+in+Complex+with+Inhibitors%3A+A+Serine%2FThreonine+Kinase+with+Tyrosine+as+a+Gatekeeper"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSudom%26aufirst%3DS.%26aulast%3DAyres%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DWalker%26aufirst%3DN.%2BP.%2BC.%26atitle%3DCrystal%2520Structures%2520of%2520IRAK-4%2520Kinase%2520in%2520Complex%2520with%2520Inhibitors%253A%2520A%2520Serine%252FThreonine%2520Kinase%2520with%2520Tyrosine%2520as%2520a%2520Gatekeeper%26jtitle%3DStructure%26date%3D2006%26volume%3D14%26spage%3D1835%26epage%3D1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="note"><p class="first last">Data collection and refinement statistics are included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S4">Supporting Information, Table S4</a>, along with crystallographic experimental procedures. The cocrystal structures of <b>1</b> and <b>2</b> in ALK have PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOB">4FOB</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOC">4FOC</a>, respectively; <b>3</b>, PF-02341066, hydrogen-bonds to the linker region of ALK through its pyridine nitrogen atom and the adjacent amine. The pyrazole ring and solubilizing group face solvent and the O-linked benzyl ring sits in the lipophilic pocket defined largely by Leu1256, Gly1269 (the X-DFG residue), and the backbone atoms of Arg1253/Asn1254 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2">2XP2</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">SAR of the sulfonamide side chain of <b>1</b> or ester moiety of <b>2</b> indicated that the cost of not occupying this lipophilic pocket amounted to an order of magnitude loss in binding affinity. Unpublished observations.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">Activity against JAK1, 2, and 3 and TYK2 were routinely monitored,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and selectivity over JAK2 was the highest hurdle for this structural class. Selected data for compounds <b>14</b>, <b>1</b>, and <b>36</b>, typical for this class, is included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S1">Supporting Information, Table S1</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Bode, C. M.; Cheng, A. C.; Choquette, D.; Lewis, Richard, T.; Potashman, M. H.; Romero, K.; Stellwagen, J. C.; Whittington, D. A.</span><span> </span><span class="NLM_article-title">Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase</span>. PCT Int. Appl. WO 2012018668,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+M.+Bode&author=A.+C.+Cheng&author=D.+Choquette&author=T.+Lewis+Richard&author=M.+H.+Potashman&author=K.+Romero&author=J.+C.+Stellwagen&author=D.+A.+Whittington&title=Benzimidazole+and+azabenzimidazole+compounds+that+inhibit+anaplastic+lymphoma+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DC.%2BM.%26atitle%3DBenzimidazole%2520and%2520azabenzimidazole%2520compounds%2520that%2520inhibit%2520anaplastic%2520lymphoma%2520kinase%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">Point changes with respect to the residues which flank the benzamide moiety are summarized for closely related kinases in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information in Table S2">Supporting Information in Table S2</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">Microsomal turnover protocol: 0.5 mg/mL of protein, 1 μM substrate, 1 mM NADPH, 30 min incubation, pH 7.4, and 37 °C.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><div class="note"><p class="first last">Screen was performed by KINOMEscan, a division of DiscoveRx, 11180 Roselle Street, San Diego. CA 92121 USA; <a href="http://kinomescan.com/" class="extLink">http://kinomescan.com/</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Screen+was+performed+by+KINOMEscan%2C+a+division+of+DiscoveRx%2C+11180+Roselle+Street%2C+San+Diego.+CA+92121+USA%3B+http%3A%2F%2Fkinomescan.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for assay protocol.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><div class="note"><p class="first last">Screen was performed by Carna Biosciences. <a href="https://www.carnabio.com/english/product/search.cgi?mode=profiling" class="extLink">https://www.carnabio.com/english/product/search.cgi?mode=profiling</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Screen+was+performed+by+Carna+Biosciences.+https%3A%2F%2Fwww.carnabio.com%2Fenglish%2Fproduct%2Fsearch.cgi%3Fmode%3Dprofiling."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">Douglas C. Saffran unpublished results. See <a class="ref internalNav" href="#notes-1" aria-label="Figure S1 in the Supporting Information">Figure S1 in the Supporting Information</a> for body weight data associated with the Karpass299 xenograft study.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">Yohannes Teffera unpublished results.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>Details of additional studies will be reported elsewhere. In March 2011, Tesaro, Inc. signed an agreement with Amgen granting Tesaro exclusive worldwide rights for the development, manufacture, commercialization, and distribution of small molecule inhibitors of ALK. For more information, please contact Dr. Mary Lynne Hedley: <a href="http://MLHedley@tesarobio.com" class="extLink"><span class="__cf_email__" data-cfemail="9bd6d7d3fefff7fee2dbeffee8fae9f4f9f2f4b5f8f4f6">[email protected]</span></a></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Details+of+additional+studies+will+be+reported+elsewhere.+In+March+2011%2C+Tesaro%2C+Inc.+signed+an+agreement+with+Amgen+granting+Tesaro+exclusive+worldwide+rights+for+the+development%2C+manufacture%2C+commercialization%2C+and+distribution+of+small+molecule+inhibitors+of+ALK.+For+more+information%2C+please+contact+Dr.+Mary+Lynne+Hedley%3A+MLHedley%40tesarobio.com"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Allen, J. R.; Bourbeau, M. P.; Chen, N.; He, E.; Kunz, R.; Rumfelt, S.</span><span> </span><span class="NLM_article-title">Pyrazine compounds as phosphodiesterase 10 inhibitors and their preparation and use in the treatment of diseases</span>. WO 2010/057121,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+R.+Allen&author=M.+P.+Bourbeau&author=N.+Chen&author=E.+He&author=R.+Kunz&author=S.+Rumfelt&title=Pyrazine+compounds+as+phosphodiesterase+10+inhibitors+and+their+preparation+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DPyrazine%2520compounds%2520as%2520phosphodiesterase%252010%2520inhibitors%2520and%2520their%2520preparation%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Allen, J. R.; Chen, N.; Falsey, J. R.; Frohn, M.; Harrington, P.; He, E.; Kaller, M. R.; Kunz, R.; Mercede, S. J.; Nguyen, T. T.; Pickrell, A. J.; Reichelt, A.; Rumfelt, S.; Rzasa, R. M.; Sham, K.; Siegmund, A. C.; Tegley, C. M.; Yao, G.</span><span> </span><span class="NLM_article-title">Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors</span>. U.S. Patent US 2010/0160280,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+R.+Allen&author=N.+Chen&author=J.+R.+Falsey&author=M.+Frohn&author=P.+Harrington&author=E.+He&author=M.+R.+Kaller&author=R.+Kunz&author=S.+J.+Mercede&author=T.+T.+Nguyen&author=A.+J.+Pickrell&author=A.+Reichelt&author=S.+Rumfelt&author=R.+M.+Rzasa&author=K.+Sham&author=A.+C.+Siegmund&author=C.+M.+Tegley&author=G.+Yao&title=Aminopyridine+and+carboxypyridine+compounds+as+phosphodiesterase+10+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DAminopyridine%2520and%2520carboxypyridine%2520compounds%2520as%2520phosphodiesterase%252010%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Castanedo, G.; Chan, B.; Goldstein, D. M.; Kondru, R. K.; Lucas, M. C.; Palmer, W. S.; Price, S.; Safina, B.; Savy, P. P. A.; Seward, E. M.; Sutherlin, D. P.; Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Preparation of bicyclic pyrimidines as selective inhibitors of the p110 delta isoform of PI3K for treating inflammation, immune diseases, and cancers</span>. WO 2010/138589,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=G.+Castanedo&author=B.+Chan&author=D.+M.+Goldstein&author=R.+K.+Kondru&author=M.+C.+Lucas&author=W.+S.+Palmer&author=S.+Price&author=B.+Safina&author=P.+P.+A.+Savy&author=E.+M.+Seward&author=D.+P.+Sutherlin&author=Z.+K.+Sweeney&title=Preparation+of+bicyclic+pyrimidines+as+selective+inhibitors+of+the+p110+delta+isoform+of+PI3K+for+treating+inflammation%2C+immune+diseases%2C+and+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%26atitle%3DPreparation%2520of%2520bicyclic%2520pyrimidines%2520as%2520selective%2520inhibitors%2520of%2520the%2520p110%2520delta%2520isoform%2520of%2520PI3K%2520for%2520treating%2520inflammation%252C%2520immune%2520diseases%252C%2520and%2520cancers%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOB','PDB','4FOB'); return false;">PDB: 4FOB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOC','PDB','4FOC'); return false;">PDB: 4FOC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LPB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LPB','PDB','3LPB'); return false;">PDB: 3LPB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FOD','PDB','4FOD'); return false;">PDB: 4FOD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2','PDB','2XP2'); return false;">PDB: 2XP2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i67"><a href="/doi/suppl/10.1021/jm3005866">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_83818"></div></div></div></div></div><hr /></hr><p class="last">IC<sub>50</sub> data from which the selectivity ratios are derived for the off-target kinases, together with protocols for in vitro selectivity assays, xenograft study, and X-ray crystallography.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3005866/suppl_file/jm3005866_si_001.pdf">jm3005866_si_001.pdf (201.34 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3005866&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm3005866" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3005866" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6798f39acf99d1d3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
